⚠ Provisional — human review required. Tiers are computationally assigned. Per OSMF Grading Methodology §5, every Tier 1/2 entry must be verified against the source paper before publication.
🦠 Long COVID / PASC

Therapeutic Agents
Long COVID / PASC

Evidence-graded candidate agents from the OSMF discovery pipeline. Click any source count to see linked trial and paper references.

205Agents
201Tier 1 (LC RCT)
2Tier 2 (Related RCT)
2815Source entries
Evidence tiers: T1 — RCT in LC/PASC/PACVS T2 — RCT in related condition T3 — Observational in LC T4 — Case series T5 — Case report T6 — Mechanistic / preclinical
205 agents
11C-PS13
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
  • T1REGISTERED-ONLY NCT06920628 ↗ — PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Seque
ACT-based group therapy
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
  • T1REGISTERED-ONLY NCT06897553 ↗ — ACT for Mental Health in Neurological Disorders
AER002
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
7 sources
  • T1REGISTERED-ONLY NCT05877508 ↗ — Anti-SARS-CoV-2 Monoclonal Antibodies for Long COVID (COVID-19)
  • T6 39947217 ↗ — Targeting the SARS-CoV-2 reservoir in long COVID
  • T6 38432691 ↗ — Emerging anti-spike monoclonal antibodies against SARS-CoV-2
  • T6 42325367 ↗ — Long COVID: current research and future directions
  • T6 PMC12982061 ↗ — Candidate treatments for long COVID: a narrative review of expert and patient-driven priorities
  • T6HARM 38221576 ↗ — A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutrali
  • T6INDIRECT 41357034 ↗ — Exploring the Effects of Pemivibart Monoclonal Antibody Infusion in Long COVID: A Case Series Offeri
ATCell
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
2 sources
  • T1 NCT05669261 ↗ — Treatment of Long COVID Symptoms Utilizing Autologous Stem Cells Following COVID-19 Infection
  • T6 41235241 ↗ — Therapeutic challenges in central nervous system viral infections: advancing mesenchymal stem cell-b
AXA1125
T1
T1 — RCT in LC/PASC/PACVS
Harm signalLong COVID
17 sources
  • T1HARM NCT05152849 ↗ — Efficacy, Safety, Tolerability of AXA1125 in Fatigue After COVID-19 Infection
  • T6INDIRECT 36349400 ↗ — Clinical trials on the pharmacological treatment of long COVID: A systematic review
  • T6INDIRECT 36642173 ↗ — A systematic review of trials currently investigating therapeutic modalities for post-acute COVID-19
  • T6INDIRECT 39356507 ↗ — Lithium Aspartate for Long COVID Fatigue and Cognitive Dysfunction: A Randomized Clinical Trial
  • T6 39326415 ↗ — Mechanisms of long COVID and the path toward therapeutics
  • T6 36969241 ↗ — Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOV
  • T6 37445634 ↗ — Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology
  • T6 37316880 ↗ — Long COVID: Costs for the German economy and health care and pension system
  • T6INDIRECT 38322108 ↗ — Autoimmunity and long COVID in children
  • T6INDIRECT 39536116 ↗ — Translating insights into therapies for Long Covid
  • T6INDIRECT 41928318 ↗ — Living evidence syntheses for long COVID therapeutics: combining rigorous protocols to build efficie
  • T4 PPR664005 ↗ — Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights Into Epidemiology
  • T6 39718498 ↗ — <sup>1</sup>H and <sup>31</sup>P MR Spectroscopy to Assess Muscle Mitochondr
  • T6 40792393 ↗ — Mitochondrial function is impaired in long COVID patients
  • T6 40384184 ↗ — Transforming Niclosamide through Nanotechnology: A Promising Approach for Long COVID Management
  • T6 39382470 ↗ — Long COVID syndrome: An unfolding enigma
  • T6 36369208 ↗ — Long COVID and rheumatology: Clinical, diagnostic, and therapeutic implications
Auricular transcutaneous vagus nerve stimulation
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
3 sources
  • T1 NCT05679505 ↗ — Vagus Nerve Stimulation for Post-COVID Syndrome
  • T1 41927730 ↗ — Post-exercise auricular vagus nerve stimulation modulates autonomic and recovery responses in physic
  • T6 36769845 ↗ — A Prospect to Ameliorate Affective Symptoms and to Enhance Cognition in Long COVID Using Auricular T
Beclomethasone
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
18 sources
  • T1 NCT05970731 ↗ — Directed Topical Drug Delivery for Treatment for PASC Hyposmia
  • T6INDIRECT 40396505 ↗ — Vaccines for preventing infections in adults with haematological malignancies
  • T6INDIRECT 34456675 ↗ — Steroids and Olfactory Training for Postviral Olfactory Dysfunction: A Systematic Review
  • T6INDIRECT 40455452 ↗ — Acceptance and Commitment Therapy-Based Parenting Program in Children With Co-Occurring Asthma and A
  • T6 35096502 ↗ — A Comprehensive Review on Novel Liposomal Methodologies, Commercial Formulations, Clinical Trials an
  • T6 35887512 ↗ — <i>Trichophyton indotineae</i>-An Emerging Pathogen Causing Recalcitrant Dermatophytoses in India an
  • T6 35373533 ↗ — International consensus statement on allergy and rhinology: Olfaction
  • T6INDIRECT 33875508 ↗ — 'Long COVID' syndrome
  • T6HARM 34147798 ↗ — Occurrence and risk assessment of pharmaceuticals and personal care products (PPCPs) against COVID-1
  • T6HARM 38664701 ↗ — The effectiveness of pharmacist-led educational model in adult patients with allergic rhinitis: a si
  • T6INDIRECT 34379888 ↗ — Pediatric P-ANCA vasculitis following COVID-19
  • T6INDIRECT 34810106 ↗ — Post-COVID-19 interstitial lung disease presenting with profound hypoxemia: Report of three cases de
  • T6INDIRECT 37100206 ↗ — Aerosol pulmonary immune engineering
  • T6INDIRECT 36450371 ↗ — Inhaled corticosteroids for the treatment of COVID-19
  • T6 35300976 ↗ — Sex and Gender in Lung Disease and Sleep Disorders: A State-of-the-Art Review
  • T6 39861782 ↗ — Nanosuspension Innovations: Expanding Horizons in Drug Delivery Techniques
  • T6 36243331 ↗ — Glucocorticoids and COVID-19
  • T6 39457048 ↗ — Immunity and Coagulation in COVID-19
CBDRA60 supplement
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT04777981 ↗ — (CBDRA60) to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-Co
CCT Long COVID
T1
T1 — RCT in LC/PASC/PACVS
Harm signalLong COVID
1 source
  • T1HARM NCT05582603 ↗ — Safety and Dosage of a Computerized Cognitive Training Program for Cognitive Dysfunction After COVID
CI-581a
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
3 sources
  • T1REGISTERED-ONLY NCT05690503 ↗ — Glutamatergic Modulation as a Treatment for Depressive Symptoms Among Patients With Post-acute Seque
  • T6 38711990 ↗ — Management of cognitive impairment associated with post-COVID-19 syndrome: recommendations for prima
  • T6 37680987 ↗ — The current landscape of long COVID clinical trials: NIH's RECOVER to Stanford Medicine's STOP-PASC
CI-581b
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
4 sources
  • T1REGISTERED-ONLY NCT05690503 ↗ — Glutamatergic Modulation as a Treatment for Depressive Symptoms Among Patients With Post-acute Seque
  • T6 39828632 ↗ — Loneliness-associated factors among older adults: Focus on friendship type and number of friends
  • T6 32973385 ↗ — Taxonomic revision of the Andean genus <i>Xenophyllum</i> (Compositae, Senecioneae)
  • T6 37680987 ↗ — The current landscape of long COVID clinical trials: NIH's RECOVER to Stanford Medicine's STOP-PASC
CO-OP Procedures
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
COVIDEx
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
11 sources
  • T1REGISTERED-ONLY NCT06156176 ↗ — Pursuing Reduction in Fatigue After COVID-19 Via Exercise and Rehabilitation (PREFACER): A Randomize
  • T6 35165665 ↗ — The Pathogenesis and Long-Term Consequences of COVID-19 Cardiac Injury
  • T6 36671402 ↗ — Bioactivity and In Silico Studies of Isoquinoline and Related Alkaloids as Promising Antiviral Agent
  • T6 35988361 ↗ — Audiological profile of adult Long COVID patients
  • T6 37249533 ↗ — Comparison of High-Intensity Interval Training to Moderate-Intensity Continuous Training for Functio
  • T6 37520616 ↗ — A COVID-19 Search Engine (CO-SE) with Transformer-based architecture
  • T6 41213692 ↗ — Pursuing Reduction in Fatigue After COVID-19 via Exercise and Rehabilitation (PREFACER): a protocol
  • T6INDIRECT 37360228 ↗ — COVID-19 knowledge deconstruction and retrieval: an intelligent bibliometric solution
  • T6 37559650 ↗ — COVID-19 progression in hospitalized patients using follow-up <i>in vivo</i> CT and <i>ex vivo</i> m
  • T6 40063348 ↗ — VITALdb: to select the best viroinformatics tools for a desired virus or application
  • T6 37630599 ↗ — COVID Variants, Villain and Victory: A Bioinformatics Perspective
Cardiac Rehabilitation
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
22 sources
  • T1REGISTERED-ONLY NCT05530317 ↗ — CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVI
  • T6INDIRECT 36223120 ↗ — Use of Cardiopulmonary Exercise Testing to Evaluate Long COVID-19 Symptoms in Adults: A Systematic R
  • T6INDIRECT 36382632 ↗ — Clinical assessment of endothelial function in convalescent COVID-19 patients: a meta-analysis with
  • T6INDIRECT 33284353 ↗ — Rehabilitation setting during and after Covid-19: An overview on recommendations
  • T6INDIRECT 36111511 ↗ — Heart failure during the COVID-19 pandemic: clinical, diagnostic, management, and organizational dil
  • T6INDIRECT 35868671 ↗ — Long COVID-19: The Need for an Interdisciplinary Approach
  • T6INDIRECT 38551518 ↗ — Barriers and facilitators for increased accessibility to quality rehabilitation services in low- and
  • T6INDIRECT 36554860 ↗ — Effectiveness of an Inpatient Virtual Reality-Based Pulmonary Rehabilitation Program among COVID-19
  • T6INDIRECT 38917451 ↗ — Effects of Cardiopulmonary Rehabilitation on Cardiorespiratory Fitness and Clinical Symptom Burden i
  • T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
  • T6 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6 37076602 ↗ — Therapeutic strategies for COVID-19: progress and lessons learned
  • T6INDIRECT 35360229 ↗ — A Useful Blood Flow Restriction Training Risk Stratification for Exercise and Rehabilitation
  • T6INDIRECT 32475821 ↗ — The Stanford Hall consensus statement for post-COVID-19 rehabilitation
  • T6INDIRECT 36202135 ↗ — Clinical guidelines for the use of lifestyle-based mental health care in major depressive disorder:
  • T6INDIRECT 32635468 ↗ — Frailty and COVID-19: A Systematic Scoping Review
  • T6 34200325 ↗ — Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors
  • T6 34368201 ↗ — Serum Metabolic Profile in Patients With Long-Covid (PASC) Syndrome: Clinical Implications
  • T6 37827576 ↗ — Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort
  • T6 33957805 ↗ — Early experiences of rehabilitation for individuals post-COVID to improve fatigue, breathlessness ex
  • T6 35176758 ↗ — Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus
Cardiopulmonary exercise training
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
7 sources
  • T1 NCT05035628 ↗ — Cardiopulmonary Rehabilitation in Long COVID-19 Patients With Persistent Breathlessness and Fatigue
  • T6INDIRECT 36606682 ↗ — Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstr
  • T1 35409815 ↗ — Cardiopulmonary Rehabilitation in Long-COVID-19 Patients with Persistent Breathlessness and Fatigue:
  • T6 36412084 ↗ — Long COVID: mechanisms, risk factors and recovery
  • T6INDIRECT 34435313 ↗ — A spark of hope: histopathological and functional recovery after critical COVID-19
  • T6 41586300 ↗ — Knowledge Gaps and Controversies on Cardiopulmonary Exercise Testing in the Assessment of Pulmonary
  • T6 40943482 ↗ — Precision Medicine Study of Post-Exertional Malaise Epigenetic Changes in Myalgic Encephalomyelitis/
Celecoxib
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVIDPOTS
44 sources
  • T1REGISTERED-ONLY NCT07597902 ↗ — SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction
  • T6INDIRECT 36219278 ↗ — Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen: Comparison of Surveillance Strategies
  • T6INDIRECT 34659109 ↗ — COVID-19-Associated Subacute Thyroiditis: Evidence-Based Data From a Systematic Review
  • T6INDIRECT 35893864 ↗ — The Efficacy of Vitamin D Supplementation in the Treatment of Fibromyalgia Syndrome and Chronic Musc
  • T6INDIRECT 37091856 ↗ — Subacute thyroiditis following COVID-19: A systematic review
  • T6INDIRECT 35395090 ↗ — The development of inflammatory arthritis following SARS-CoV-2 infection: a systematic review of the
  • T6INDIRECT 40597703 ↗ — Subacute thyroiditis as a post-COVID-19 complication: a systematic review
  • T1 37660680 ↗ — Efficacy and safety of celecoxib monotherapy for treatment of moderate depressive symptoms following
  • T6INDIRECT 41562079 ↗ — Patient-reported improvements from use of IMC-2 alone and IMC-2 and Paxlovid&lt;sup&gt;®&lt;/sup&gt;
  • T6 35039676 ↗ — Immune targets for therapeutic development in depression: towards precision medicine
  • T6 23988267 ↗ — Molecular mechanisms underlying chronic inflammation-associated cancers
  • T6 33733315 ↗ — COVID-19 and the clinical course of rheumatic manifestations
  • T6 32840756 ↗ — Pain Management During the COVID-19 Pandemic
  • T6INDIRECT 29926477 ↗ — Local anaesthetics and regional anaesthesia versus conventional analgesia for preventing persistent
  • T6INDIRECT 29694674 ↗ — Local anaesthetics and regional anaesthesia versus conventional analgesia for preventing persistent
  • T6INDIRECT 24683057 ↗ — Pharmacological interventions for prevention or treatment of postoperative pain in people undergoing
  • T6INDIRECT 33179245 ↗ — Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults
  • T6INDIRECT 36269595 ↗ — Antidepressants for hip and knee osteoarthritis
  • T6INDIRECT 31207169 ↗ — The Efficacy, Tolerability, and Joint Safety of Fasinumab in Osteoarthritis Pain: A Phase IIb/III Do
  • T6INDIRECT 31680610 ↗ — Outpatient total hip or knee arthroplasty in ambulatory surgery center versus arthroplasty ward: a r
  • T6INDIRECT 24954491 ↗ — Role of preoperative pain, muscle function, and activity level in discharge readiness after fast-tra
  • T6 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
  • T6INDIRECT 33409010 ↗ — Reactive Arthritis After COVID-19 Infection
  • T6INDIRECT 36969241 ↗ — Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOV
  • T6INDIRECT 33421734 ↗ — The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacol
  • T6INDIRECT 34015983 ↗ — SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives
  • T6INDIRECT 36736220 ↗ — Lung fibrosis: Post-COVID-19 complications and evidences
  • T6 38868666 ↗ — Alzheimer's disease and its treatment-yesterday, today, and tomorrow
  • T6 39861782 ↗ — Nanosuspension Innovations: Expanding Horizons in Drug Delivery Techniques
  • T6 37759498 ↗ — A Molecular Troika of Angiogenesis, Coagulopathy and Endothelial Dysfunction in the Pathology of Ava
  • T6 37251376 ↗ — The chemokine landscape: one system multiple shades
  • T6INDIRECT 26084539 ↗ — International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
  • T6INDIRECT 20357277 ↗ — Pain management in the cirrhotic patient: the clinical challenge
  • T6INDIRECT 27973405 ↗ — Chronic Pain in Children and Adolescents: Diagnosis and Treatment of Primary Pain Disorders in Head,
  • T6INDIRECT 37139824 ↗ — American Geriatrics Society 2023 updated AGS Beers Criteria® for potentially inappropriate medicatio
  • T6INDIRECT 21445724 ↗ — European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological
  • T6INDIRECT 23227356 ↗ — Ehlers-danlos syndrome, hypermobility type: an underdiagnosed hereditary connective tissue disorder
  • T6 20696139 ↗ — Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic dise
  • T6 23588782 ↗ — Applications of CYP450 testing in the clinical setting
  • T6 29315692 ↗ — Comprehensive review of cardiovascular toxicity of drugs and related agents
  • T6 30712918 ↗ — Type 2 diabetes mellitus and osteoarthritis
  • T6 30578418 ↗ — Trans-ethnic association study of blood pressure determinants in over 750,000 individuals
  • T6 30354828 ↗ — Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the Ameri
  • T6 22066560 ↗ — Why still in hospital after fast-track hip and knee arthroplasty?
CogniFit's CCT Post COVID-19
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT05571852 ↗ — Personalized Computerized Training Program for Cognitive Dysfunction After COVID-19
Cold Atmospheric Plasma
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
12 sources
  • T1 NCT07279272 ↗ — The Effect of the Human Regenerator Jet Device on the Quality of Life of Adult Individuals [HR-QoL]
  • T6 40124344 ↗ — Treatment of lung diseases &lt;i&gt;via&lt;/i&gt; nanoparticles and nanorobots: Are these viable alt
  • T6 36421668 ↗ — Review of Developments in Combating COVID-19 by Vaccines, Inhibitors, Radiations, and Nonthermal Pla
  • T6 40843597 ↗ — European S2k Guideline on Chronic Pruritus
  • T6 38257957 ↗ — Cold Atmospheric Helium Plasma in the Post-COVID-19 Era: A Promising Tool for the Disinfection of Si
  • T6 37290960 ↗ — EACR 2023: Innovative Cancer Science, 12-15 June 2023, Torino, Italy
  • T6INDIRECT 41930351 ↗ — Unraveling Chronic Pain: From Mechanisms and Risks to Diagnosis and Treatment
  • T6INDIRECT 40917828 ↗ — Medical gases in respiratory diseases: ozone, argon, and nitric oxide as game-changers in therapeuti
  • T4 PMC10206698 ↗ — E-Poster abstracts
  • T4 PMC9931687 ↗ — Abstracts
  • T4 PMC7650373 ↗ — Full SNO 2020 Abstracts PDF
  • T6 36451994 ↗ — Coronavirus outbreaks and infection prevention in dentistry: a narrative review
Compass 31
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
25 sources
  • T1REGISTERED-ONLY NCT06027255 ↗ — Long COVID Immune Profiling
  • T6INDIRECT 34509649 ↗ — Post-COVID syndrome. A case series and comprehensive review
  • T6INDIRECT 41973314 ↗ — Stellate Ganglion Block in the Treatment of Long COVID: A Systematic Review
  • T6INDIRECT 39987007 ↗ — Exercise rehabilitation for people with postural tachycardia syndrome at two secondary care centres
  • T6INDIRECT 39374820 ↗ — Inspiratory muscle training improves autonomic function in myalgic encephalomyelitis/chronic fatigue
  • T6INDIRECT 36042189 ↗ — A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pand
  • T6INDIRECT 34386903 ↗ — Autonomic dysfunction in post-COVID patients with and witfhout neurological symptoms: a prospective
  • T6 36326545 ↗ — Psychiatric and neurological complications of long COVID
  • T6 34069603 ↗ — European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus
  • T6 36410797 ↗ — HEART rate variability biofeedback for long COVID symptoms (HEARTLOC): protocol for a feasibility st
  • T6 38454468 ↗ — IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in
  • T6INDIRECT 34821709 ↗ — Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know?
  • T6INDIRECT 34265539 ↗ — Preparing for the long-haul: Autonomic complications of COVID-19
  • T6INDIRECT 36580747 ↗ — Investigating the possible mechanisms of autonomic dysfunction post-COVID-19
  • T6INDIRECT 38390594 ↗ — Dysautonomia following Lyme disease: a key component of post-treatment Lyme disease syndrome?
  • T6INDIRECT 33927679 ↗ — COVID-19 Dysautonomia
  • T6 37390745 ↗ — Molecular mimicry and autoimmunity in the time of COVID-19
  • T6 38396973 ↗ — Autoimmune Autonomic Neuropathy: From Pathogenesis to Diagnosis
  • T6 40002491 ↗ — Small-Fiber Neuropathy: An Etiology-Oriented Review
  • T6 38362266 ↗ — Meaningful digital biomarkers derived from wearable sensors to predict daily fatigue in multiple scl
  • T6 38873615 ↗ — Antibody-mediated autoimmunity in symptom-based disorders: position statement and proceedings from a
  • T6 39888240 ↗ — Small fiber neuropathy in the post-COVID condition and Myalgic Encephalomyelitis/Chronic Fatigue Syn
  • T6 39526678 ↗ — Small fiber neuropathy associated with COVID-19 infection and vaccination: A prospective case-contro
  • T6 36283919 ↗ — Long COVID: An inevitable sequela of SARS-CoV-2 infection
  • T6 36353127 ↗ — Characterization of autonomic symptom burden in long COVID: A global survey of 2,314 adults
Complementary and Integrative Medicine online intervention, routine care and book
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT06004362 ↗ — Complementary and Integrative Medicine as an Online Intervention in Patients With Post-covid Syndrom
Complementary self-help strategies in addition to treatment as usual
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT05798221 ↗ — Complementary Self-help Strategies for Patients With Post-COVID-19 Syndrome
Comprehensive Rehabilitation
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
30 sources
  • T1 NCT06156202 ↗ — Evaluating a Comprehensive Multimodal Outpatient Rehabilitation Program for PASC Program to Improve
  • T6INDIRECT 41057923 ↗ — Health-related quality of life in COVID-19 patients: a systematic review and meta-analysis of EQ-5D
  • T6INDIRECT 40083165 ↗ — Effect of pulmonary rehabilitation for patients with long COVID-19: a systematic review and meta-ana
  • T6INDIRECT 35564579 ↗ — Rehabilitation Interventions for Post-Acute COVID-19 Syndrome: A Systematic Review
  • T6INDIRECT 34540862 ↗ — Follow-Ups on Persistent Symptoms and Pulmonary Function Among Post-Acute COVID-19 Patients: A Syste
  • T6INDIRECT 38551518 ↗ — Barriers and facilitators for increased accessibility to quality rehabilitation services in low- and
  • T6INDIRECT 38214046 ↗ — Evidence-based position paper on physical and rehabilitation medicine professional practice for pers
  • T6INDIRECT 39978856 ↗ — Post-Hospitalisation COVID-19 Rehabilitation (PHOSP-R): a randomised controlled trial of exercise-ba
  • T6INDIRECT 36554860 ↗ — Effectiveness of an Inpatient Virtual Reality-Based Pulmonary Rehabilitation Program among COVID-19
  • T6INDIRECT 33831043 ↗ — Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary
  • T6 32817258 ↗ — COVID-19: interim guidance on rehabilitation in the hospital and post-hospital phase from a European
  • T6 34051516 ↗ — Physical and mental health complications post-COVID-19: Scoping review
  • T6 32669623 ↗ — Survivorship after COVID-19 ICU stay
  • T6INDIRECT 36159093 ↗ — Rehabilitation in long COVID-19: A mini-review
  • T6INDIRECT 35968401 ↗ — Post-COVID lung disease(s)
  • T6INDIRECT 34240576 ↗ — Providing rehabilitation to patients recovering from COVID-19: A scoping review
  • T6INDIRECT 34133481 ↗ — Rehabilitation of patients after COVID-19 recovery: An experience at the Physical and Rehabilitation
  • T6INDIRECT 38081885 ↗ — Clinical characteristics of Long COVID patients presenting to a dedicated academic post-COVID-19 cli
  • T6INDIRECT 34160029 ↗ — Apparent Discordance Between the Epidemiology of COVID-19 and Recommended Outcomes and Treatments: A
  • T6 39267913 ↗ — Evaluation of fibroblast activation protein-specific PET/CT in a patient with post-COVID pneumonitis
  • T6 37077114 ↗ — Clinical effectiveness of medical ozone therapy in COVID-19: the evidence and gaps map
  • T6 38579075 ↗ — Advances in the application of traditional Chinese medicine during the COVID-19 recovery period: A r
  • T6 36689040 ↗ — Solanum nigrum L. in COVID-19 and post-COVID complications: a propitious candidate
  • T6 39199317 ↗ — The Physiological Impact of Melatonin, Its Effect on the Course of Diseases and Their Therapy and th
  • T6 35615417 ↗ — ERS International Congress 2021: highlights from the Respiratory Clinical Care and Physiology Assemb
  • T6 36008648 ↗ — World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2022)
  • T6 32396683 ↗ — The SARS-CoV-2/COVID-19 pandemic and challenges in stroke care in India
  • T6 36362782 ↗ — Psychological and Cognitive Effects of Long COVID: A Narrative Review Focusing on the Assessment and
  • T6 38123233 ↗ — Balancing the value and risk of exercise-based therapy post-COVID-19: a narrative review
  • T6 36690948 ↗ — Association between long COVID, functional activity, and health-related quality of life in older adu
Concordant Care Training
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
Controls
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
24 sources
  • T1 NCT04718506 ↗ — Rehabilitation for Post-COVID-19 Syndrome Through a Supervised Exercise Intervention
  • T6INDIRECT 34973396 ↗ — Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis
  • T6INDIRECT 35429399 ↗ — Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analys
  • T6INDIRECT 36215063 ↗ — Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symp
  • T6INDIRECT 36951832 ↗ — Risk Factors Associated With Post-COVID-19 Condition: A Systematic Review and Meta-analysis
  • T6INDIRECT 33760236 ↗ — Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection
  • T6INDIRECT 35121209 ↗ — Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta
  • T6INDIRECT 33661992 ↗ — Population risk factors for severe disease and mortality in COVID-19: A global systematic review and
  • T6INDIRECT 34167876 ↗ — Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A syst
  • T6INDIRECT 35739136 ↗ — Long-COVID in children and adolescents: a systematic review and meta-analyses
  • T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
  • T6 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
  • T6 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6INDIRECT 34024217 ↗ — Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
  • T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6INDIRECT 34687662 ↗ — The 2021 report of the Lancet Countdown on health and climate change: code red for a healthy future
  • T6 38433280 ↗ — NF-κB in biology and targeted therapy: new insights and translational implications
  • T6 36050306 ↗ — Lactate metabolism in human health and disease
  • T6 35927511 ↗ — The roles of extracellular vesicles in the immune system
  • T6 32526206 ↗ — SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
  • T6 37165196 ↗ — Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
  • T6 35132265 ↗ — Long-term cardiovascular outcomes of COVID-19
  • T6 33181098 ↗ — Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies o
  • T6 33431578 ↗ — Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients
Cycling
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
28 sources
  • T1 NCT07454395 ↗ — Is Swimming a More Tolerable Form of Movement for Individuals With Myalgic Encephalomyelitis/ Chroni
  • T6INDIRECT 33760236 ↗ — Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection
  • T6INDIRECT 34192010 ↗ — Changes in physical activity and sedentary behaviours from before to during the COVID-19 pandemic lo
  • T6INDIRECT 35866452 ↗ — Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection
  • T6INDIRECT 36606682 ↗ — Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstr
  • T6INDIRECT 33284353 ↗ — Rehabilitation setting during and after Covid-19: An overview on recommendations
  • T6INDIRECT 33637294 ↗ — Rehabilitation to enable recovery from COVID-19: a rapid systematic review
  • T6INDIRECT 36476156 ↗ — Effects of a concurrent training, respiratory muscle exercise, and self-management recommendations o
  • T6INDIRECT 38573638 ↗ — Functional Limitations and Exercise Intolerance in Patients With Post-COVID Condition: A Randomized
  • T6INDIRECT 34591653 ↗ — Immune signatures underlying post-acute COVID-19 lung sequelae
  • T6 22896693 ↗ — The pancreas cancer microenvironment
  • T6 37165196 ↗ — Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer
  • T6 33431578 ↗ — Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients
  • T6INDIRECT 34687662 ↗ — The 2021 report of the Lancet Countdown on health and climate change: code red for a healthy future
  • T6INDIRECT 34997689 ↗ — Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of Covid-19
  • T6INDIRECT 37748514 ↗ — Distinguishing features of long COVID identified through immune profiling
  • T6INDIRECT 35307156 ↗ — 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocard
  • T6INDIRECT 38123343 ↗ — Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Dise
  • T6INDIRECT 33251093 ↗ — Impact of the COVID-19 pandemic on travel behavior in Istanbul: A panel data analysis
  • T6 24661096 ↗ — Protein design: toward functional metalloenzymes
  • T6 39326415 ↗ — Mechanisms of long COVID and the path toward therapeutics
  • T6 36701528 ↗ — Spin Hyperpolarization in Modern Magnetic Resonance
  • T6 35216672 ↗ — Multiple early factors anticipate post-acute COVID-19 sequelae
  • T6 35434682 ↗ — Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal in
  • T6 35216673 ↗ — A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
  • T6 37977174 ↗ — The 2023 report of the Lancet Countdown on health and climate change: the imperative for a health-ce
  • T6 33243837 ↗ — Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies
  • T6 33288662 ↗ — IgA dominates the early neutralizing antibody response to SARS-CoV-2
DAOIB
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
2 sources
  • T1REGISTERED-ONLY NCT05764538 ↗ — DAOIB for the Treatment of Brain Fog
  • T6 38711990 ↗ — Management of cognitive impairment associated with post-COVID-19 syndrome: recommendations for prima
DMSO-based otic solution with betahistine, dexamethasone, and lidocaine
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT07567274 ↗ — DMSO Dual-Route Therapy for Refractory Tinnitus in Long-COVID and Post-COVID-19 Vaccine Injury
DMSO-based transdermal cream with levocarnitine and N-acetylcysteine
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT07567274 ↗ — DMSO Dual-Route Therapy for Refractory Tinnitus in Long-COVID and Post-COVID-19 Vaccine Injury
Delayed AIM Question and Answer sessions
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
  • T1REGISTERED-ONLY NCT05057676 ↗ — Autoimmune Intervention Mastery Course Study
Delayed Autoimmune Intervention Mastery Course
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
  • T1REGISTERED-ONLY NCT05057676 ↗ — Autoimmune Intervention Mastery Course Study
Dietary and Lifestyle Recommendations
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
3 sources
  • T1REGISTERED-ONLY NCT07627815 ↗ — Evaluating the Safety and Efficacy of PNMR as Treatment for Long COVID
  • T6 38912070 ↗ — Telemedicine in Cardiology: Enhancing Access to Care and Improving Patient Outcomes
  • T6 PMC11470995 ↗ — UEG Week 2024 Poster Presentations
Digital Physiotherapy Practice
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
6 sources
  • T1 NCT04742946 ↗ — Digital Physiotherapy Practice in Long Covid-19 Patients
  • T1 35954922 ↗ — The Effectiveness of a Four-Week Digital Physiotherapy Intervention to Improve Functional Capacity a
  • T6 37444803 ↗ — Effectiveness of Digital Physiotherapy Practice Compared to Usual Care in Long COVID Patients: A Sys
  • T6 37754586 ↗ — Telerehabilitation in Low-Resource Settings to Improve Postural Balance in Older Adults: A Non-Infer
  • T6 38590093 ↗ — Experiences of people with Long Covid with a digital physiotherapy intervention: A qualitative study
  • T6 40422292 ↗ — Telerehabilitation as an innovative strategy for the management of anxiety and dyspnea in post-COVID
Dual Task exercise
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
6 sources
  • T1REGISTERED-ONLY NCT07254377 ↗ — Design and Validation of Innovative Strategies Based on Dual-Task Approach
  • T6 33786571 ↗ — Community-Based Peer-Led Intervention for Healthy Ageing and Evaluation of the 'HAPPY' Program
  • T6 35294921 ↗ — The Acceptability of Digital Technology and Tele-Exercise in the Age of COVID-19: Cross-sectional St
  • T6 32510123 ↗ — Letter to the Editor: The Role of a Geriatrician Has Become Even More Important in an Academic Insti
  • T6 40929575 ↗ — Cycling-Based Telerehabilitation: Acceptability and Feasibility Study
  • T6 PMC12755232 ↗ — Full GSA 2025 Abstract Book PDF
Dynamic neural retraining system
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
3 sources
  • T1REGISTERED-ONLY NCT06933173 ↗ — RCT of Mind-body in Long COVID and Myalgic Encephalomyelitis
  • T6 36982194 ↗ — Towards a Better Understanding of the Complexities of Myalgic Encephalomyelitis/Chronic Fatigue Synd
  • T6INDIRECT 38792737 ↗ — Combining Double-Dose and High-Dose Pulsed Dapsone Combination Therapy for Chronic Lyme Disease/Post
Echinochrome A
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
7 sources
  • T1 NCT05531019 ↗ — COVID-19 Sequelae: Treatment and Monitoring. A Dietary Supplement Based on Sea Urchin Eggs With Echi
  • T6 38282092 ↗ — Marine natural products and human immunity: novel biomedical resources for anti-infection of SARS-Co
  • T6 40722944 ↗ — Post-COVID Condition and Neuroinflammation: Possible Management with Antioxidants
  • T6 PPR713523 ↗ — EuroQol-5D-3L in Long Covid Patients After Supplementation with EchA Marine®, a Sea Urchin Eggs Extr
  • T6 PPR670468 ↗ — EuroQol-5D-3L in Long Covid patients After Supplementation with EchA Marine<sup>®</sup>, a Sea Urchi
  • T6 PPR669788 ↗ — EuroQol-5D-3L in Long Covid patients After Supplementation with EchA Marine®, a Sea Urchin Eggs Extr
  • T4 PMC6031936 ↗ — Posters
Education
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
22 sources
  • T1REGISTERED-ONLY NCT06404060 ↗ — RECOVER-ENERGIZE Platform Protocol_Appendix A (Exercise Intolerance)
  • T1 NCT06404047 ↗ — RECOVER-ENERGIZE Platform Protocol
  • T6INDIRECT 34973396 ↗ — Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis
  • T6INDIRECT 36215063 ↗ — Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symp
  • T6INDIRECT 36951832 ↗ — Risk Factors Associated With Post-COVID-19 Condition: A Systematic Review and Meta-analysis
  • T6INDIRECT 33760236 ↗ — Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection
  • T6INDIRECT 35739136 ↗ — Long-COVID in children and adolescents: a systematic review and meta-analyses
  • T6INDIRECT 34634250 ↗ — Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in
  • T6INDIRECT 34192010 ↗ — Changes in physical activity and sedentary behaviours from before to during the COVID-19 pandemic lo
  • T1 32503818 ↗ — Medical and Surgical Education Challenges and Innovations in the COVID-19 Era: A Systematic Review
  • T6INDIRECT 34339806 ↗ — Psychiatric and neuropsychiatric sequelae of COVID-19 - A systematic review
  • T6INDIRECT 34749198 ↗ — Alcohol and other substance use during the COVID-19 pandemic: A systematic review
  • T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
  • T6 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
  • T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6INDIRECT 32201335 ↗ — Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID
  • T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6 35927511 ↗ — The roles of extracellular vesicles in the immune system
  • T6 39174535 ↗ — Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strateg
  • T6 33965003 ↗ — The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
  • T6 34127835 ↗ — Hypertension-induced cognitive impairment: from pathophysiology to public health
  • T6 35132265 ↗ — Long-term cardiovascular outcomes of COVID-19
Education Packet Training
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
Efgartigimod
T1
T1 — RCT in LC/PASC/PACVS
Harm signalWithdrawnLong COVID
15 sources
  • T1HARM NCT05633407 ↗ — Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS
  • T1WITHDRAWN NCT05918978 ↗ — Open Label Extension of Efgartigimod in Adults With Post-COVID-19 POTS
  • T6 33802650 ↗ — In Translation: FcRn across the Therapeutic Spectrum
  • T6 38617189 ↗ — Structure and function of therapeutic antibodies approved by the US FDA in 2023
  • T6 39736771 ↗ — Platelet signaling in immune landscape: comprehensive mechanism and clinical therapy
  • T6 39189008 ↗ — Cardiovascular disease and covid-19: A systematic review
  • T6 37396922 ↗ — Fighting Post-COVID and ME/CFS - development of curative therapies
  • T5 39820999 ↗ — Efgartigimod treatment for therapy-refractory autoimmune encephalitis with coexistent NMDAR and LGI1
  • T6INDIRECT 38390594 ↗ — Dysautonomia following Lyme disease: a key component of post-treatment Lyme disease syndrome?
  • T6INDIRECT 37204997 ↗ — Postural Orthostatic Tachycardia Syndrome in COVID-19: A Contemporary Review of Mechanisms, Clinical
  • T6INDIRECT 36140251 ↗ — Autoantibodies as Biomarker and Therapeutic Target in Systemic Sclerosis
  • T6INDIRECT 40156757 ↗ — Targeting the Neonatal Fc Receptor in Autoimmune Diseases: Pipeline and Progress
  • T6INDIRECT 41089328 ↗ — Immunotherapies for postural orthostatic tachycardia syndrome, other common autonomic disorders, and
  • T6INDIRECT 37614956 ↗ — Targeting type 2 inflammation in bullous pemphigoid: current and emerging therapeutic approaches
  • T6 39684504 ↗ — Advancing Therapeutic and Vaccine Proteins: Switching from Recombinant to Ribosomal Delivery-A Human
Ensitrelvir
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
23 sources
  • T1REGISTERED-ONLY NCT06161688 ↗ — Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID
  • T6INDIRECT 38314855 ↗ — Favipiravir for treating COVID-19
  • T1 38972603 ↗ — Prevention of post COVID-19 condition by early treatment with ensitrelvir in the phase 3 SCORPIO-SR
  • T1 39960062 ↗ — Ensitrelvir for the Treatment of Nonhospitalized Adults with COVID-19: Results from the SCORPIO-HR,
  • T1 38890511 ↗ — Efficacy and Safety of Ensitrelvir for Asymptomatic or Mild COVID-19: An Exploratory Analysis of a M
  • T6INDIRECT 38197702 ↗ — SARS-CoV-2 viral dynamics in a placebo-controlled phase 2 study of patients infected with the SARS-C
  • T6INDIRECT 40222976 ↗ — Meplazumab, a CD147 antibody, for severe COVID-19: a double-blind, randomized, placebo-controlled, p
  • T6 37076602 ↗ — Therapeutic strategies for COVID-19: progress and lessons learned
  • T6 39326415 ↗ — Mechanisms of long COVID and the path toward therapeutics
  • T6 37173515 ↗ — Accelerating antiviral drug discovery: lessons from COVID-19
  • T6 36969241 ↗ — Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOV
  • T6HARM 37897341 ↗ — The IUPHAR/BPS Guide to PHARMACOLOGY in 2024
  • T5 38333218 ↗ — Case report: Ensitrelvir for treatment of persistent COVID-19 in lymphoma patients: a report of two
  • T6INDIRECT 36603694 ↗ — Nirmatrelvir and COVID-19: development, pharmacokinetics, clinical efficacy, resistance, relapse, an
  • T6INDIRECT 39897928 ↗ — SARS-CoV-2 drug resistance and therapeutic approaches
  • T6INDIRECT 39536116 ↗ — Translating insights into therapies for Long Covid
  • T6INDIRECT 38633552 ↗ — COVID-19: An Update on Epidemiology, Prevention and Treatment, September-2023
  • T6INDIRECT 39379249 ↗ — The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular ther
  • T6INDIRECT 39132824 ↗ — Persistence of an Infectious Form of SARS-CoV-2 After Protease Inhibitor Treatment of Permissive Cel
  • T6 37112923 ↗ — Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagno
  • T6 39947217 ↗ — Targeting the SARS-CoV-2 reservoir in long COVID
  • T6 38771027 ↗ — COVID-19 therapeutics
  • T6 36510683 ↗ — Insights for COVID-19 in 2023
Evidence-Based Informational Support
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
  • T1REGISTERED-ONLY NCT06871293 ↗ — Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19
Exercise
T1
T1 — RCT in LC/PASC/PACVS
RegisteredWithdrawnLong COVIDME/CFS
46 sources
  • T1 NCT04718506 ↗ — Rehabilitation for Post-COVID-19 Syndrome Through a Supervised Exercise Intervention
  • T1REGISTERED-ONLY NCT05566483 ↗ — Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and
  • T1 NCT04841759 ↗ — The Effects of a Multi-factorial Rehabilitation Program for Healthcare Workers Suffering From Post-C
  • T2 NCT04378634 ↗ — Epigenetics of Post-exertional Malaise in Patients With ME/CFS
  • T6WITHDRAWN NCT06065033 ↗ — Exercise Interventions in Post-acute Sequelae of Covid-19
  • T6INDIRECT 34373540 ↗ — More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
  • T6INDIRECT 33760236 ↗ — Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection
  • T6INDIRECT 35739136 ↗ — Long-COVID in children and adolescents: a systematic review and meta-analyses
  • T1 36731907 ↗ — Exercise as medicine for depressive symptoms? A systematic review and meta-analysis with meta-regres
  • T6INDIRECT 34643720 ↗ — Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review
  • T6INDIRECT 34192010 ↗ — Changes in physical activity and sedentary behaviours from before to during the COVID-19 pandemic lo
  • T6INDIRECT 34580069 ↗ — Characterising long COVID: a living systematic review
  • T6INDIRECT 32503818 ↗ — Medical and Surgical Education Challenges and Innovations in the COVID-19 Era: A Systematic Review
  • T6INDIRECT 34339806 ↗ — Psychiatric and neuropsychiatric sequelae of COVID-19 - A systematic review
  • T6INDIRECT 34268556 ↗ — Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review
  • T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
  • T6 33753937 ↗ — Post-acute COVID-19 syndrome
  • T6INDIRECT 32437679 ↗ — Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a syst
  • T6INDIRECT 28089638 ↗ — The effects of acute psychological stress on circulating and stimulated inflammatory markers: A syst
  • T6INDIRECT 22018588 ↗ — Validity of the International Physical Activity Questionnaire Short Form (IPAQ-SF): a systematic rev
  • T6INDIRECT 18287602 ↗ — Surgical versus nonsurgical therapy for lumbar spinal stenosis
  • T6INDIRECT 17119140 ↗ — Surgical vs nonoperative treatment for lumbar disk herniation: the Spine Patient Outcomes Research T
  • T2 21334061 ↗ — Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and spe
  • T6INDIRECT 17119141 ↗ — Surgical vs nonoperative treatment for lumbar disk herniation: the Spine Patient Outcomes Research T
  • T6 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
  • T6 18923511 ↗ — The molecular neurobiology of depression
  • T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6INDIRECT 34024217 ↗ — Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
  • T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6INDIRECT 34687662 ↗ — The 2021 report of the Lancet Countdown on health and climate change: code red for a healthy future
  • T6 33497610 ↗ — Adaptive immunity to SARS-CoV-2 and COVID-19
  • T6 38433280 ↗ — NF-κB in biology and targeted therapy: new insights and translational implications
  • T6 36050306 ↗ — Lactate metabolism in human health and disease
  • T6 35304603 ↗ — Exerkines in health, resilience and disease
  • T6 34248921 ↗ — Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Con
  • T6 34308300 ↗ — Characterizing long COVID in an international cohort: 7 months of symptoms and their impact
  • T6INDIRECT 29016840 ↗ — 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atr
  • T6INDIRECT 19375665 ↗ — Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
  • T6INDIRECT 19713422 ↗ — Guidelines for the diagnosis and management of syncope (version 2009)
  • T6INDIRECT 25266247 ↗ — Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task fo
  • T6 23798298 ↗ — Lack of exercise is a major cause of chronic diseases
  • T6 17493201 ↗ — Geriatric syndromes: clinical, research, and policy implications of a core geriatric concept
  • T6 20201874 ↗ — Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disea
  • T6 29884281 ↗ — Interoception and Mental Health: A Roadmap
  • T6 30496104 ↗ — Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseas
  • T6 23459093 ↗ — The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses
Exercise Therapy
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
27 sources
  • T1REGISTERED-ONLY NCT06042751 ↗ — Psychosomatic, Physical Activity or Both for Post-covid19 Syndrom
  • T1 36731907 ↗ — Exercise as medicine for depressive symptoms? A systematic review and meta-analysis with meta-regres
  • T6INDIRECT 35182760 ↗ — ESCMID rapid guidelines for assessment and management of long COVID
  • T6INDIRECT 37725376 ↗ — Rehabilitation Interventions for Physical Capacity and Quality of Life in Adults With Post-COVID-19
  • T1 37586104 ↗ — Effect of Physical Exercise-Based Rehabilitation on Long COVID: A Systematic Review and Meta-analysi
  • T1 35908659 ↗ — Effect of Pulmonary Rehabilitation Approaches on Dyspnea, Exercise Capacity, Fatigue, Lung Functions
  • T6INDIRECT 36323418 ↗ — Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and me
  • T6INDIRECT 35564579 ↗ — Rehabilitation Interventions for Post-Acute COVID-19 Syndrome: A Systematic Review
  • T6INDIRECT 33637294 ↗ — Rehabilitation to enable recovery from COVID-19: a rapid systematic review
  • T1 36111386 ↗ — Rehabilitation for post-COVID-19 condition through a supervised exercise intervention: A randomized
  • T1 38573638 ↗ — Functional Limitations and Exercise Intolerance in Patients With Post-COVID Condition: A Randomized
  • T6INDIRECT 35079817 ↗ — Chronic Fatigue and Postexertional Malaise in People Living With Long COVID: An Observational Study
  • T6 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
  • T6INDIRECT 34024217 ↗ — Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
  • T6INDIRECT 34997689 ↗ — Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of Covid-19
  • T6INDIRECT 34682909 ↗ — Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): An Overview
  • T6INDIRECT 35853576 ↗ — Postural orthostatic tachycardia syndrome as a sequela of COVID-19
  • T6INDIRECT 34265539 ↗ — Preparing for the long-haul: Autonomic complications of COVID-19
  • T6 34991982 ↗ — An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
  • T6 36412084 ↗ — Long COVID: mechanisms, risk factors and recovery
  • T6 36043493 ↗ — The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid
  • T6 38887284 ↗ — Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease
  • T6 37475124 ↗ — Mitigating neurological, cognitive, and psychiatric sequelae of COVID-19-related critical illness
  • T6 33677650 ↗ — Is postural orthostatic tachycardia syndrome (POTS) a central nervous system disorder?
  • T6 32455961 ↗ — Potential Application of Whole Body Vibration Exercise For Improving The Clinical Conditions of COVI
  • T6 37795783 ↗ — Psychosocial interventions for survivors of rape and sexual assault experienced during adulthood
  • T6 37080828 ↗ — Long COVID: pathophysiological factors and abnormalities of coagulation
Experimental group
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
22 sources
  • T1 NCT05289128 ↗ — EEG as Predictor of HD-tDCS Effectiveness in Long COVID-19
  • T6INDIRECT 33781283 ↗ — Mental burden and its risk and protective factors during the early phase of the SARS-CoV-2 pandemic:
  • T6INDIRECT 33871065 ↗ — Digital interventions for the management of chronic obstructive pulmonary disease
  • T6INDIRECT 35564579 ↗ — Rehabilitation Interventions for Post-Acute COVID-19 Syndrome: A Systematic Review
  • T6INDIRECT 34523128 ↗ — Continuing education meetings and workshops: effects on professional practice and healthcare outcome
  • T6INDIRECT 35414491 ↗ — Telerehabilitation improves physical function and reduces dyspnoea in people with COVID-19 and post-
  • T6INDIRECT 36606682 ↗ — Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstr
  • T6INDIRECT 36111386 ↗ — Rehabilitation for post-COVID-19 condition through a supervised exercise intervention: A randomized
  • T6INDIRECT 36191860 ↗ — Home-based respiratory muscle training on quality of life and exercise tolerance in long-term post-C
  • T6INDIRECT 35489367 ↗ — An online breathing and wellbeing programme (ENO Breathe) for people with persistent symptoms follow
  • T6INDIRECT 35450527 ↗ — Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Tr
  • T6 37848036 ↗ — Serotonin reduction in post-acute sequelae of viral infection
  • T6INDIRECT 37365191 ↗ — Neuropsychological deficits in patients with persistent COVID-19 symptoms: a systematic review and m
  • T6INDIRECT 33520961 ↗ — A Review on Modifications of Amniotic Membrane for Biomedical Applications
  • T6INDIRECT 34123972 ↗ — Coronavirus Disease 2019 in Children
  • T6INDIRECT 37695464 ↗ — Virtual and augmented reality in intensive care medicine: a systematic review
  • T6INDIRECT 36458984 ↗ — Brain functional connectivity alterations associated with neuropsychological performance 6-9 months
  • T6 34133077 ↗ — Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-1
  • T6 34624208 ↗ — Role of miR-2392 in driving SARS-CoV-2 infection
  • T6 39198643 ↗ — Fibrin drives thromboinflammation and neuropathology in COVID-19
  • T6 31121312 ↗ — The inclusion of zinc into mineralized collagen scaffolds for craniofacial bone repair applications
  • T6 37919524 ↗ — SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-γ and NK cells
Experimental group/ Active HD-tDCS
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT05289115 ↗ — Protocol for Assistance to Patients With Long Covid-19 Undergoing Treatment With HD-tDCS
Experimental: Paxlovid 15 day dosing
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT05595369 ↗ — RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptom
Experimental: Paxlovid 25 day dosing
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT05595369 ↗ — RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptom
Extension for Community Healthcare Outcomes
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
23 sources
  • T1REGISTERED-ONLY NCT05167227 ↗ — Does a Technology Enabled Multi-disciplinary Team-based Care Model for the Management of Long COVID
  • T6INDIRECT 39856560 ↗ — Ten pressure points in primary care during COVID-19: findings from an international narrative review
  • T6 36063284 ↗ — HIV Care Meets Telehealth: a Review of Successes, Disparities, and Unresolved Challenges
  • T6 38145115 ↗ — Pandemic telehealth flexibilities for buprenorphine treatment: a synthesis of evidence and policy im
  • T6 34511221 ↗ — Telemedicine and current clinical practice trends in the COVID-19 pandemic
  • T6 32535870 ↗ — Surgical Oncologists and the COVID-19 Pandemic: Guiding Cancer Patients Effectively through Turbulen
  • T6 36194041 ↗ — Appropriate Use of Telehealth Visits in Endocrinology: Policy Perspective of the Endocrine Society
  • T6 37573421 ↗ — A technology-enabled multi-disciplinary team-based care model for the management of Long COVID and o
  • T6INDIRECT 38093376 ↗ — Professional care workforce: a rapid review of evidence supporting methods of recruitment, retention
  • T6INDIRECT 36082018 ↗ — Using Peer Power to Reduce Health Disparities: Implementation of a Diabetes Support Coach Program in
  • T6INDIRECT 34297318 ↗ — Abstracts from the 2021 Annual Meeting of the Society of General Internal Medicine
  • T6INDIRECT 35669936 ↗ — Postacute Sequelae of SARS-CoV-2 Infection-Lessons Learned From a Coordinated Health System Response
  • T6INDIRECT 36714541 ↗ — Implementation and impacts of virtual team-based care planning for older persons in formal care sett
  • T6INDIRECT 37577254 ↗ — Mentoring approaches in a safe surgery program in Tanzania: Lessons learned during COVID-19 and reco
  • T6INDIRECT 37265709 ↗ — Connecting Behavioral Health Specialists With Schools: Adapting a Telementoring Series During COVID-
  • T6 35572020 ↗ — Canadian Conference on Medical Education 2022 abstracts
  • T6 35991483 ↗ — Annual Meeting of the Canadian Association for the Study of the Liver (CASL), the Canadian Network o
  • T6 34926835 ↗ — Program Abstracts from The GSA 2021 Annual Scientific Meeting, "Disruption to Transformation: Aging
  • T6 40986224 ↗ — World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2025)
  • T6 PMC8105566 ↗ — Canadian Conference on Medical Education 2021 Abstracts Les résumés de la Conférence canadienne sur
  • T6 PMC12755232 ↗ — Full GSA 2025 Abstract Book PDF
  • T6 34066829 ↗ — A Narrative Review of Factors Historically Influencing Telehealth Use across Six Medical Specialties
  • T6 38449917 ↗ — Burnout, Compassion Fatigue, and the Long Haul of Caring for Long COVID
Flavonoids
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
24 sources
  • T1 NCT06064838 ↗ — Effects of Cacao Flavonoids in Long COVID-19 Patients (FLALOC)
  • T6INDIRECT 35455977 ↗ — Systematic Review of the Common Pathophysiological Mechanisms in COVID-19 and Neurodegeneration: The
  • T6INDIRECT 36204816 ↗ — Genetics of COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review
  • T6INDIRECT 36035707 ↗ — Mainstreaming orphan millets for advancing climate smart agriculture to secure nutrition and health
  • T6INDIRECT 36439263 ↗ — Cys-loop receptors on cannabinoids: All high?
  • T6INDIRECT 40822451 ↗ — Exploring the clinical effects of &lt;i&gt;Andrographis paniculata&lt;/i&gt;-derived compounds, its
  • T6INDIRECT 36505757 ↗ — The Effect of Pomegranate Juice and Sumac Consumption in the Treatment of Outpatients with COVID-19
  • T6INDIRECT 37891178 ↗ — Standardized Brazilian green propolis extract (EPP-AF®) in COVID-19 outcomes: a randomized double-bl
  • T6INDIRECT 39940991 ↗ — Mitochondria-Derived Vesicles and Inflammatory Profiles of Adults with Long COVID Supplemented with
  • T6INDIRECT 35276467 ↗ — Efficacy of a multiple-indication antiviral herbal drug (Saliravira®) for COVID-19 outpatients: A pr
  • T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
  • T6 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6 35566252 ↗ — Flavonoids as Potential Anti-Inflammatory Molecules: A Review
  • T6INDIRECT 38378653 ↗ — Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatme
  • T6INDIRECT 36364899 ↗ — A Comprehensive Review on Nutraceuticals: Therapy Support and Formulation Challenges
  • T6INDIRECT 32455612 ↗ — Novel Coronavirus (COVID-19) and Dentistry-A Comprehensive Review of Literature
  • T6INDIRECT 36464706 ↗ — Small molecules in the treatment of COVID-19
  • T6INDIRECT 37298527 ↗ — Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeut
  • T6INDIRECT 33421734 ↗ — The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacol
  • T6 37359549 ↗ — The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to
  • T6 21526386 ↗ — Engineering microbial factories for synthesis of value-added products
  • T6 36198912 ↗ — COVID-19 and cellular senescence
  • T6 35874958 ↗ — Long COVID and its Management
  • T6 33847020 ↗ — Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue
Follow Up Phone Calls
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVIDME/CFS
43 sources
  • T1REGISTERED-ONLY NCT06095297 ↗ — Long COVID Brain Fog: Cognitive Rehabilitation Trial
  • T2REGISTERED-ONLY NCT07523113 ↗ — ME/CFS Brain Fog: Cognitive Rehabilitation Trial
  • T6INDIRECT 37299488 ↗ — Effectiveness of Lifestyle Nutrition and Physical Activity Interventions for Childhood Obesity and A
  • T6INDIRECT 38847297 ↗ — Integrated care models for youth mental health: A systematic review and meta-analysis
  • T6INDIRECT 35902951 ↗ — Impact of the COVID-19 pandemic on suicidal attempts and death rates: a systematic review
  • T6INDIRECT 34857029 ↗ — Clinical and cost-effectiveness of a New psychosocial intervention to support Independence in Dement
  • T6INDIRECT 36056378 ↗ — Research interrupted: applying the CONSERVE 2021 Statement to a randomized trial of rehabilitation d
  • T6INDIRECT 37739466 ↗ — Dietary supplements to reduce symptom severity and duration in people with SARS-CoV-2: a double-blin
  • T1 38312212 ↗ — Pulmonary Function and Survival 1 Year After Dupilumab Treatment of Acute Moderate to Severe Coronav
  • T6 34162913 ↗ — Acute and persistent symptoms in non-hospitalized PCR-confirmed COVID-19 patients
  • T6 34874962 ↗ — Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: A cohort
  • T6 36512382 ↗ — 'I don't know what to do or where to go'. Experiences of accessing healthcare support from the persp
  • T6 34861604 ↗ — Long term predictors of breathlessness, exercise intolerance, chronic fatigue and well-being in hosp
  • T6 38580370 ↗ — Personalised Exercise-Rehabilitation FOR people with Multiple long-term conditions (PERFORM): protoc
  • T6INDIRECT 29376559 ↗ — Physical activity for women with breast cancer after adjuvant therapy
  • T6INDIRECT 27883365 ↗ — Educational interventions for the management of cancer-related fatigue in adults
  • T6INDIRECT 34532852 ↗ — Cannabinoids for the treatment of dementia
  • T6INDIRECT 28854852 ↗ — Effects of Self-Management Interventions in Patients With Irritable Bowel Syndrome: Systematic Revie
  • T6INDIRECT 28931531 ↗ — Clinical and cost-effectiveness of the Lightning Process in addition to specialist medical care for
  • T6INDIRECT 26179651 ↗ — Assessing Cognitive behavioural Therapy in Irritable Bowel (ACTIB): protocol for a randomised contro
  • T6INDIRECT 24304689 ↗ — The feasibility and acceptability of conducting a trial of specialist medical care and the Lightning
  • T6INDIRECT 35671133 ↗ — Reframe the pain: Divided attention and positive memory reframing to reduce needle pain and distress
  • T6INDIRECT 24315246 ↗ — Early experience with a brief, multimodal, multidisciplinary treatment program for fibromyalgia
  • T6 35940683 ↗ — Optimal Emergency Department Care Practices for Persons Living With Dementia: A Scoping Review
  • T6INDIRECT 33653852 ↗ — Treatment of unexplained coma and hypokinetic-rigid syndrome in a patient with COVID-19
  • T6INDIRECT 33313986 ↗ — ESICM LIVES 2020
  • T6INDIRECT 35859555 ↗ — Immediate and short-term prevalence of depression in covid-19 patients and its correlation with cont
  • T6 35747260 ↗ — Cost and Satisfaction Implications of Using Telehealth for Plagiocephaly
  • T6 38350825 ↗ — Fourth Controlled Human Infection Model (CHIM) meeting - CHIMs in endemic countries, May 22-23, 2023
  • T6 40542608 ↗ — Special Issue: Abstracts of the 11&lt;sup&gt;th&lt;/sup&gt; Congress of the European Academy of Neur
  • T6 41386990 ↗ — Canadian Spine Society: 25th Annual Scientific Conference, February 25 to 28, 2025, Fairmont Le Mano
  • T6 35122083 ↗ — Editorial: Post Acute Care for Frail Older Persons: Time for a Standardized Model of Care
  • T6 PMC13111897 ↗ — 2026 International Congress Abstract Supplement
  • T6 34551007 ↗ — SARS-CoV-2 pneumonia follow-up and long COVID in primary care: A retrospective observational study i
  • T6INDIRECT 29196279 ↗ — Using mHealth Technology in a Self-Management Intervention to Promote Physical Activity Among Adults
  • T6INDIRECT 25869016 ↗ — Abstracts from the 38th annual meeting of the society of general internal medicine
  • T6INDIRECT 32725471 ↗ — Abstracts from the 2020 Annual Meeting of the Society of General Internal Medicine
  • T6INDIRECT 36365042 ↗ — The Troublesome Ticks Research Protocol: Developing a Comprehensive, Multidiscipline Research Plan f
  • T6INDIRECT 30480124 ↗ — Program Abstracts from the 21st International Association of Gerontology and Geriatrics (IAGG) World
  • T6 28156288 ↗ — Proceedings of the 15th International Congress on Circumpolar Health
  • T6 24085684 ↗ — Abstracts of the 2013 Annual Meeting of the American College of Rheumatology. October 25-30, 2013. S
  • T6 36832443 ↗ — Developmental Pathway Choices of Young People Presenting to a Gender Service with Gender Distress: A
  • T6 36471349 ↗ — Personalised rehabilitation to improve return to work in patients with persistent spinal pain syndro
Freeze Dried Potato Starch Capsule
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
  • T1REGISTERED-ONLY NCT05227170 ↗ — Impact of Lp299v on Vascular Function in Patients With PASC
Functional and cognitive rehabilitation strategy
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
  • T1REGISTERED-ONLY NCT06871293 ↗ — Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19
HB-adMSCs
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
16 sources
  • T1 NCT05126563 ↗ — Randomized Double-Blind Phase 2 Study of Allogeneic HB-adMSCs for the Treatment of Chronic Post-COVI
  • T6INDIRECT 35782071 ↗ — Association between Mesenchymal Stem Cells and COVID-19 Therapy: Systematic Review and Current Trend
  • T6 35187617 ↗ — Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical app
  • T6 35897770 ↗ — Immunomodulation of Mesenchymal Stem Cells in Acute Lung Injury: From Preclinical Animal Models to T
  • T6 39144566 ↗ — Emerging Landscape of Mesenchymal Stem Cell Senescence Mechanisms and Implications on Therapeutic St
  • T6 36600055 ↗ — Critical roles of cytokine storm and bacterial infection in patients with COVID-19: therapeutic pote
  • T6 37395459 ↗ — Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem Cells in COVID-19 Treatment
  • T6INDIRECT 38005826 ↗ — Immune-Cell-Based Therapy for COVID-19: Current Status
  • T6INDIRECT 41235241 ↗ — Therapeutic challenges in central nervous system viral infections: advancing mesenchymal stem cell-b
  • T6INDIRECT 35426198 ↗ — Stem Cell-based therapies for COVID-19-related acute respiratory distress syndrome
  • T6INDIRECT 42325370 ↗ — Viral persistence in long COVID: Research advances and treatment strategies
  • T6INDIRECT 42024210 ↗ — Abstracts Presented at the 32nd Annual Conference of the International Society for Quality of Life R
  • T4 PMC11245638 ↗ — ISEV2024 Abstract Book
  • T4 PMC9662107 ↗ — 46th Annual Conference of AOMSI
  • T6 34831101 ↗ — Molecular Mechanisms of Multi-Organ Failure in COVID-19 and Potential of Stem Cell Therapy
  • T6 35174448 ↗ — Stem cell therapy for COVID-19 pneumonia
HOBSCOTCH-PACS
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
  • T1REGISTERED-ONLY NCT06391489 ↗ — HOBSCOTCH for People With Post Acute COVID-19 Syndrome (PACS)
Health Education
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
26 sources
  • T1REGISTERED-ONLY NCT05890599 ↗ — Yoga Versus Health Education for the Treatment of Persistent Fatigue in Patients With Post COVID-19
  • T6INDIRECT 36731907 ↗ — Exercise as medicine for depressive symptoms? A systematic review and meta-analysis with meta-regres
  • T6INDIRECT 34807630 ↗ — Changes in alcohol use during COVID-19 and associations with contextual and individual difference va
  • T6INDIRECT 33766163 ↗ — Prevalence of depressive symptoms among Chinese university students amid the COVID-19 pandemic: a sy
  • T6INDIRECT 33871065 ↗ — Digital interventions for the management of chronic obstructive pulmonary disease
  • T1 36634261 ↗ — The Usability, Feasibility, Acceptability, and Efficacy of Digital Mental Health Services in the COV
  • T6INDIRECT 36978166 ↗ — Ethnic minority representation in UK COVID-19 trials: systematic review and meta-analysis
  • T6INDIRECT 37391766 ↗ — Growing old in China in socioeconomic and epidemiological context: systematic review of social care
  • T6INDIRECT 36606682 ↗ — Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstr
  • T1 34693988 ↗ — Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pu
  • T6INDIRECT 32454187 ↗ — Review of trials currently testing treatment and prevention of COVID-19
  • T6 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T4 35390342 ↗ — The Lancet Global Health Commission on financing primary health care: putting people at the centre
  • T4 34315427 ↗ — COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID
  • T4 32685700 ↗ — Germany's digital health reforms in the COVID-19 era: lessons and opportunities for other countries
  • T6INDIRECT 32745693 ↗ — Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus
  • T6INDIRECT 38123343 ↗ — Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Dise
  • T4 35331261 ↗ — Health care workers' experiences during the COVID-19 pandemic: a scoping review
  • T6 37907497 ↗ — The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of lon
  • T6 39419055 ↗ — Global health 2050: the path to halving premature death by mid-century
  • T6 33909761 ↗ — Brazilian Guidelines of Hypertension - 2020
  • T6 36115368 ↗ — The Lancet Commission on lessons for the future from the COVID-19 pandemic
  • T6 32760367 ↗ — Impact of Vaccines; Health, Economic and Social Perspectives
  • T6 37777291 ↗ — The need to promote sleep health in public health agendas across the globe
  • T6 35338841 ↗ — The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact,
Heat therapy
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
17 sources
  • T1REGISTERED-ONLY NCT06928116 ↗ — Heat thErapy And mobiLity in COVID-19 Survivors
  • T6 38231996 ↗ — Recent Advances in Micro- and Nano-Drug Delivery Systems Based on Natural and Synthetic Biomaterials
  • T6 36376534 ↗ — Updates on the Diagnosis and Treatment of Peripheral Autonomic Neuropathies
  • T6 38813611 ↗ — Socioeconomic status as a potential mediator of arterial aging in marginalized ethnic and racial gro
  • T6 39379918 ↗ — Sex-specific differences of cardiopulmonary fitness and pulmonary function in exercise-based rehabil
  • T6 32840677 ↗ — 56<sup>th</sup> EASD Annual Meeting of the European Association for the Study of Diabetes : 21-25 Se
  • T6INDIRECT 36412591 ↗ — A Multimodal Approach in the Treatment of Persistent Post-COVID
  • T6INDIRECT 37366663 ↗ — Treatments of COVID-19-Associated Taste and Saliva Secretory Disorders
  • T6INDIRECT 36008648 ↗ — World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2022)
  • T6INDIRECT 36467817 ↗ — COVID-19 infection and pain in adolescents with sickle cell disease: A case series
  • T6INDIRECT 41091675 ↗ — Return-to-work for people living with long COVID: A scoping review of interventions and recommendati
  • T6INDIRECT 40986224 ↗ — World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2025)
  • T6 41598223 ↗ — Sarcopenia as a Multisystem Disorder-Connections with Neural and Cardiovascular Systems-A Related PR
  • T6 42293373 ↗ — Thermal stress: an untapped potential in rehabilitation? An opinion paper on Finnish sauna and whole
  • T6 36972259 ↗ — Influence of high-energy laser therapy to the patellar tendon on its ligamentous microcirculation: A
  • T6 40724716 ↗ — Healthcare Interventions in the Management of Rheumatic Diseases: A Narrative Analysis of Effectiven
  • T6 37190098 ↗ — A Preliminary Study of Mild Heat Stress on Inflammasome Activation in Murine Macrophages
Hi-Ox device
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
  • T1REGISTERED-ONLY NCT06928506 ↗ — Effect of Hi-OxSR for the Treatment of Post COVID Condition
Hi-OxSR device
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
  • T1REGISTERED-ONLY NCT06928506 ↗ — Effect of Hi-OxSR for the Treatment of Post COVID Condition
Home-based physical training
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
3 sources
  • T1 NCT05360563 ↗ — Home-based Exercise Program in Patients With the Post-COVID-19 Condition
  • T6 37288400 ↗ — Impact of Covid-19 lockdown on sleep quality, physical activity, and body weight among university st
  • T6 40423283 ↗ — Return-to-Play Timeline and Recovery Predictors After COVID-19 Infection in Elite Football Players
Hydroxy gas
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT06159296 ↗ — Effect of Inhaled Hydroxy Gas on Long COVID Symptoms
IVIG + Coordinated Care
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
2 sources
  • T1 NCT06305780 ↗ — RECOVER-AUTONOMIC Platform Protocol
  • T6 PMC12982061 ↗ — Candidate treatments for long COVID: a narrative review of expert and patient-driven priorities
Ibudilast
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
13 sources
  • T1 NCT05513560 ↗ — RECLAIM: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine
  • T6INDIRECT 39446164 ↗ — Pentoxifylline in COVID-19 and considerations for its research in long COVID
  • T6INDIRECT 38783390 ↗ — Efficacy of intrathecal mesenchymal stem cell-neural progenitor therapy in progressive MS: results f
  • T6 37076602 ↗ — Therapeutic strategies for COVID-19: progress and lessons learned
  • T6 33240091 ↗ — Challenges for Drug Repurposing in the COVID-19 Pandemic Era
  • T6 36969241 ↗ — Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOV
  • T6HARM 33421734 ↗ — The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacol
  • T6 37396922 ↗ — Fighting Post-COVID and ME/CFS - development of curative therapies
  • T6INDIRECT 39536116 ↗ — Translating insights into therapies for Long Covid
  • T6INDIRECT 39599909 ↗ — Beyond Antivirals: Alternative Therapies for Long COVID
  • T4 PMC11627187 ↗ — ACNP 63rd Annual Meeting: Poster Abstracts P305-P608
  • T6 38611624 ↗ — Long COVID: Long-Term Impact of SARS-CoV2
  • T6 38622939 ↗ — Review of COVID-19 Therapeutics by Mechanism: From Discovery to Approval
IgPro20
T1
T1 — RCT in LC/PASC/PACVS
WithdrawnLong COVID
2 sources
  • T1WITHDRAWN NCT06524739 ↗ — Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in Post
  • T6 41089328 ↗ — Immunotherapies for postural orthostatic tachycardia syndrome, other common autonomic disorders, and
Immediate Autoimmune Intervention Mastery Course
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
  • T1REGISTERED-ONLY NCT05057676 ↗ — Autoimmune Intervention Mastery Course Study
Immediate Question and Answer sessions.
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
  • T1REGISTERED-ONLY NCT05057676 ↗ — Autoimmune Intervention Mastery Course Study
Immulina TM
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT05524532 ↗ — Effects of Immulina TM Supplements With PASC Patients
Immunoadsorption
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
24 sources
  • T1 NCT05710770 ↗ — Immunoadsorption in Patients With Chronic Fatigue Syndrome Including Patients With Post-COVID-19 CFS
  • T6INDIRECT 38459000 ↗ — Possible temporal relationship between SARS-CoV-2 infection and anti-NMDA receptor encephalitis: a m
  • T6INDIRECT 39994269 ↗ — Plasma exchange therapy for the post COVID-19 condition: a phase II, double-blind, placebo-controlle
  • T1 36719401 ↗ — Immunoadsorption to treat patients with severe post-COVID syndrome
  • T6 38534355 ↗ — Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders
  • T6 33880442 ↗ — Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID
  • T6 33668514 ↗ — Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestatio
  • T6 37662515 ↗ — Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: result
  • T6 35806214 ↗ — Long COVID: Association of Functional Autoantibodies against G-Protein-Coupled Receptors with an Imp
  • T6 38454468 ↗ — IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in
  • T6 40176165 ↗ — Immunoadsorption study Mainz in adults with post-COVID syndrome (IAMPOCO)-a single-blinded sham-cont
  • T6INDIRECT 37002488 ↗ — Immunopathogenesis and immunomodulatory therapy for myocarditis
  • T6INDIRECT 39240417 ↗ — Towards an understanding of physical activity-induced post-exertional malaise: Insights into microva
  • T6INDIRECT 38256459 ↗ — Advancing Research and Treatment: An Overview of Clinical Trials in Myalgic Encephalomyelitis/Chroni
  • T6INDIRECT 36298623 ↗ — COVID-19 Vaccine-Associated Optic Neuropathy: A Systematic Review of 45 Patients
  • T6INDIRECT 37007494 ↗ — Review of therapeutic mechanisms and applications based on SARS-CoV-2 neutralizing antibodies
  • T6INDIRECT 37388279 ↗ — Long COVID: Complications, Underlying Mechanisms, and Treatment Strategies
  • T6INDIRECT 37396922 ↗ — Fighting Post-COVID and ME/CFS - development of curative therapies
  • T6 38510714 ↗ — Diagnostic and Therapeutic Aptamers: A Promising Pathway to Improved Cardiovascular Disease Manageme
  • T6 36431053 ↗ — A Review Pertaining to SARS-CoV-2 and Autoimmune Diseases: What Is the Connection?
  • T6 39727052 ↗ — Key Pathophysiological Role of Skeletal Muscle Disturbance in Post COVID and Myalgic Encephalomyelit
  • T6 39351782 ↗ — Antibodies in neurological diseases: Established, emerging, explorative
  • T6 36140251 ↗ — Autoantibodies as Biomarker and Therapeutic Target in Systemic Sclerosis
  • T6 34263741 ↗ — Pathomechanisms and possible interventions in myalgic encephalomyelitis/chronic fatigue syndrome (ME
In-lab Brain Health Training
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
  • T1REGISTERED-ONLY NCT06095297 ↗ — Long COVID Brain Fog: Cognitive Rehabilitation Trial
In-lab Instrumental Activities of Living Training
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
  • T1REGISTERED-ONLY NCT06095297 ↗ — Long COVID Brain Fog: Cognitive Rehabilitation Trial
Inspiratory muscle training
T1
T1 — RCT in LC/PASC/PACVS
Long COVIDME/CFS
41 sources
  • T1 NCT04718506 ↗ — Rehabilitation for Post-COVID-19 Syndrome Through a Supervised Exercise Intervention
  • T2 NCT05196529 ↗ — Inspiratory Muscle Training in ME/CFS and COVID-19 Survivors
  • T6 NCT05024474 ↗ — Effects of Inspiratory Muscle Training After Covid-19 (ReCOV)
  • T6INDIRECT 37725376 ↗ — Rehabilitation Interventions for Physical Capacity and Quality of Life in Adults With Post-COVID-19
  • T6INDIRECT 34523128 ↗ — Continuing education meetings and workshops: effects on professional practice and healthcare outcome
  • T6INDIRECT 35265644 ↗ — Effect of Pulmonary Rehabilitation for Patients With Post-COVID-19: A Systematic Review and Meta-Ana
  • T1 36606682 ↗ — Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstr
  • T6INDIRECT 39603702 ↗ — Interventions for the management of long covid (post-covid condition): living systematic review
  • T1 35236727 ↗ — Inspiratory muscle training enhances recovery post-COVID-19: a randomised controlled trial
  • T6INDIRECT 36111386 ↗ — Rehabilitation for post-COVID-19 condition through a supervised exercise intervention: A randomized
  • T6INDIRECT 36476156 ↗ — Effects of a concurrent training, respiratory muscle exercise, and self-management recommendations o
  • T6INDIRECT 36191860 ↗ — Home-based respiratory muscle training on quality of life and exercise tolerance in long-term post-C
  • T6INDIRECT 35409815 ↗ — Cardiopulmonary Rehabilitation in Long-COVID-19 Patients with Persistent Breathlessness and Fatigue:
  • T6INDIRECT 35203084 ↗ — Outpatient Pulmonary Rehabilitation in Patients with Long COVID Improves Exercise Capacity, Function
  • T6 36412084 ↗ — Long COVID: mechanisms, risk factors and recovery
  • T6INDIRECT 26358158 ↗ — Exercise therapy for fatigue in multiple sclerosis
  • T6INDIRECT 37651553 ↗ — Interventions for fatigue in people with kidney failure requiring dialysis
  • T6INDIRECT 35768406 ↗ — Interventions for mental health, cognition, and psychological wellbeing in long COVID: a systematic
  • T6INDIRECT 38214047 ↗ — Rehabilitation and COVID-19: systematic review by Cochrane Rehabilitation
  • T6INDIRECT 37344767 ↗ — Clinical effectiveness of rehabilitation in ambulatory care for patients with persisting symptoms af
  • T6INDIRECT 25753362 ↗ — Protocol for the PREHAB study-Pre-operative Rehabilitation for reduction of Hospitalization After co
  • T6 31092666 ↗ — PREhabilitation for improving QUality of recovery after ELective cardiac surgery (PREQUEL) study: pr
  • T6INDIRECT 36130789 ↗ — Effectiveness of home-based pulmonary rehabilitation: systematic review and meta-analysis
  • T6INDIRECT 37193738 ↗ — Effectiveness of a telerehabilitation intervention using ReCOVery APP of long COVID patients: a rand
  • T6INDIRECT 36560801 ↗ — Efficacy of Therapeutic Exercise in Reversing Decreased Strength, Impaired Respiratory Function, Dec
  • T6INDIRECT 36198415 ↗ — The effects of COVID-19 on respiratory muscle performance: making the case for respiratory muscle te
  • T6INDIRECT 33364571 ↗ — Pulmonary Rehabilitation in COVID-19 patients: A scoping review of current practice and its applicat
  • T6 37907497 ↗ — The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of lon
  • T6 35416359 ↗ — Muscle dysfunction in the long coronavirus disease 2019 syndrome: Pathogenesis and clinical approach
  • T6 34066560 ↗ — Probiotics, Photobiomodulation, and Disease Management: Controversies and Challenges
  • T6 35615417 ↗ — ERS International Congress 2021: highlights from the Respiratory Clinical Care and Physiology Assemb
  • T6 40724982 ↗ — Pulmonary Embolism in Acute Ischaemic Stroke: Evolving Evidence, Diagnostic Challenges, and a Novel
  • T6 37099534 ↗ — Battling the unknown: Using composite vignettes to portray lived experiences of COVID-19 and long-CO
  • T6 37216955 ↗ — Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical c
  • T6INDIRECT 39010975 ↗ — Evidence for exercise-based interventions across 45 different long-term conditions: an overview of s
  • T6INDIRECT 34160029 ↗ — Apparent Discordance Between the Epidemiology of COVID-19 and Recommended Outcomes and Treatments: A
  • T6INDIRECT 39663173 ↗ — Defining and measuring long COVID fatigue: a scoping review
  • T6INDIRECT 39337079 ↗ — A Pilot Study on the Effects of Exercise Training on Cardiorespiratory Performance, Quality of Life,
  • T6INDIRECT 34633571 ↗ — ESICM LIVES 2021: Part 2
  • T6 38999923 ↗ — The Effect of Physical Activity/Exercise on miRNA Expression and Function in Non-Communicable Diseas
  • T6 8322233 ↗ — Skeletal muscle metabolism during exercise and recovery in patients with respiratory failure
Ketamine only
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
3 sources
  • T1 NCT06821087 ↗ — Evaluating the Neuromodulatory Effect of Ketamine in Long COVID-19
  • T6 38322143 ↗ — Listening to music during intranasal (es)ketamine therapy in patients with treatment-resistant depre
  • T6 42186575 ↗ — Early suicidal ideation change and suicidality-associated emergency department utilization after ket
Keytruda
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
12 sources
  • T1REGISTERED-ONLY NCT07388550 ↗ — Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2
  • T6 32925078 ↗ — COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications
  • T6 38617189 ↗ — Structure and function of therapeutic antibodies approved by the US FDA in 2023
  • T6 37894850 ↗ — A Comparison between SARS-CoV-2 and Gram-Negative Bacteria-Induced Hyperinflammation and Sepsis
  • T6 34784300 ↗ — PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immu
  • T6 34297318 ↗ — Abstracts from the 2021 Annual Meeting of the Society of General Internal Medicine
  • T6INDIRECT 37290960 ↗ — EACR 2023: Innovative Cancer Science, 12-15 June 2023, Torino, Italy
  • T4 PMC9421640 ↗ — 21st ISoP Annual Meeting “A New Era of Pharmacovigilance: Challenges and Opportunities” 20–23 Septem
  • T4 PMC11499952 ↗ — Abstract Book : Topic: 13th International Symposium on Hodgkin Lymphoma; October 2024
  • T4 PMC11177578 ↗ — EHA2024 Hybrid Congress
  • T6 40733649 ↗ — Research and Clinical Progress of Therapeutic Tumor Vaccines
  • T6 39684504 ↗ — Advancing Therapeutic and Vaccine Proteins: Switching from Recombinant to Ribosomal Delivery-A Human
Larazotide Acetate
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
12 sources
  • T1REGISTERED-ONLY NCT05747534 ↗ — AT1001 for the Treatment of Long COVID
  • T6INDIRECT 39774607 ↗ — Mucosal immune response in biology, disease prevention and treatment
  • T6 39326415 ↗ — Mechanisms of long COVID and the path toward therapeutics
  • T6 35563874 ↗ — Obstructive Sleep Apnea as a Risk Factor for COVID-19 Severity-The Gut Microbiome as a Common Player
  • T6 35727635 ↗ — Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-
  • T6 35868344 ↗ — Gut-brain communication in COVID-19: molecular mechanisms, mediators, biomarkers, and therapeutics
  • T6INDIRECT 36147602 ↗ — Zonulin, a marker of gut permeability, is associated with mortality in a cohort of hospitalised peru
  • T4 PMC13290681 ↗ — Abstract
  • T4 PMC11755068 ↗ — Abstract
  • T4 PMC10627784 ↗ — APPSPGHAN 2023
  • T6 35887067 ↗ — Celiac Disease and Targeting the Molecular Mechanisms of Autoimmunity in COVID Pandemic
  • T6 41304215 ↗ — Changes in the Gut Microbiota of Patients After SARS-CoV-2 Infection: What Do We Know?
LingZhi capsule
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
  • T1REGISTERED-ONLY NCT06739720 ↗ — RCT of Efficacy and Safety of CP003 on CFS/ME or Post-COVID Fatigue
Long COVID
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
24 sources
  • T6 37080828 ↗ — Long COVID: pathophysiological factors and abnormalities of coagulation.
  • T6 35176758 ↗ — Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus.
  • T6 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations.
  • T1 34373540 ↗ — More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
  • T1 34973396 ↗ — Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis
  • T1 35429399 ↗ — Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analys
  • T1 36215063 ↗ — Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symp
  • T1 36951832 ↗ — Risk Factors Associated With Post-COVID-19 Condition: A Systematic Review and Meta-analysis
  • T1 35121209 ↗ — Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta
  • T1 34463956 ↗ — Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-A systematic review an
  • T1 34634250 ↗ — Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in
  • T6INDIRECT 34643720 ↗ — Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review
  • T1 34580069 ↗ — Characterising long COVID: a living systematic review
  • T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
  • T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T4 34024217 ↗ — Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
  • T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6 33497610 ↗ — Adaptive immunity to SARS-CoV-2 and COVID-19
  • T6 34248921 ↗ — Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Con
  • T6 35105985 ↗ — Pathological sequelae of long-haul COVID
  • T6 33743212 ↗ — COVID-19 and the human innate immune system
  • T6 35216672 ↗ — Multiple early factors anticipate post-acute COVID-19 sequelae
  • T6 34308300 ↗ — Characterizing long COVID in an international cohort: 7 months of symptoms and their impact
  • T6 35132265 ↗ — Long-term cardiovascular outcomes of COVID-19
Long COVID Coping and Recovery Intervention
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT05453201 ↗ — Developing an Integrative, Recovery-Based, Post-Acute COVID-19 Syndrome (PACS) Psychotherapeutic Int
Long COVID or Post-acute Sequelae of COVID
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
27 sources
  • T6 34248921 ↗ — Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Con
  • T1 40476637 ↗ — Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of Symptoms 3 Years Post-SARS-
  • T1 41605818 ↗ — Prevalence of new-onset diabetes following COVID-19 infection: A systematic review and meta-analysis
  • T1 35955740 ↗ — COVID-19 and the Immune Response: A Multi-Phasic Approach to the Treatment of COVID-19
  • T1 39052056 ↗ — Definitions and symptoms of the post-COVID syndrome: an updated systematic umbrella review
  • T1 40075382 ↗ — Health-related quality of life in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Post COVID-
  • T1 36186977 ↗ — The rationale for the treatment of long-Covid symptoms - A cardiologist's view
  • T1 40084919 ↗ — The Omics Landscape of Long COVID-A Comprehensive Systematic Review to Advance Biomarker, Target and
  • T6INDIRECT 41869328 ↗ — Global trends in research of neuroimmune in lung diseases over past decade: a bibliometric analysis
  • T1 38386633 ↗ — Loss of socioemotional and occupational roles in individuals with Long COVID according to sociodemog
  • T6 37667052 ↗ — SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)
  • T6 34398188 ↗ — Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease
  • T4 34961785 ↗ — Neonates and COVID-19: state of the art : Neonatal Sepsis series
  • T4 37179568 ↗ — Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
  • T4 34452459 ↗ — COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential B
  • T6INDIRECT 37105860 ↗ — Maternal and neonatal outcomes following SARS-CoV-2 infection
  • T4 36836515 ↗ — A Systematic Review of Chest Imaging Findings in Long COVID Patients
  • T6INDIRECT 36998202 ↗ — Viruses and amyloids - a vicious liaison
  • T6INDIRECT 37004544 ↗ — Direct and indirect impact of SARS-CoV-2 on the brain
  • T6INDIRECT 36169154 ↗ — Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of aut
  • T6 35215871 ↗ — The Human Virome: Viral Metagenomics, Relations with Human Diseases, and Therapeutic Applications
  • T6 36551869 ↗ — Understanding Long COVID; Mitochondrial Health and Adaptation-Old Pathways, New Problems
  • T6 34801526 ↗ — The impact of DAMP-mediated inflammation in severe COVID-19 and related disorders
  • T6 37483591 ↗ — Eosinophils as potential biomarkers in respiratory viral infections
  • T6 35449732 ↗ — Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation
  • T6 37064029 ↗ — A review of cytokine-based pathophysiology of Long COVID symptoms
  • T6 36015078 ↗ — The Occurrence of Hyperactivated Platelets and Fibrinaloid Microclots in Myalgic Encephalomyelitis/C
Long COVID or post-COVID
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
28 sources
  • T6 34024217 ↗ — Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments.
  • T1 36215063 ↗ — Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symp
  • T1 36951832 ↗ — Risk Factors Associated With Post-COVID-19 Condition: A Systematic Review and Meta-analysis
  • T1 35739136 ↗ — Long-COVID in children and adolescents: a systematic review and meta-analyses
  • T1 36990297 ↗ — COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-an
  • T1 37084750 ↗ — Safety and effectiveness of vaccines against COVID-19 in children aged 5-11 years: a systematic revi
  • T1 38965510 ↗ — Post-COVID syndrome prevalence: a systematic review and meta-analysis
  • T6INDIRECT 34791425 ↗ — The role of vitamin B12 in viral infections: a comprehensive review of its relationship with the mus
  • T1HARM 36349400 ↗ — Clinical trials on the pharmacological treatment of long COVID: A systematic review
  • T1 36476156 ↗ — Effects of a concurrent training, respiratory muscle exercise, and self-management recommendations o
  • T6INDIRECT 38848477 ↗ — Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection: The S
  • T3 33789877 ↗ — Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study
  • T4 34163217 ↗ — The Conundrum of 'Long-COVID-19': A Narrative Review
  • T4 36051247 ↗ — Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID sympt
  • T4 34386785 ↗ — Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort
  • T4 34036253 ↗ — Characteristics and predictors of acute and chronic post-COVID syndrome: A systematic review and met
  • T4 34095290 ↗ — Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study
  • T6 36412084 ↗ — Long COVID: mechanisms, risk factors and recovery
  • T6 34028807 ↗ — COVID-19 and pulmonary fibrosis: A potential role for lung epithelial cells and fibroblasts
  • T6 36851614 ↗ — Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Aut
  • T6 36385449 ↗ — Neuropsychiatric aspects of long COVID: A comprehensive review
  • T6 36071155 ↗ — Long Covid: where we stand and challenges ahead
  • T6 37192595 ↗ — COVID-19, post-acute COVID-19 syndrome (PACS, "long COVID") and post-COVID-19 vaccination syndrome (
  • T6 36210445 ↗ — Pathophysiology of Post-COVID syndromes: a new perspective
  • T6 35264003 ↗ — Long-term outcomes of pediatric infections: from traditional infectious diseases to long Covid
  • T6 33785495 ↗ — Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-
  • T6 35472304 ↗ — Clinical characteristics with inflammation profiling of long COVID and association with 1-year recov
  • T6 34582441 ↗ — Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study
Low carbohydrate diet intervention
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
2 sources
  • T1 NCT05836402 ↗ — Long COVID-19 Syndrome Lifestyle Intervention Study
  • T6 38123343 ↗ — Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Dise
Low-dose sirolimus
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
3 sources
  • T1REGISTERED-ONLY NCT06960928 ↗ — Low Dose Sirolimus in People With Post-Acute Sequelae of COVID-19 (PASC) Long COVID-19
  • T6 41096951 ↗ — Heterogeneity of Cellular Senescence, Senotyping, and Targeting by Senolytics and Senomorphics in Lu
  • T6 39936727 ↗ — Brazilian Thoracic Association recommendations for the management of lymphangioleiomyomatosis
MSC-derived exosomes
T1
T1 — RCT in LC/PASC/PACVS
Harm signalLong COVID
16 sources
  • T1HARM NCT05808400 ↗ — Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cell Exosomes in Treating Chronic Cough After
  • T6INDIRECT 32454187 ↗ — Review of trials currently testing treatment and prevention of COVID-19
  • T6INDIRECT 35782071 ↗ — Association between Mesenchymal Stem Cells and COVID-19 Therapy: Systematic Review and Current Trend
  • T6 35927511 ↗ — The roles of extracellular vesicles in the immune system
  • T6 35787632 ↗ — Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next g
  • T6 38378653 ↗ — Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatme
  • T6 38152837 ↗ — Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications
  • T6 37907497 ↗ — The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of lon
  • T6INDIRECT 35279630 ↗ — Mesenchymal stem cell treatment for COVID-19
  • T6INDIRECT 36015310 ↗ — Practical Considerations for Translating Mesenchymal Stromal Cell-Derived Extracellular Vesicles fro
  • T6INDIRECT 37763198 ↗ — Fresh Umbilical Cord Blood-A Source of Multipotent Stem Cells, Collection, Banking, Cryopreservation
  • T6INDIRECT 34685567 ↗ — Mesenchymal Stem Cells in the Treatment of COVID-19, a Promising Future
  • T6INDIRECT 38275749 ↗ — Mesenchymal Stem Cell-Based Therapies in the Post-Acute Neurological COVID Syndrome: Current Landsca
  • T6INDIRECT 38738585 ↗ — Extracellular vesicles as human therapeutics: A scoping review of the literature
  • T6INDIRECT 37874422 ↗ — ESICM LIVES 2023
  • T6 38931833 ↗ — Insight into the Functional Dynamics and Challenges of Exosomes in Pharmaceutical Innovation and Pre
Maltodextrin
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
30 sources
  • T1 NCT06620406 ↗ — Synbiotic Therapy for NP-PASC
  • T6INDIRECT 38270314 ↗ — The effect of COVID-19 and COVID-19 vaccination on serum anti-Mullerian hormone: A systematic review
  • T6INDIRECT 37175942 ↗ — Endotheliopathy in Acute COVID-19 and Long COVID
  • T6INDIRECT 36409650 ↗ — A systematic review of the biological mediators of fat taste and smell
  • T6INDIRECT 36186977 ↗ — The rationale for the treatment of long-Covid symptoms - A cardiologist's view
  • T6INDIRECT 38424099 ↗ — Effect of gut microbiome modulation on muscle function and cognition: the PROMOTe randomised control
  • T6INDIRECT 35011103 ↗ — Effects of <i>Loigolactobacillus coryniformis</i> K8 CECT 5711 on the Immune Response of Elderly Sub
  • T6INDIRECT 39599737 ↗ — Effect of Postbiotic <i>Bifidobacterium longum</i> CECT 7347 on Gastrointestinal Symptoms, Serum Bio
  • T6INDIRECT 36084236 ↗ — Palmitoylethanolamide Reduces Proinflammatory Markers in Unvaccinated Adults Recently Diagnosed with
  • T6INDIRECT 39683507 ↗ — Efficacy of ETB-F01, Heat-Killed <i>Akkermansia muciniphila</i> Strain EB-AMDK19, in Patients with R
  • T6 32857878 ↗ — Thrombosis in COVID-19
  • T6 21821740 ↗ — Oxidoreductive cellulose depolymerization by the enzymes cellobiose dehydrogenase and glycoside hydr
  • T6 23102010 ↗ — Production of four Neurospora crassa lytic polysaccharide monooxygenases in Pichia pastoris monitore
  • T6INDIRECT 34937265 ↗ — Central retinal vein occlusion post-COVID-19 vaccination
  • T6INDIRECT 36828919 ↗ — Long-term interplay between COVID-19 and chronic kidney disease
  • T6INDIRECT 36686624 ↗ — Guillain-Barré syndrome associated with COVID-19: A systematic review
  • T6INDIRECT 36033885 ↗ — Microbiota and COVID-19: Long-term and complex influencing factors
  • T6INDIRECT 34889662 ↗ — Does COVID-19 Cause Hypertension?
  • T6INDIRECT 34755562 ↗ — Covid-19-Induced Dysautonomia: A Menace of Sympathetic Storm
  • T6INDIRECT 34115763 ↗ — Ayurveda botanicals in COVID-19 management: An in silico multi-target approach
  • T6 27877783 ↗ — A review on powder-based additive manufacturing for tissue engineering: selective laser sintering an
  • T6 11729261 ↗ — Comparative biology of IncQ and IncQ-like plasmids
  • T6 33646622 ↗ — Sex-based differences in severity and mortality in COVID-19
  • T6 36386929 ↗ — Glutathione: A Samsonian life-sustaining small molecule that protects against oxidative stress, agei
  • T6 34896650 ↗ — Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Repor
  • T6 22123987 ↗ — Synthesis of three advanced biofuels from ionic liquid-pretreated switchgrass using engineered Esche
  • T6 10899854 ↗ — Attenuated nontoxinogenic and nonencapsulated recombinant Bacillus anthracis spore vaccines protect
  • T6 24324265 ↗ — A C4-oxidizing lytic polysaccharide monooxygenase cleaving both cellulose and cello-oligosaccharides
  • T6 25201969 ↗ — A family of starch-active polysaccharide monooxygenases
  • T6 22132148 ↗ — The putative endoglucanase PcGH61D from Phanerochaete chrysosporium is a metal-dependent oxidative e
Microdosing of mindfulness
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
  • T1REGISTERED-ONLY NCT05676008 ↗ — A Study of Positive Emotions With Long COVID-19
Microsponge
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
2 sources
  • T1 NCT05970731 ↗ — Directed Topical Drug Delivery for Treatment for PASC Hyposmia
  • T6 34825334 ↗ — Biocosmetics: technological advances and future outlook
Mid and long-term neurological and neuropsychiatric manifestations of post-COVID
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
6 sources
  • T1 35121209 ↗ — Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta
  • T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
  • T6 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6 37867774 ↗ — Susceptibility and severity of COVID-19 and risk of psychiatric disorders in European populations: a
  • T6INDIRECT 38656063 ↗ — Long COVID-19 and mnemonic effects: an integrative literature review
Mind Body Intervention #1
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
  • T1REGISTERED-ONLY NCT06045338 ↗ — Mind Body Intervention for Long COVID-19
Mindfulness - Mindful Awareness Practices
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT05566379 ↗ — Mindfulness in Post Acute Sequelae of SARS-CoV-2 Infection (PASC) Dysautonomia
Minimal-Dose Home-Based Resistance Exercise
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
Modafinil
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVIDPOTS
57 sources
  • T1 NCT06404086 ↗ — RECOVER-SLEEP: Platform Protocol
  • T1 NCT06404099 ↗ — RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia)
  • T2REGISTERED-ONLY NCT00262470 ↗ — Treatment of Orthostatic Intolerance
  • T2REGISTERED-ONLY NCT01988883 ↗ — Modafinil and Cognitive Function in POTS
  • T6INDIRECT 39882369 ↗ — Oral medications for the treatment of postural orthostatic tachycardia syndrome; a systematic review
  • T6INDIRECT 38228914 ↗ — Connectivity-guided intermittent theta burst versus repetitive transcranial magnetic stimulation for
  • T6INDIRECT 39207396 ↗ — Undervaluing nondrug rewards or overvaluing cocaine? Cocaine demand relates to cocaine use severity
  • T6 34991982 ↗ — An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
  • T6 34390682 ↗ — Post-COVID-19 Tachycardia Syndrome: A Distinct Phenotype of Post-Acute COVID-19 Syndrome
  • T6INDIRECT 33723532 ↗ — Long-Haul Post-COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrom
  • T6 33755344 ↗ — Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers"
  • T6 34346558 ↗ — Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fati
  • T6 35577469 ↗ — Telehealth cancer-related fatigue clinic model for cancer survivors: a pilot randomised controlled t
  • T6 38384879 ↗ — Self-managing symptoms of Long COVID: an education and strategies research protocol
  • T6HARM 35277411 ↗ — Pharmacological and non-pharmacological interventions for adults with ADHD: protocol for a systemati
  • T6INDIRECT 27153153 ↗ — Pharmacological treatment for Kleine-Levin syndrome
  • T6INDIRECT 35651342 ↗ — Sleep Disturbances in Pediatric Craniopharyngioma: A Systematic Review
  • T6INDIRECT 40653179 ↗ — The evidence for treatments for postural orthostatic tachycardia syndrome: a systematic review of ra
  • T6INDIRECT 41225175 ↗ — Systematic literature review: treatment of postural orthostatic tachycardia syndrome (POTS)
  • T2 25222185 ↗ — Hemodynamic profiles and tolerability of modafinil in the treatment of postural tachycardia syndrome
  • T6INDIRECT 37447210 ↗ — Combination of Chemically Characterized Pomegranate Extract and Hydrophilic Vitamins against Prolong
  • T6 22519513 ↗ — The solute carrier 6 family of transporters
  • T6INDIRECT 23753844 ↗ — Postural tachycardia syndrome (POTS)
  • T6 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
  • T6 34144933 ↗ — Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019
  • T6INDIRECT 29744873 ↗ — Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - as
  • T6INDIRECT 26447539 ↗ — Interventions for fatigue in Parkinson's disease
  • T6INDIRECT 36190739 ↗ — Pharmacological interventions for prevention of weight gain in people with schizophrenia
  • T6INDIRECT 27863901 ↗ — A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease f
  • T6INDIRECT 32402075 ↗ — Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines
  • T6INDIRECT 36138129 ↗ — The impact of pharmacological and non-pharmacological interventions on physical health outcomes in p
  • T6INDIRECT 36971690 ↗ — Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
  • T6INDIRECT 20679638 ↗ — Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease
  • T6INDIRECT 17134849 ↗ — Safety, tolerability and efficacy of levodopa-carbidopa treatment for cocaine dependence: two double
  • T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
  • T6INDIRECT 35853576 ↗ — Postural orthostatic tachycardia syndrome as a sequela of COVID-19
  • T6INDIRECT 33421734 ↗ — The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacol
  • T6INDIRECT 36946625 ↗ — An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing m
  • T6INDIRECT 36002784 ↗ — Treatment of Cushing's syndrome with osilodrostat: practical applications of recent studies with cas
  • T6INDIRECT 33681293 ↗ — Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiat
  • T6INDIRECT 36169154 ↗ — Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of aut
  • T6 39125722 ↗ — Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detectio
  • T6 34646278 ↗ — Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?
  • T6 35454890 ↗ — A New Approach to Understanding Cancer-Related Fatigue: Leveraging the 3P Model to Facilitate Risk P
  • T6 35883527 ↗ — Pathological Features and Neuroinflammatory Mechanisms of SARS-CoV-2 in the Brain and Potential Ther
  • T6INDIRECT 22021174 ↗ — The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor sy
  • T6INDIRECT 26084539 ↗ — International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
  • T6INDIRECT 19484833 ↗ — Evidence-based recommendations for the assessment and management of sleep disorders in older persons
  • T6INDIRECT 25200111 ↗ — Drooling in Parkinson's disease: a review
  • T6INDIRECT 29101940 ↗ — REM Sleep Behavior Disorder: Diagnosis, Clinical Implications, and Future Directions
  • T6 26595642 ↗ — Lewy body dementias
  • T6 28837986 ↗ — Sleep Disturbance, Cognitive Decline, and Dementia: A Review
  • T6 24699931 ↗ — Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected
  • T6 33924103 ↗ — Treatment Options for Motor and Non-Motor Symptoms of Parkinson's Disease
  • T6 19603170 ↗ — Primary biliary cirrhosis
  • T6 23065655 ↗ — A practical guide to the therapy of narcolepsy and hypersomnia syndromes
  • T6 20815187 ↗ — Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment
Multicomponent intervention
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
23 sources
  • T1 NCT06492590 ↗ — Long COVID-19 Intervention (COVIDL/MIQoL)
  • T6INDIRECT 36098262 ↗ — Long COVID in children and adolescents
  • T6INDIRECT 38695826 ↗ — Measures implemented in the school setting to contain the COVID-19 pandemic
  • T6INDIRECT 35037252 ↗ — Measures implemented in the school setting to contain the COVID-19 pandemic
  • T6INDIRECT 37784017 ↗ — Learning from the covid-19 outbreaks in long-term care facilities: a systematic review
  • T6INDIRECT 35533528 ↗ — Effects of mental health interventions among people hospitalized with COVID-19 infection: A systemat
  • T6INDIRECT 35442432 ↗ — Effect of Culturally Tailored, Internet-Delivered Cognitive Behavioral Therapy for Insomnia in Black
  • T6INDIRECT 39813042 ↗ — Palliative Care Initiated in the Emergency Department: A Cluster Randomized Clinical Trial
  • T6INDIRECT 38941601 ↗ — The Effect of an mHealth Self-Monitoring Intervention (MI-BP) on Blood Pressure Among Black Individu
  • T6 35402784 ↗ — Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and
  • T6 35143770 ↗ — Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in Eng
  • T6 37712135 ↗ — Lifestyle management of hypertension: International Society of Hypertension position paper endorsed
  • T6HARM 33949747 ↗ — Suicidal ideation and thoughts of self-harm during the COVID-19 pandemic: The role of COVID-19-relat
  • T6INDIRECT 33936607 ↗ — COVID-19, when fourteen days are not enough-A case series of affected healthcare workers
  • T6INDIRECT 34297318 ↗ — Abstracts from the 2021 Annual Meeting of the Society of General Internal Medicine
  • T6INDIRECT 34633565 ↗ — ESICM LIVES 2021: Part 1
  • T6INDIRECT 39033994 ↗ — Rationale, Design and Baseline Characteristics of a Randomized Controlled Trial of a Cardiovascular
  • T6 39458423 ↗ — Acute Sarcopenia: Mechanisms and Management
  • T6 39294611 ↗ — Nutraceuticals and pharmacological to balance the transitional microbiome to extend immunity during
  • T6 37110200 ↗ — Amino Acid Profiles in Older Adults with Frailty: Secondary Analysis from MetaboFrail and BIOSPHERE
  • T6 38126653 ↗ — Scientists of Tomorrow/ Cientistas do Amanhã : a project to inspire, stimulate scientific thinking,
  • T6 34932190 ↗ — Abstracts of the 17th Congress of the European Geriatric Medicine Society : Live from Athens and Onl
  • T6 33166163 ↗ — Behavioral economics of substance use: Understanding and reducing harmful use during the COVID-19 pa
Multimodal intervention in Long Covid19
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
Muse S™ Headband system
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
N-803
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
23 sources
  • T1REGISTERED-ONLY NCT07108036 ↗ — A Study to Assess Anktiva in Patients With Long Covid-19.
  • T6INDIRECT 34167876 ↗ — Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A syst
  • T6INDIRECT 36889797 ↗ — Comparison of mental health symptoms before and during the covid-19 pandemic: evidence from a system
  • T6INDIRECT 33766163 ↗ — Prevalence of depressive symptoms among Chinese university students amid the COVID-19 pandemic: a sy
  • T6INDIRECT 35785594 ↗ — Persistent neurological manifestations in long COVID-19 syndrome: A systematic review and meta-analy
  • T6INDIRECT 36098262 ↗ — Long COVID in children and adolescents
  • T6INDIRECT 33380413 ↗ — Effectiveness, safety and acceptability of medical abortion at home versus in the clinic: a systemat
  • T6INDIRECT 35866452 ↗ — Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection
  • T6INDIRECT 33151274 ↗ — The impact of the COVID-19 pandemic on the care and management of patients with acute cardiovascular
  • T6INDIRECT 35544369 ↗ — Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age
  • T6INDIRECT 34559863 ↗ — Social distancing in America: Understanding long-term adherence to COVID-19 mitigation recommendatio
  • T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
  • T6 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6INDIRECT 38378653 ↗ — Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatme
  • T6INDIRECT 35027697 ↗ — Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the Internat
  • T6INDIRECT 33836148 ↗ — 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective coho
  • T6INDIRECT 35143770 ↗ — Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in Eng
  • T6 24661096 ↗ — Protein design: toward functional metalloenzymes
  • T6 36454715 ↗ — CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond
  • T6 3070321 ↗ — Linkage map of Salmonella typhimurium, edition VII
  • T6 33785495 ↗ — Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-
  • T6 35472304 ↗ — Clinical characteristics with inflammation profiling of long COVID and association with 1-year recov
NE3107
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
3 sources
  • T1REGISTERED-ONLY NCT06847191 ↗ — NE3107 in Adults With Neurological Symptoms of Long COVID
  • T6 39174535 ↗ — Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strateg
  • T6 41767744 ↗ — Inflammatory mechanisms underlying early Alzheimer's disease pathology: evidence from the aging rhes
NeuroFlex
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
3 sources
  • T1REGISTERED-ONLY NCT05705193 ↗ — Brain-Training Treatment for Long COVID in Older Adults
  • T6 38755688 ↗ — RECOVER-NEURO: study protocol for a multi-center, multi-arm, phase 2, randomized, active comparator
  • T6 PMC11925478 ↗ — ABSTRACTS
Nivolumab and Ipilimumab
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
14 sources
  • T1REGISTERED-ONLY NCT05597800 ↗ — Nivolumab/Ipilimumab and Chemotherapy Combination in Advanced NSCLC Patients With HIV, HBV, HCV and
  • T6INDIRECT 41029573 ↗ — The efficacy analysis of neoadjuvant chemoimmunotherapy followed by surgery in stage III locally adv
  • T6 29564184 ↗ — How does the tumor microenvironment play a role in hepatobiliary tumors?
  • T6 32650215 ↗ — Recommendations for detection, prioritization, and treatment of thoracic oncology patients during th
  • T6 37391394 ↗ — SARS-CoV-2 infection and COVID-19 vaccination in cancer patients undergoing immune checkpoint inhibi
  • T6 40211538 ↗ — DNA-based immunotherapy for cancer: In vivo approaches for recalcitrant targets
  • T6 35830116 ↗ — Brazilian Society of Cardiology Guideline on Myocarditis - 2022
  • T6INDIRECT 36561623 ↗ — Diabetes insipidus: A rare endocrine complication of immune check point inhibitors: A case report an
  • T6INDIRECT 38929875 ↗ — The Long Journey towards Personalized Targeted Therapy in Poorly Differentiated Thyroid Carcinoma (P
  • T6INDIRECT 36143403 ↗ — Immune Checkpoint Inhibitor-Induced Myocarditis vs. COVID-19 Vaccine-Induced Myocarditis-Same or Dif
  • T6INDIRECT 40542608 ↗ — Special Issue: Abstracts of the 11&lt;sup&gt;th&lt;/sup&gt; Congress of the European Academy of Neur
  • T6INDIRECT 36648635 ↗ — World Molecular Imaging Congress 2022
  • T4 PMC9548092 ↗ — UEG Week 2022 Oral Presentations
  • T6 40733649 ↗ — Research and Clinical Progress of Therapeutic Tumor Vaccines
No Interventions
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
22 sources
  • T1REGISTERED-ONLY NCT07352254 ↗ — OutreAch MediCal Care for HousEbound Patients With Post-COVID-19 Syndrome or ME/CFS of Any Cause (AC
  • T6INDIRECT 34373540 ↗ — More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
  • T6INDIRECT 36951832 ↗ — Risk Factors Associated With Post-COVID-19 Condition: A Systematic Review and Meta-analysis
  • T6INDIRECT 33760236 ↗ — Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection
  • T6INDIRECT 33661992 ↗ — Population risk factors for severe disease and mortality in COVID-19: A global systematic review and
  • T6INDIRECT 35124265 ↗ — Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic rev
  • T6INDIRECT 34634250 ↗ — Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in
  • T6INDIRECT 34192010 ↗ — Changes in physical activity and sedentary behaviours from before to during the COVID-19 pandemic lo
  • T6INDIRECT 36681084 ↗ — Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron va
  • T6INDIRECT 32503818 ↗ — Medical and Surgical Education Challenges and Innovations in the COVID-19 Era: A Systematic Review
  • T6INDIRECT 33180097 ↗ — Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Random
  • T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
  • T6 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
  • T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6INDIRECT 34024217 ↗ — Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
  • T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6INDIRECT 34281357 ↗ — Myocarditis With COVID-19 mRNA Vaccines
  • T6 33497610 ↗ — Adaptive immunity to SARS-CoV-2 and COVID-19
  • T6 38433280 ↗ — NF-κB in biology and targeted therapy: new insights and translational implications
  • T6 22896693 ↗ — The pancreas cancer microenvironment
  • T6 32422178 ↗ — Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
  • T6 35304603 ↗ — Exerkines in health, resilience and disease
Non-invasive vagus nerve stimulation
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
22 sources
  • T1 NCT05630040 ↗ — VNS for Long-COVID-19
  • T6INDIRECT 39456932 ↗ — Rheumatoid Arthritis and COVID-19 at the Intersection of Immunology and Infectious Diseases: A Relat
  • T6INDIRECT 36940750 ↗ — Prefrontal tDCS modulates autonomic responses in COVID-19 inpatients
  • T6INDIRECT 41927730 ↗ — Post-exercise auricular vagus nerve stimulation modulates autonomic and recovery responses in physic
  • T6 36412084 ↗ — Long COVID: mechanisms, risk factors and recovery
  • T6 33324324 ↗ — Applications of Non-invasive Neuromodulation for the Management of Disorders Related to COVID-19
  • T6 35054856 ↗ — Disorders of the Cholinergic System in COVID-19 Era-A Review of the Latest Research
  • T6 36002874 ↗ — A pilot randomized controlled trial of supervised, at-home, self-administered transcutaneous auricul
  • T6 35463130 ↗ — Non-invasive Vagus Nerve Stimulation for COVID-19: Results From a Randomized Controlled Trial (SAVIO
  • T6 40481908 ↗ — Transcutaneous Auricular Vagal Nerve Stimulation for the Treatment of the Fatigue Syndrome in Patien
  • T6 42342403 ↗ — Effects of auricular vagal neuromodulation therapy combined with slow-paced diaphragmatic breathing
  • T4 PMC13290870 ↗ — Without getting under your skin: non-invasive stimulation activates the vagus nerve
  • T4 PMC12941859 ↗ — Postural Orthostatic Tachycardia Syndrome, Menopause and Hormone Replacement Therapy: Clinical Decis
  • T6INDIRECT 40545525 ↗ — Abstracts from the 18 th European Headache Congress (EHC) : Rotterdam, The Netherlands. 4-7 December
  • T6INDIRECT 40553043 ↗ — Classification of Individuals With COVID-19 and Post-COVID-19 Condition and Healthy Controls Using H
  • T6INDIRECT 38426548 ↗ — Association of Chiropractic Colleges Educational Conference and Research Agenda Conference 2024: The
  • T6 41373850 ↗ — Integrative Neuroimmune Role of the Parasympathetic Nervous System, Vagus Nerve and Gut Microbiota i
  • T6 41299695 ↗ — The virology of Omicron: pathophysiology, immune regulation, and clinical impact of SARS-CoV-2 sub v
  • T6 36004877 ↗ — Understanding the Pivotal Role of the Vagus Nerve in Health from Pandemics
  • T6 40254579 ↗ — Long COVID clinical evaluation, research and impact on society: a global expert consensus
  • T6 38756213 ↗ — Transcutaneous vagus nerve stimulation improves Long COVID symptoms in a female cohort: a pilot stud
  • T6 40261198 ↗ — Multidisciplinary collaborative guidance on the assessment and treatment of patients with Long COVID
Olfactory Training Kit - "The Olfactory Kit, by AdvancedRx"
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
  • T1REGISTERED-ONLY NCT06204432 ↗ — Sodium Citrate in Smell Retraining for People With Post-COVID-19 Olfactory Dysfunction
On Site Exercise Rehabilitation
T1
T1 — RCT in LC/PASC/PACVS
WithdrawnLong COVID
1 source
  • T1WITHDRAWN NCT05398692 ↗ — Long COVID-19 Rehabilitation & Recovery Research Program
Osteopathic Manipulative Therapy Long-COVID protocol
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
  • T1REGISTERED-ONLY NCT06883513 ↗ — Osteopathic Manipulative Therapy Effects on Post-Acute Sequelae of COVID-19 (PASC) or Long COVID
Osteopathic Manipulative Therapy NOT Long-COVID treatment protocol
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
  • T1REGISTERED-ONLY NCT06883513 ↗ — Osteopathic Manipulative Therapy Effects on Post-Acute Sequelae of COVID-19 (PASC) or Long COVID
PASC CoRE
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
8 sources
  • T1 NCT05965739 ↗ — RECOVER-NEURO: Platform Protocol, Appendix_A to Measure the Effects of BrainHQ, PASC CoRE and tDCS I
  • T1 NCT05965752 ↗ — RECOVER-NEURO: Platform Protocol to Measure the Effects of Cognitive Dysfunction Interventions on Lo
  • T6INDIRECT 41212544 ↗ — Evaluation of Interventions for Cognitive Symptoms in Long COVID: A Randomized Clinical Trial
  • T6 37745021 ↗ — Characterization of long COVID temporal sub-phenotypes by distributed representation learning from e
  • T6 38755688 ↗ — RECOVER-NEURO: study protocol for a multi-center, multi-arm, phase 2, randomized, active comparator
  • T6 38865966 ↗ — Challenges and opportunities in long COVID research
  • T6 PPR674291 ↗ — Characterization of Long Covid Temporal Sub-Phenotypes by Distributed Learning from Electronic Healt
  • T6INDIRECT 38188200 ↗ — Spinal cord infarction attributed to SARS-CoV-2, with post-acute sequelae of COVID-19: A case report
Paragon Novel Metabolic Regulator
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
  • T1REGISTERED-ONLY NCT07627815 ↗ — Evaluating the Safety and Efficacy of PNMR as Treatment for Long COVID
Pascal device
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT06739668 ↗ — Humanity Neurotech Device Clinical Trial in Adults With Long COVID Cognitive Dysfunction
Peer Mentoring
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
25 sources
  • T1REGISTERED-ONLY NCT06095297 ↗ — Long COVID Brain Fog: Cognitive Rehabilitation Trial
  • T6INDIRECT 41101955 ↗ — Interventions to enhance gender equity in academic medicine: a systematic review
  • T6INDIRECT 39036099 ↗ — Medical education during the coronavirus disease 2019 pandemic: an umbrella review
  • T6INDIRECT 40597208 ↗ — Global perspectives on challenges, coping strategies, and future preparedness of nursing home staff
  • T6INDIRECT 35073499 ↗ — Pilot Social Network Weight Loss Intervention With Two Immigrant Populations During the COVID-19 Pan
  • T6 34887173 ↗ — Mind the gap: Inequalities in mental health care and lack of social support in Parkinson disease
  • T6 40746683 ↗ — A review of recruitment and retention strategies in U.S. local health departments: insights and prac
  • T6 36082018 ↗ — Using Peer Power to Reduce Health Disparities: Implementation of a Diabetes Support Coach Program in
  • T6 35070487 ↗ — The NCSBN 2022 Environmental Scan: Resiliency, Achievement, and Public Protection
  • T6 37753982 ↗ — Teacher Support, Academic Self-Efficacy, Student Engagement, and Academic Achievement in Emergency O
  • T6 33148602 ↗ — Rapid implementation and improvement of a virtual student placement model in response to the COVID-1
  • T6INDIRECT 34297318 ↗ — Abstracts from the 2021 Annual Meeting of the Society of General Internal Medicine
  • T6INDIRECT 37790179 ↗ — Proceedings of the Sixth Conference of the Society for Implementation Research Collaboration (SIRC)
  • T6INDIRECT 34011360 ↗ — Proceedings from the 13th Annual Conference on the Science of Dissemination and Implementation : Vir
  • T6INDIRECT 38504346 ↗ — Proceedings of the 6th UK and Ireland implementation science research conference
  • T6INDIRECT 37465735 ↗ — International Congress on Academic Medicine: 2023 medical education abstracts: United today for a he
  • T6INDIRECT 34235134 ↗ — Extending the Population Health Workforce Through Service Learning Internships During COVID: A Commu
  • T6 39811040 ↗ — Dissecting Loneliness in the Digital Age: An Insight into the Experiences of Medical Students Amid a
  • T6 37915328 ↗ — Pedagogical impact of integration of musculoskeletal anatomy blended learning on physiotherapy educa
  • T6 34926835 ↗ — Program Abstracts from The GSA 2021 Annual Scientific Meeting, "Disruption to Transformation: Aging
  • T6 34544746 ↗ — Research and Education Poster Abstracts Presented at the 122nd Virtual Annual Meeting of the America
  • T6 31898181 ↗ — The Veterans Health Administration's Contribution to Cancer Education
  • T6 36448246 ↗ — Training and cultivating the translational science workforce: Responses of Clinical and Translationa
  • T6 38664744 ↗ — Risk factors for smoking in adolescence: evidence from a cross-sectional survey in Switzerland
  • T6 38181035 ↗ — The impact of online education during the Covid-19 pandemic on the professional identity formation o
Pentoxifylline
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
20 sources
  • T1 NCT05513560 ↗ — RECLAIM: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine
  • T1 39446164 ↗ — Pentoxifylline in COVID-19 and considerations for its research in long COVID
  • T6INDIRECT 38695785 ↗ — Effects of additional exercise therapy after a successful vascular intervention for people with symp
  • T6INDIRECT 34291812 ↗ — Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  • T6INDIRECT 36062970 ↗ — Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction
  • T6INDIRECT 34291813 ↗ — Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction
  • T6INDIRECT 36063364 ↗ — Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  • T6INDIRECT 35948654 ↗ — Epidemiology and clinical evolution of non-multisystem inflammatory syndrome (MIS-C) dermatological
  • T6INDIRECT 42210924 ↗ — Neurobiological mechanisms of olfactory dysfunction: a ten-year bibliometric and visualization analy
  • T6INDIRECT 37944311 ↗ — Alpha-lipoic acid does not improve olfactory training results in olfactory loss due to COVID-19: a d
  • T6 37076602 ↗ — Therapeutic strategies for COVID-19: progress and lessons learned
  • T6 36899952 ↗ — Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutic
  • T6 35373533 ↗ — International consensus statement on allergy and rhinology: Olfaction
  • T6INDIRECT 36713204 ↗ — The role of oxidative stress in the pathogenesis of infections with coronaviruses
  • T6INDIRECT 36969241 ↗ — Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOV
  • T6INDIRECT 33668969 ↗ — Drug Repurposing in the COVID-19 Era: Insights from Case Studies Showing Pharmaceutical Peculiaritie
  • T6INDIRECT 38998660 ↗ — <i>Aloe vera</i>-An Extensive Review Focused on Recent Studies
  • T6 33240091 ↗ — Challenges for Drug Repurposing in the COVID-19 Pandemic Era
  • T6 37511055 ↗ — Endothelin-1 in Health and Disease
  • T6 37649125 ↗ — Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders
Personalized Cardiopulmonary Rehabilitation
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
2 sources
  • T1REGISTERED-ONLY NCT06404060 ↗ — RECOVER-ENERGIZE Platform Protocol_Appendix A (Exercise Intolerance)
  • T1 NCT06404047 ↗ — RECOVER-ENERGIZE Platform Protocol
Personalized multidisciplinary day-hospital intervention
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT05532904 ↗ — Multidisciplinary Day-hospital Versus Waiting List Management of Post-COVID-19 Persistent Symptoms (
Physical Fatigue
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
32 sources
  • T1REGISTERED-ONLY NCT07278388 ↗ — Neural Mechanisms of Fatigue in Post-Acute Sequela of SARS-CoV-2
  • T6INDIRECT 34752489 ↗ — A mixed-methods systematic review of post-viral fatigue interventions: Are there lessons for long Co
  • T6INDIRECT 35341944 ↗ — Aromatherapy blend of thyme, orange, clove bud, and frankincense boosts energy levels in post-COVID-
  • T6INDIRECT 36693536 ↗ — Non-invasive brain stimulation for fatigue in post-acute sequelae of SARS-CoV-2 (PASC)
  • T6INDIRECT 36674117 ↗ — Positive Impacts of a Four-Week Neuro-Meditation Program on Cognitive Function in Post-Acute Sequela
  • T6INDIRECT 36700245 ↗ — Randomized controlled trial of home-based vs. hospital-based pulmonary rehabilitation in post COVID-
  • T6INDIRECT 38528512 ↗ — Effect of home-based pulmonary rehabilitation on exercise capacity in post COVID-19 patients: a rand
  • T6INDIRECT 38272997 ↗ — Transcranial direct current stimulation (tDCS) in the treatment of neuropsychiatric symptoms of long
  • T1 37698618 ↗ — Physical exercise as a treatment for persisting symptoms post-COVID infection: review of ongoing stu
  • T6INDIRECT 36042189 ↗ — A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pand
  • T6 33166287 ↗ — Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial i
  • T6 34163090 ↗ — Long COVID in a prospective cohort of home-isolated patients
  • T6 36051247 ↗ — Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID sympt
  • T6INDIRECT 35287333 ↗ — Long-Term COVID 19 Sequelae in Adolescents: the Overlap with Orthostatic Intolerance and ME/CFS
  • T6INDIRECT 35636906 ↗ — Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
  • T4 34051516 ↗ — Physical and mental health complications post-COVID-19: Scoping review
  • T6INDIRECT 34649946 ↗ — Neuropsychologic Profiles and Cerebral Glucose Metabolism in Neurocognitive Long COVID Syndrome
  • T6INDIRECT 36873426 ↗ — Structural brain changes in patients with post-COVID fatigue: a prospective observational study
  • T6INDIRECT 34564089 ↗ — A Randomized Controlled Trial of the Efficacy of Systemic Enzymes and Probiotics in the Resolution o
  • T6 37457901 ↗ — Post-COVID cognitive dysfunction: current status and research recommendations for high risk populati
  • T6 35454890 ↗ — A New Approach to Understanding Cancer-Related Fatigue: Leveraging the 3P Model to Facilitate Risk P
  • T6 36202253 ↗ — Post-viral fatigue in COVID-19: A review of symptom assessment methods, mental, cognitive, and physi
  • T6 35414261 ↗ — Brain Fog in Hypothyroidism: What Is It, How Is It Measured, and What Can Be Done About It
  • T6 33381041 ↗ — Panacis Quinquefolii Radix: A Review of the Botany, Phytochemistry, Quality Control, Pharmacology, T
  • T6 37064029 ↗ — A review of cytokine-based pathophysiology of Long COVID symptoms
  • T6 34494964 ↗ — Severe Fatigue in Long COVID: Web-Based Quantitative Follow-up Study in Members of Online Long COVID
  • T6 35085824 ↗ — Neuropsychological, Medical, and Psychiatric Findings After Recovery From Acute COVID-19: A Cross-se
  • T6 32758891 ↗ — Into the looking glass: Post-viral syndrome post COVID-19
  • T6 35734582 ↗ — Non-invasive brain stimulation and neuroenhancement
  • T6 33359928 ↗ — Neuropsychological and neurophysiological correlates of fatigue in post-acute patients with neurolog
  • T6 34069603 ↗ — European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (EUROMENE): Expert Consensus
  • T6 34563706 ↗ — Mast cell activation symptoms are prevalent in Long-COVID
Physical activity behavioural modification
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
2 sources
  • T1 NCT05752331 ↗ — Feasibility of Personalised Health Behaviour Coaching to Support Symptoms and Activities of Daily Li
  • T6 35615417 ↗ — ERS International Congress 2021: highlights from the Respiratory Clinical Care and Physiology Assemb
Physical therapy
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
27 sources
  • T1REGISTERED-ONLY NCT07254377 ↗ — Design and Validation of Innovative Strategies Based on Dual-Task Approach
  • T6INDIRECT 34373540 ↗ — More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
  • T6INDIRECT 34167876 ↗ — Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: A syst
  • T6INDIRECT 33262076 ↗ — Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis
  • T6INDIRECT 38101521 ↗ — Persistence of post-COVID symptoms in the general population two years after SARS-CoV-2 infection: A
  • T6INDIRECT 33729021 ↗ — Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus di
  • T6INDIRECT 35182760 ↗ — ESCMID rapid guidelines for assessment and management of long COVID
  • T1 37725376 ↗ — Rehabilitation Interventions for Physical Capacity and Quality of Life in Adults With Post-COVID-19
  • T6INDIRECT 36560633 ↗ — Long-COVID Symptoms in Individuals Infected with Different SARS-CoV-2 Variants of Concern: A Systema
  • T6INDIRECT 34523128 ↗ — Continuing education meetings and workshops: effects on professional practice and healthcare outcome
  • T6INDIRECT 34741822 ↗ — Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who rec
  • T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
  • T6 34248921 ↗ — Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Con
  • T6INDIRECT 34997689 ↗ — Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of Covid-19
  • T6INDIRECT 36555931 ↗ — Age, Sex and Previous Comorbidities as Risk Factors Not Associated with SARS-CoV-2 Infection for Lon
  • T6INDIRECT 32475821 ↗ — The Stanford Hall consensus statement for post-COVID-19 rehabilitation
  • T6INDIRECT 36051247 ↗ — Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID sympt
  • T6INDIRECT 35307156 ↗ — 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocard
  • T6 36606682 ↗ — Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstr
  • T6 32885037 ↗ — COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside
  • T6 39482575 ↗ — Hallmarks of primary headache: part 1 - migraine
  • T6 34216297 ↗ — COVID-19 and Myositis: What We Know So Far
  • T6 37277738 ↗ — The role of peripheral inflammatory insults in Alzheimer's disease: a review and research roadmap
  • T6 33347610 ↗ — Silent hypoxaemia in COVID-19 patients
  • T6 35079817 ↗ — Chronic Fatigue and Postexertional Malaise in People Living With Long COVID: An Observational Study
  • T6 33909761 ↗ — Brazilian Guidelines of Hypertension - 2020
  • T6 33807869 ↗ — Defining Post-COVID Symptoms (Post-Acute COVID, Long COVID, Persistent Post-COVID): An Integrative C
Prednisolone /
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
23 sources
  • T1 NCT05638633 ↗ — Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome
  • T6INDIRECT 33246166 ↗ — COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current lite
  • T6INDIRECT 35182760 ↗ — ESCMID rapid guidelines for assessment and management of long COVID
  • T6INDIRECT 36921716 ↗ — COVID-19-associated mucormycosis: a systematic review and meta-analysis of 958 cases
  • T6INDIRECT 34396514 ↗ — Systemic corticosteroids for the treatment of COVID-19
  • T6INDIRECT 34839149 ↗ — A systematic review of cases of CNS demyelination following COVID-19 vaccination
  • T6INDIRECT 36988252 ↗ — Adverse events following COVID-19 mRNA vaccines: A systematic review of cardiovascular complication,
  • T6INDIRECT 34386902 ↗ — Association of CNS demyelination and COVID-19 infection: an updated systematic review
  • T6INDIRECT 33036570 ↗ — Implications of COVID-19 in high burden countries for HIV/TB: A systematic review of evidence
  • T6INDIRECT 33429174 ↗ — Corticosteroid nasal spray for recovery of smell sensation in COVID-19 patients: A randomized contro
  • T6INDIRECT 33084029 ↗ — Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 mon
  • T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
  • T6 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6INDIRECT 34156034 ↗ — Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebra
  • T6INDIRECT 32201335 ↗ — Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID
  • T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6INDIRECT 38378653 ↗ — Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatme
  • T6INDIRECT 33219837 ↗ — Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological
  • T6INDIRECT 32637987 ↗ — The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings
  • T6 37076602 ↗ — Therapeutic strategies for COVID-19: progress and lessons learned
  • T6 34991982 ↗ — An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
  • T6 34716418 ↗ — Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison
  • T6 33166287 ↗ — Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial i
Processing Speed Training
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVIDME/CFS
7 sources
  • T1REGISTERED-ONLY NCT06095297 ↗ — Long COVID Brain Fog: Cognitive Rehabilitation Trial
  • T2REGISTERED-ONLY NCT07523113 ↗ — ME/CFS Brain Fog: Cognitive Rehabilitation Trial
  • T6 PMC11688754 ↗ — Full GSA 2024 Abstract Book PDF
  • T6 24960594 ↗ — NIH Toolbox Cognitive Battery (NIHTB-CB): the NIHTB Pattern Comparison Processing Speed Test
  • T6 25859431 ↗ — Psychological intervention for improving cognitive function in cancer survivors: a literature review
  • T6 36175973 ↗ — Effectiveness of the Unified Barlow Protocol (UP) and neuropsychological treatment in cancer survivo
  • T6 PMC6840740 ↗ — Program Abstracts from the GSA 2019 Annual Scientific Meeting “Strength in Age—Harnessing the Power
Psychotherapy
T1
T1 — RCT in LC/PASC/PACVS
RegisteredWithdrawnLong COVIDME/CFS
56 sources
  • T1REGISTERED-ONLY NCT06042751 ↗ — Psychosomatic, Physical Activity or Both for Post-covid19 Syndrom
  • T2WITHDRAWN NCT05967052 ↗ — Investigation of Treating Chronic Fatigue Syndrome After COVID With Pharmacotherapy (Pregabalin) or
  • T6INDIRECT 36731907 ↗ — Exercise as medicine for depressive symptoms? A systematic review and meta-analysis with meta-regres
  • T6INDIRECT 33781283 ↗ — Mental burden and its risk and protective factors during the early phase of the SARS-CoV-2 pandemic:
  • T6INDIRECT 33426733 ↗ — Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus-2 infection: A systemat
  • T6INDIRECT 34592585 ↗ — Telehealth utilization during the Covid-19 pandemic: A systematic review
  • T6INDIRECT 34523128 ↗ — Continuing education meetings and workshops: effects on professional practice and healthcare outcome
  • T6INDIRECT 34600257 ↗ — The early impact of COVID-19 on the incidence, prevalence, and severity of alcohol use and other dru
  • T6INDIRECT 36032234 ↗ — Post-COVID-19 fatigue: A systematic review
  • T6INDIRECT 34844624 ↗ — The impact of the novel coronavirus disease (COVID-19) pandemic on drug overdose-related deaths in t
  • T6INDIRECT 35322449 ↗ — A mixed-studies systematic review of the experiences of body image, disordered eating, and eating di
  • T6INDIRECT 36129719 ↗ — Effectiveness of Standard Sequential Bilateral Repetitive Transcranial Magnetic Stimulation vs Bilat
  • T6 32682460 ↗ — How mental health care should change as a consequence of the COVID-19 pandemic
  • T6 36192553 ↗ — How COVID-19 shaped mental health: from infection to pandemic effects
  • T6INDIRECT 20350028 ↗ — The effect of mindfulness-based therapy on anxiety and depression: A meta-analytic review
  • T6INDIRECT 22895961 ↗ — Exercise interventions on health-related quality of life for cancer survivors
  • T6INDIRECT 26730878 ↗ — Exercise-based cardiac rehabilitation for coronary heart disease
  • T6INDIRECT 22895974 ↗ — Exercise interventions on health-related quality of life for people with cancer during active treatm
  • T6INDIRECT 24805797 ↗ — Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis
  • T6INDIRECT 18165893 ↗ — Internet-administered cognitive behavior therapy for health problems: a systematic review
  • T6INDIRECT 24881045 ↗ — Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing p
  • T6INDIRECT 11265953 ↗ — Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial
  • T6INDIRECT 28943228 ↗ — Effect of Lactobacillus rhamnosus HN001 in Pregnancy on Postpartum Symptoms of Depression and Anxiet
  • T6INDIRECT 8555852 ↗ — Cognitive behaviour therapy for the chronic fatigue syndrome: a randomized controlled trial
  • T6 18923511 ↗ — The molecular neurobiology of depression
  • T6 23798298 ↗ — Lack of exercise is a major cause of chronic diseases
  • T6INDIRECT 32685700 ↗ — Germany's digital health reforms in the COVID-19 era: lessons and opportunities for other countries
  • T6INDIRECT 35373533 ↗ — International consensus statement on allergy and rhinology: Olfaction
  • T6INDIRECT 34682909 ↗ — Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): An Overview
  • T6INDIRECT 34027514 ↗ — Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort st
  • T6INDIRECT 34051516 ↗ — Physical and mental health complications post-COVID-19: Scoping review
  • T6 37907497 ↗ — The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of lon
  • T6 33441072 ↗ — PTSD in the COVID-19 Era
  • T6 34155207 ↗ — SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals
  • T6 37713568 ↗ — Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epide
  • T6 36202135 ↗ — Clinical guidelines for the use of lifestyle-based mental health care in major depressive disorder:
  • T6 33049215 ↗ — COVID-19 and Cancer: Current Challenges and Perspectives
  • T6 34505369 ↗ — The growing field of digital psychiatry: current evidence and the future of apps, social media, chat
  • T6 33444560 ↗ — Effects of the COVID-19 pandemic on primary care-recorded mental illness and self-harm episodes in t
  • T6 41092926 ↗ — Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life e
  • T6INDIRECT 23076904 ↗ — Printed educational materials: effects on professional practice and healthcare outcomes
  • T6INDIRECT 30284240 ↗ — Psychological interventions for needle-related procedural pain and distress in children and adolesce
  • T6INDIRECT 24366490 ↗ — Cultural concepts of distress and psychiatric disorders: literature review and research recommendati
  • T6INDIRECT 20471738 ↗ — Sleep disturbance as transdiagnostic: consideration of neurobiological mechanisms
  • T6INDIRECT 15774430 ↗ — Depression in multiple sclerosis: a review
  • T6INDIRECT 12830308 ↗ — Patients presenting with somatic complaints: epidemiology, psychiatric comorbidity and management
  • T6INDIRECT 24518354 ↗ — Social media: a review and tutorial of applications in medicine and health care
  • T6INDIRECT 25365763 ↗ — Interoceptive dysfunction: toward an integrated framework for understanding somatic and affective di
  • T6 17716101 ↗ — Stress and health: psychological, behavioral, and biological determinants
  • T6 29884281 ↗ — Interoception and Mental Health: A Roadmap
  • T6 36116464 ↗ — Amyotrophic lateral sclerosis
  • T6 29876878 ↗ — Role of the Prefrontal Cortex in Pain Processing
  • T6 31379879 ↗ — The Role of Inflammation in Depression and Fatigue
  • T6 23459093 ↗ — The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses
  • T6 27159638 ↗ — Irritable bowel syndrome
  • T6 17488783 ↗ — Guidelines on the irritable bowel syndrome: mechanisms and practical management
Pulsed ectromagnetid field therapy
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT05379517 ↗ — Pulmonary Rehabilitation Program With Pulsed Electromagnetic Field Therapy in Patients With Post-cov
Qigong
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
29 sources
  • T1 NCT05675995 ↗ — Qigong for Post Acute Sequelae of COVID-19 Infection
  • T6INDIRECT 37802177 ↗ — Effectiveness of Rehabilitation Interventions on Adults With COVID-19 and Post-COVID-19 Condition. A
  • T6INDIRECT 36833525 ↗ — Tai Chi Exercise for Mental and Physical Well-Being in Patients with Depressive Symptoms: A Systemat
  • T6INDIRECT 36249181 ↗ — Do patients with and survivors of COVID-19 benefit from telerehabilitation? A meta-analysis of rando
  • T6INDIRECT 36804363 ↗ — Health maintenance through home-based interventions for community-dwelling older people with sarcope
  • T6INDIRECT 35108624 ↗ — Respiratory rehabilitation in patients recovering from severe acute respiratory syndrome: A systemat
  • T6INDIRECT 40083165 ↗ — Effect of pulmonary rehabilitation for patients with long COVID-19: a systematic review and meta-ana
  • T6INDIRECT 38214047 ↗ — Rehabilitation and COVID-19: systematic review by Cochrane Rehabilitation
  • T6INDIRECT 35615091 ↗ — Use of Traditional, Complementary and Integrative Medicine During the COVID-19 Pandemic: A Systemati
  • T6INDIRECT 36982095 ↗ — Does Physical Exercise Enhance the Immune Response after Vaccination? A Systematic Review for Clinic
  • T6 32369030 ↗ — Considerations for Postacute Rehabilitation for Survivors of COVID-19
  • T6 34095290 ↗ — Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study
  • T6 35990058 ↗ — Depression and anxiety among children and adolescents pre and post COVID-19: A comparative meta-anal
  • T6INDIRECT 35533528 ↗ — Effects of mental health interventions among people hospitalized with COVID-19 infection: A systemat
  • T1 38807958 ↗ — Evaluating qigong as integrative support for COVID-19 and Long-COVID-19 rehabilitation: a systematic
  • T6INDIRECT 37091719 ↗ — Late-life depression: Epidemiology, phenotype, pathogenesis and treatment before and during the COVI
  • T6INDIRECT 38925790 ↗ — Neuroimmune recognition and regulation in the respiratory system
  • T6INDIRECT 37577106 ↗ — The use of complementary and alternative medicine for the treatment of gastrointestinal symptoms in
  • T6INDIRECT 35966751 ↗ — Complementary and Alternative Medicine for Long COVID: Scoping Review and Bibliometric Analysis
  • T6 36575646 ↗ — What can we learn from the Baduanjin rehabilitation as COVID-19 treatment?: A narrative review
  • T6 41366804 ↗ — Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): diagnosis and management
  • T6 33733717 ↗ — Translational research on Myology and Mobility Medicine: 2021 semi-virtual PDM3 from Thermae of Euga
  • T6 39234315 ↗ — 18&lt;sup&gt;th&lt;/sup&gt; Asian Federation of Sports Medicine Congress cum 8&lt;sup&gt;th&lt;/sup&
  • T6 37505151 ↗ — 2023 International Conference on Life, Health and Modern Medicine
  • T6 34926835 ↗ — Program Abstracts from The GSA 2021 Annual Scientific Meeting, "Disruption to Transformation: Aging
  • T6 33358750 ↗ — Integrative medicine considerations for convalescence from mild-to-moderate COVID-19 disease
  • T6 36681118 ↗ — Influence of electromagnetic fields on the circadian rhythm: Implications for human health and disea
  • T6 36387947 ↗ — Mindfulness Meditation Interventions for Long COVID: Biobehavioral Gene Expression and Neuroimmune F
  • T6 39220224 ↗ — Traditional Chinese Rehabilitation Exercise (TCRE) for Myofascial Pain: Current Evidence and Further
Reaction Time Training
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVIDME/CFS
5 sources
  • T1REGISTERED-ONLY NCT06095297 ↗ — Long COVID Brain Fog: Cognitive Rehabilitation Trial
  • T2REGISTERED-ONLY NCT07523113 ↗ — ME/CFS Brain Fog: Cognitive Rehabilitation Trial
  • T6INDIRECT 40952658 ↗ — Effects of exergaming with a resistance component versus traditional resistance training on sarcopen
  • T6 37190625 ↗ — The Use of Neurofeedback in Sports Training: Systematic Review
  • T6 39727822 ↗ — Physical Exercise Intervention Characteristics and Outcomes in Frail and Pre-Frail Older Adults
Rehabilitation program
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
25 sources
  • T1 NCT05848518 ↗ — Exercise for Health in Patients With Post-acute Sequelae of COVID-19
  • T1 NCT06952127 ↗ — Feasibility and Preliminary Efficacy of a Group-based Telerehabilitation Program in People With Post
  • T6INDIRECT 35182760 ↗ — ESCMID rapid guidelines for assessment and management of long COVID
  • T1 37725376 ↗ — Rehabilitation Interventions for Physical Capacity and Quality of Life in Adults With Post-COVID-19
  • T6INDIRECT 34339806 ↗ — Psychiatric and neuropsychiatric sequelae of COVID-19 - A systematic review
  • T6INDIRECT 34592585 ↗ — Telehealth utilization during the Covid-19 pandemic: A systematic review
  • T1 35564579 ↗ — Rehabilitation Interventions for Post-Acute COVID-19 Syndrome: A Systematic Review
  • T1 35265644 ↗ — Effect of Pulmonary Rehabilitation for Patients With Post-COVID-19: A Systematic Review and Meta-Ana
  • T1 36606682 ↗ — Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstr
  • T6INDIRECT 37155736 ↗ — Efficacy of Cognitive-Behavioral Therapy Targeting Severe Fatigue Following Coronavirus Disease 2019
  • T1 35409815 ↗ — Cardiopulmonary Rehabilitation in Long-COVID-19 Patients with Persistent Breathlessness and Fatigue:
  • T6INDIRECT 33831043 ↗ — Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary
  • T6 34024217 ↗ — Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
  • T6 39326415 ↗ — Mechanisms of long COVID and the path toward therapeutics
  • T6INDIRECT 34710173 ↗ — Impact of Covid-19 on health-related quality of life of patients: A structured review
  • T6INDIRECT 35493431 ↗ — Long COVID and neuropsychiatric manifestations (Review)
  • T6INDIRECT 34218857 ↗ — Post-COVID-19 Syndrome (Long Haul Syndrome): Description of a Multidisciplinary Clinic at Mayo Clini
  • T6 32529595 ↗ — Post-COVID-19 global health strategies: the need for an interdisciplinary approach
  • T6 37907497 ↗ — The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of lon
  • T6 37457901 ↗ — Post-COVID cognitive dysfunction: current status and research recommendations for high risk populati
  • T6 35566253 ↗ — The Pathophysiology of Long COVID throughout the Renin-Angiotensin System
  • T6 34870247 ↗ — Neurological consequences of COVID-19 and brain related pathogenic mechanisms: A new challenge for n
  • T6 36836568 ↗ — Long COVID: Clinical Framing, Biomarkers, and Therapeutic Approaches
  • T6 34067776 ↗ — Post-COVID-19 Syndrome and the Potential Benefits of Exercise
  • T6 34390682 ↗ — Post-COVID-19 Tachycardia Syndrome: A Distinct Phenotype of Post-Acute COVID-19 Syndrome
Repetitive Transcranial Magnetic Stimulation
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
26 sources
  • T1REGISTERED-ONLY NCT07278206 ↗ — Brain Stimulation in Long COVID
  • T6INDIRECT 38329083 ↗ — Efficacy and safety of transcranial magnetic stimulation on cognition in mild cognitive impairment,
  • T6INDIRECT 39388006 ↗ — Gray matter and cognitive alteration related to chronic obstructive pulmonary disease patients: comb
  • T6INDIRECT 34752489 ↗ — A mixed-methods systematic review of post-viral fatigue interventions: Are there lessons for long Co
  • T6INDIRECT 39384321 ↗ — Systematic review of interventions for mental health, cognition and psychological well-being in long
  • T1 36129719 ↗ — Effectiveness of Standard Sequential Bilateral Repetitive Transcranial Magnetic Stimulation vs Bilat
  • T1 38228914 ↗ — Connectivity-guided intermittent theta burst versus repetitive transcranial magnetic stimulation for
  • T6INDIRECT 36455453 ↗ — Co-ultramicronized palmitoylethanolamide/luteolin normalizes GABA<sub>B</sub>-ergic activity and cor
  • T6INDIRECT 35974039 ↗ — Improving taste sensitivity in healthy adults using taste recall training: a randomized controlled t
  • T6INDIRECT 40094666 ↗ — Donepezil for Fatigue and Psychological Symptoms in Post-COVID-19 Condition: A Randomized Clinical T
  • T6INDIRECT 36610206 ↗ — Real world research on transcranial magnetic stimulation treatment strategies for neuropsychiatric s
  • T6 35734582 ↗ — Non-invasive brain stimulation and neuroenhancement
  • T6 33537521 ↗ — Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic
  • T6INDIRECT 37004143 ↗ — A 30-Year-Old Woman with an 8-Week History of Anxiety, Depression, Insomnia, and Mild Cognitive Impa
  • T6INDIRECT 36831861 ↗ — Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Di
  • T6INDIRECT 39744683 ↗ — Photobiomodulation: shining a light on depression
  • T6INDIRECT 41688232 ↗ — Clinical utility and prospective of TMS-EEG: Updated review from an international expert group
  • T6 37372912 ↗ — What Do We Know about Nociplastic Pain?
  • T6 38931833 ↗ — Insight into the Functional Dynamics and Challenges of Exosomes in Pharmaceutical Innovation and Pre
  • T6 36225892 ↗ — A comprehensive review of transcranial magnetic stimulation in secondary dementia
  • T6 39519182 ↗ — Understanding Endothelial Dysfunction and Its Role in Ischemic Stroke After the Outbreak of Recanali
  • T6 37304012 ↗ — Matrix disequilibrium in Alzheimer's disease and conditions that increase Alzheimer's disease risk
  • T6 33324324 ↗ — Applications of Non-invasive Neuromodulation for the Management of Disorders Related to COVID-19
  • T6 38367046 ↗ — Artificial intelligence in neurology: opportunities, challenges, and policy implications
  • T6 35720084 ↗ — Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic
  • T6 38944141 ↗ — Stress and Inflammation Target Dorsolateral Prefrontal Cortex Function: Neural Mechanisms Underlying
Rice Protein Powder with Vitamin C
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
  • T1REGISTERED-ONLY OSMF-VS4P-001 ↗ — Effect of Metabolic Modulation on a Post-acute COVID-19 Vaccination Syndrome (PACVS) Cohort
Ritonavir
T1
T1 — RCT in LC/PASC/PACVS
Harm signalLong COVID
28 sources
  • T1 NCT05576662 ↗ — Paxlovid for Treatment of Long Covid
  • T1HARM NCT05668091 ↗ — A Decentralized, Randomized Phase 2 Efficacy and Safety Study of Nirmatrelvir/Ritonavir in Adults wi
  • T1 NCT05965726 ↗ — RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms
  • T6INDIRECT 33549624 ↗ — COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid
  • T6INDIRECT 33426733 ↗ — Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus-2 infection: A systemat
  • T6INDIRECT 34396514 ↗ — Systemic corticosteroids for the treatment of COVID-19
  • T6INDIRECT 34318930 ↗ — Ivermectin for preventing and treating COVID-19
  • T6INDIRECT 34452974 ↗ — Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19: Sys
  • T6INDIRECT 34386902 ↗ — Association of CNS demyelination and COVID-19 infection: an updated systematic review
  • T6INDIRECT 33036570 ↗ — Implications of COVID-19 in high burden countries for HIV/TB: A systematic review of evidence
  • T6INDIRECT 32454187 ↗ — Review of trials currently testing treatment and prevention of COVID-19
  • T1 38848477 ↗ — Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection: The S
  • T1 37276589 ↗ — Effectiveness of COVID-19 Treatment With Nirmatrelvir-Ritonavir or Molnupiravir Among U.S. Veterans:
  • T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
  • T6 32201335 ↗ — Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID
  • T6INDIRECT 33723416 ↗ — The first 12 months of COVID-19: a timeline of immunological insights
  • T6INDIRECT 33856918 ↗ — COVID-19 and Cardiovascular Disease: From Bench to Bedside
  • T6INDIRECT 33609255 ↗ — A Review of Persistent Post-COVID Syndrome (PPCS)
  • T6INDIRECT 32857878 ↗ — Thrombosis in COVID-19
  • T6INDIRECT 33219837 ↗ — Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological
  • T6INDIRECT 33595463 ↗ — COVID-19 and Eye: A Review of Ophthalmic Manifestations of COVID-19
  • T6 37076602 ↗ — Therapeutic strategies for COVID-19: progress and lessons learned
  • T6 33965003 ↗ — The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
  • T6 39326415 ↗ — Mechanisms of long COVID and the path toward therapeutics
  • T6 34991982 ↗ — An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
  • T6 35271343 ↗ — The immunology and immunopathology of COVID-19
  • T6 33892403 ↗ — Long COVID: An overview
  • T6 33431578 ↗ — Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients
Routine care and book
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT06004362 ↗ — Complementary and Integrative Medicine as an Online Intervention in Patients With Post-covid Syndrom
Selzentry
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
6 sources
  • T1REGISTERED-ONLY NCT06511063 ↗ — Antiviral Clinical Trial for Long Covid-19
  • T6 39947217 ↗ — Targeting the SARS-CoV-2 reservoir in long COVID
  • T6 40559563 ↗ — Digestive Manifestations of Post-COVID-19: A Focus on Therapeutic Strategies
  • T6 36678799 ↗ — Modulating Immune Response in Viral Infection for Quantitative Forecasts of Drug Efficacy
  • T6 42325367 ↗ — Long COVID: current research and future directions
  • T6 PMC12982061 ↗ — Candidate treatments for long COVID: a narrative review of expert and patient-driven priorities
Sirolimus
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
20 sources
  • T1REGISTERED-ONLY NCT04948203 ↗ — Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID
  • T6INDIRECT 38105461 ↗ — Outpatient randomized controlled trials to reduce COVID-19 hospitalization: Systematic review and me
  • T6INDIRECT 36029185 ↗ — Prevalence of NSAID use among people with COVID-19 and the association with COVID-19-related outcome
  • T6INDIRECT 36473651 ↗ — Efficacy and safety of COVID-19 vaccines
  • T6INDIRECT 34679203 ↗ — Antibiotics for the treatment of COVID-19
  • T6INDIRECT 37175556 ↗ — Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary
  • T6INDIRECT 36111511 ↗ — Heart failure during the COVID-19 pandemic: clinical, diagnostic, management, and organizational dil
  • T6INDIRECT 36786873 ↗ — A systematic review of the incidence, management and prognosis of new-onset autoimmune connective ti
  • T6INDIRECT 34837648 ↗ — Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a th
  • T6INDIRECT 33084029 ↗ — Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 mon
  • T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
  • T6 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6INDIRECT 33586189 ↗ — COVID-19: immunopathology, pathophysiological mechanisms, and treatment options
  • T6INDIRECT 34375047 ↗ — Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Trea
  • T6INDIRECT 34793455 ↗ — COVID-19-associated mucormycosis: Evidence-based critical review of an emerging infection burden dur
  • T6INDIRECT 33890986 ↗ — Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-
  • T6 37060495 ↗ — Pathological angiogenesis: mechanisms and therapeutic strategies
  • T6 34991982 ↗ — An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
  • T6 37018987 ↗ — Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy?
Smell Training
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
23 sources
  • T1REGISTERED-ONLY NCT05855369 ↗ — Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)
  • T6INDIRECT 36349400 ↗ — Clinical trials on the pharmacological treatment of long COVID: A systematic review
  • T6INDIRECT 35957578 ↗ — Qualitative Olfactory Dysfunction and COVID-19: An Evidence-Based Review with Recommendations for th
  • T6INDIRECT 36062970 ↗ — Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction
  • T6INDIRECT 34456675 ↗ — Steroids and Olfactory Training for Postviral Olfactory Dysfunction: A Systematic Review
  • T6INDIRECT 36063364 ↗ — Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  • T6INDIRECT 37531338 ↗ — Effect of any form of steroids in comparison with that of other medications on the duration of olfac
  • T6INDIRECT 36976171 ↗ — Treatment of Olfactory Disorders After SARS - CoViD 2 Virus Infection
  • T6INDIRECT 41555643 ↗ — The APOLLO trial: a proof-of-concept study for vitamin A nasal drops in COVID-19-related postinfecti
  • T6 35373533 ↗ — International consensus statement on allergy and rhinology: Olfaction
  • T6 32854169 ↗ — Management of new onset loss of sense of smell during the COVID-19 pandemic - BRS Consensus Guidelin
  • T6 34559820 ↗ — Altered smell and taste: Anosmia, parosmia and the impact of long Covid-19
  • T6 38898278 ↗ — Human SARS-CoV-2 challenge uncovers local and systemic response dynamics
  • T6INDIRECT 37496529 ↗ — Efficacy of Stellate Ganglion Block in Treating Long-Term COVID-19-Related Olfactory and Gustatory D
  • T6INDIRECT 36949968 ↗ — A Review of Stellate Ganglion Block as an Adjunctive Treatment Modality
  • T6 35894511 ↗ — COVID-19 and olfactory dysfunction: a looming wave of dementia?
  • T6 35874953 ↗ — Revealing the mystery of persistent smell loss in Long COVID patients
  • T6 37366867 ↗ — Post-COVID-19 Anosmia and Therapies: Stay Tuned for New Drugs to Sniff Out
  • T6 34191699 ↗ — SARS-Cov-2 Damage on the Nervous System and Mental Health
  • T6 36835589 ↗ — Chemosensory Ability and Sensitivity in Health and Disease: Epigenetic Regulation and COVID-19
  • T6 35448042 ↗ — Changes in the Intranetwork and Internetwork Connectivity of the Default Mode Network and Olfactory
  • T6 36196612 ↗ — Preliminary Guidelines for the Clinical Evaluation and Management of Long COVID
  • T6 36180640 ↗ — Neurological consequences of COVID-19
Sodium Citrate
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
26 sources
  • T1REGISTERED-ONLY NCT06204432 ↗ — Sodium Citrate in Smell Retraining for People With Post-COVID-19 Olfactory Dysfunction
  • T6INDIRECT 35182760 ↗ — ESCMID rapid guidelines for assessment and management of long COVID
  • T6INDIRECT 35957578 ↗ — Qualitative Olfactory Dysfunction and COVID-19: An Evidence-Based Review with Recommendations for th
  • T6INDIRECT 34456675 ↗ — Steroids and Olfactory Training for Postviral Olfactory Dysfunction: A Systematic Review
  • T6INDIRECT 38459338 ↗ — A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models
  • T6INDIRECT 36507615 ↗ — Use of platelet-rich plasma for COVID-19-related olfactory loss: a randomized controlled trial
  • T1 35942688 ↗ — Effect of Sodium Gluconate on Decreasing Elevated Nasal Calcium and Improving Olfactory Function Pos
  • T6INDIRECT 40504522 ↗ — Stellate Ganglion Block for the Treatment of COVID-19-Induced Parosmia: A Randomized Clinical Trial
  • T6INDIRECT 39763448 ↗ — Treatment with Sulodexide Downregulates Biomarkers for Endothelial Dysfunction in Convalescent COVID
  • T6INDIRECT 33999778 ↗ — Distinct phenotypes of platelet, monocyte, and neutrophil activation occur during the acute and conv
  • T6 32526206 ↗ — SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract
  • T6 34425843 ↗ — Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accomp
  • T6 37848036 ↗ — Serotonin reduction in post-acute sequelae of viral infection
  • T6INDIRECT 35373533 ↗ — International consensus statement on allergy and rhinology: Olfaction
  • T6INDIRECT 36148558 ↗ — Neurological post-acute sequelae of SARS-CoV-2 infection
  • T6INDIRECT 34870148 ↗ — Pathophysiology and possible treatments for olfactory-gustatory disorders in patients affected by CO
  • T6INDIRECT 37388279 ↗ — Long COVID: Complications, Underlying Mechanisms, and Treatment Strategies
  • T6INDIRECT 35870428 ↗ — COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis
  • T6INDIRECT 35867861 ↗ — SARS-CoV-2 triggers pericyte-mediated cerebral capillary constriction
  • T6 29520143 ↗ — Nanotechnology-based drug delivery systems for control of microbial biofilms: a review
  • T6 35365631 ↗ — Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates
  • T6 34087216 ↗ — Physical phenotype of blood cells is altered in COVID-19
  • T6 34021148 ↗ — Peripheral and lung resident memory T cell responses against SARS-CoV-2
  • T6 36131342 ↗ — Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows m
  • T6 29472725 ↗ — An ancient family of lytic polysaccharide monooxygenases with roles in arthropod development and bio
  • T6 34328172 ↗ — SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microcl
Solriamfetol
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
11 sources
  • T1 NCT06404086 ↗ — RECOVER-SLEEP: Platform Protocol
  • T1 NCT06404099 ↗ — RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia)
  • T6 39125722 ↗ — Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detectio
  • T6 36313516 ↗ — Sleep medicine: Practice, challenges and new frontiers
  • T6 40046430 ↗ — Neurological sequelae of long COVID: a comprehensive review of diagnostic imaging, underlying mechan
  • T6 35887329 ↗ — Proteomic Biomarkers of the Apnea Hypopnea Index and Obstructive Sleep Apnea: Insights into the Path
  • T6 40261198 ↗ — Multidisciplinary collaborative guidance on the assessment and treatment of patients with Long COVID
  • T6INDIRECT 41054740 ↗ — Drug Interactions With Excessive Daytime Sleepiness Treatments
  • T6INDIRECT 36454442 ↗ — Abstracts of the 52nd Annual Conference of the Italian Society of Neurology
  • T6 34658002 ↗ — Current Management of Residual Excessive Daytime Sleepiness Due to Obstructive Sleep Apnea: Insights
  • T6 35035550 ↗ — Highlights of the ERS Lung Science Conference and Sleep and Breathing Conference 2021 and the new EC
Specific DB program/Diaphragmatic manipulation program
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT06330376 ↗ — Diaphragmatic Breathing Exercises for Post-COVID-19 Diaphragmatic Dysfunction (DD)
Splenic Ultrasound
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
4 sources
  • T1 NCT06189066 ↗ — Long COVID Ultrasound Trial
  • T6 39833963 ↗ — Next generation bioelectronic medicine: making the case for non-invasive closed-loop autonomic neuro
  • T6 41781173 ↗ — A Review of Vagus Nerve Stimulation for Disease: Comprehensive Theory and Evidence for Mechanisms of
  • T6 39259857 ↗ — Severe Invasive Pneumococcal Disease Caused by Serotype 19A in Children Under Five Years in Tāmaki M
Structured Pacing
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
13 sources
  • T1 NCT06404047 ↗ — RECOVER-ENERGIZE Platform Protocol
  • T1 NCT06404073 ↗ — RECOVER-ENERGIZE Platform Protocol_Appendix B (Structured Pacing (PEM))
  • T6 37326700 ↗ — Rehabilitative interventions in patients with persistent post COVID-19 symptoms-a review of recent a
  • T6 36461167 ↗ — Effect of using a structured pacing protocol on post-exertional symptom exacerbation and health stat
  • T6 38658496 ↗ — Practical Recommendations for Exercise Training in Patients with Long COVID with or without Post-exe
  • T6 37166076 ↗ — Reduced Exercise Capacity, Chronotropic Incompetence, and Early Systemic Inflammation in Cardiopulmo
  • T6 37569053 ↗ — Physical Activity in Long COVID: A Comparative Study of Exercise Rehabilitation Benefits in Patients
  • T6 41213692 ↗ — Pursuing Reduction in Fatigue After COVID-19 via Exercise and Rehabilitation (PREFACER): a protocol
  • T6 40397936 ↗ — Multimodal Web-Based Telerehabilitation for Patients With Post-COVID-19 Condition: Protocol for a Ra
  • T6INDIRECT 41862909 ↗ — Pharmacological and non-pharmacological management of long COVID
  • T6 38612615 ↗ — Possible Role of Cannabis in the Management of Neuroinflammation in Patients with Post-COVID Conditi
  • T6 42214072 ↗ — Wearable- and Mobile App-Based Activity Pacing and Fatigue Management in Post-COVID-19 Condition: Ex
  • T6 41768410 ↗ — Rehabilitation strategies for long COVID: integrating human factors engineering
SuperCAP Program
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT06315894 ↗ — Supervised Computerized Active Program for People With Post-COVID Syndrome (SuperCAP Study)
Swimming
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
25 sources
  • T1 NCT07454395 ↗ — Is Swimming a More Tolerable Form of Movement for Individuals With Myalgic Encephalomyelitis/ Chroni
  • T6INDIRECT 34769800 ↗ — Impact of the COVID-19 Pandemic on Sedentary Time and Behaviour in Children and Adults: A Systematic
  • T6INDIRECT 37359525 ↗ — Lipopolysaccharide-induced depression-like model in mice: meta-analysis and systematic evaluation
  • T6INDIRECT 37666869 ↗ — Effectiveness of physical activity interventions on reducing perceived fatigue among adults with chr
  • T6INDIRECT 35716338 ↗ — SARS-CoV-2 effects on sperm parameters: a meta-analysis study
  • T6INDIRECT 34192010 ↗ — Changes in physical activity and sedentary behaviours from before to during the COVID-19 pandemic lo
  • T6INDIRECT 33284353 ↗ — Rehabilitation setting during and after Covid-19: An overview on recommendations
  • T6INDIRECT 37062429 ↗ — TFOS lifestyle: Impact of societal challenges on the ocular surface
  • T6INDIRECT 36642173 ↗ — A systematic review of trials currently investigating therapeutic modalities for post-acute COVID-19
  • T6INDIRECT 36476156 ↗ — Effects of a concurrent training, respiratory muscle exercise, and self-management recommendations o
  • T6INDIRECT 35954922 ↗ — The Effectiveness of a Four-Week Digital Physiotherapy Intervention to Improve Functional Capacity a
  • T6 33243837 ↗ — Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies
  • T6 34067776 ↗ — Post-COVID-19 Syndrome and the Potential Benefits of Exercise
  • T6INDIRECT 33723532 ↗ — Long-Haul Post-COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrom
  • T6INDIRECT 33735380 ↗ — Physical Therapy Management of an Individual With Post-COVID Syndrome: A Case Report
  • T6INDIRECT 34403043 ↗ — Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor's pag
  • T6INDIRECT 35307156 ↗ — 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocard
  • T6INDIRECT 38123343 ↗ — Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Dise
  • T6INDIRECT 36202135 ↗ — Clinical guidelines for the use of lifestyle-based mental health care in major depressive disorder:
  • T6 36876744 ↗ — The British Society for Sexual Medicine Guidelines on Male Adult Testosterone Deficiency, with State
  • T6 34606374 ↗ — Sensory Perception in Bacterial Cyclic Diguanylate Signal Transduction
  • T6 37152753 ↗ — Mechanistic insights into nanoparticle surface-bacterial membrane interactions in overcoming antibio
  • T6 33909761 ↗ — Brazilian Guidelines of Hypertension - 2020
  • T6 36857178 ↗ — SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-C
  • T6 37712135 ↗ — Lifestyle management of hypertension: International Society of Hypertension position paper endorsed
Synbiotic IVS-1
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
2 sources
  • T1 NCT06620406 ↗ — Synbiotic Therapy for NP-PASC
  • T6 41952158 ↗ — Targeting immunosenescence in lung diseases: mechanistic insights and clinical interventions
Synthetic Vitamin B1
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
TNX-102 SL
T1
T1 — RCT in LC/PASC/PACVS
Harm signalLong COVID
4 sources
  • T1HARM NCT05472090 ↗ — A Phase 2 Study to Evaluate the Efficacy and Safety of TNX-102 SL in Patients With Multi-Site Pain A
  • T6 37907497 ↗ — The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of lon
  • T6 40384184 ↗ — Transforming Niclosamide through Nanotechnology: A Promising Approach for Long COVID Management
  • T6 37316880 ↗ — Long COVID: Costs for the German economy and health care and pension system
Tailored lighting Active
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
2 sources
Telerehabilitation program
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
31 sources
  • T1 NCT05866224 ↗ — Telerehabilitation Program and Detraining in Patients With Post-COVID-19 Sequelae
  • T6INDIRECT 35908659 ↗ — Effect of Pulmonary Rehabilitation Approaches on Dyspnea, Exercise Capacity, Fatigue, Lung Functions
  • T1 36249181 ↗ — Do patients with and survivors of COVID-19 benefit from telerehabilitation? A meta-analysis of rando
  • T1 35414491 ↗ — Telerehabilitation improves physical function and reduces dyspnoea in people with COVID-19 and post-
  • T6INDIRECT 38214047 ↗ — Rehabilitation and COVID-19: systematic review by Cochrane Rehabilitation
  • T6INDIRECT 35868671 ↗ — Long COVID-19: The Need for an Interdisciplinary Approach
  • T1 38477069 ↗ — Evidence-based position paper on Physical and Rehabilitation Medicine (PRM) professional practice on
  • T6INDIRECT 36700571 ↗ — Effects of a home-based pulmonary rehabilitation program with and without telecoaching on health-rel
  • T1 38009852 ↗ — Effects of a telerehabilitation program and detraining on cardiorespiratory fitness in patients with
  • T1 38320238 ↗ — Educational, Exercise, and Occupational Therapy-Based Telerehabilitation Program Versus "Wait-and-Se
  • T6 33642858 ↗ — Pulmonary Rehabilitation in a Post-COVID-19 World: Telerehabilitation as a New Standard in Patients
  • T6 37581410 ↗ — Pulmonary Rehabilitation for Adults with Chronic Respiratory Disease: An Official American Thoracic
  • T6 34640447 ↗ — Effectiveness of a Primary Care Telerehabilitation Program for Post-COVID-19 Patients: A Feasibility
  • T6INDIRECT 36849853 ↗ — Could the fibromyalgia syndrome be triggered or enhanced by COVID-19?
  • T6INDIRECT 35789736 ↗ — The effect of exercise rehabilitation on COVID-19 outcomes: a systematic review of observational and
  • T6INDIRECT 35968401 ↗ — Post-COVID lung disease(s)
  • T6INDIRECT 36615087 ↗ — Post-Acute Sequelae of COVID-19: The Potential Role of Exercise Therapy in Treating Patients and Ath
  • T6INDIRECT 36530872 ↗ — Cardiopulmonary disease as sequelae of long-term COVID-19: Current perspectives and challenges
  • T6INDIRECT 33364571 ↗ — Pulmonary Rehabilitation in COVID-19 patients: A scoping review of current practice and its applicat
  • T4 33395048 ↗ — An Improvised Pulmonary Telerehabilitation Program for Postacute COVID-19 Patients Would Be Feasible
  • T6 37255115 ↗ — Telemedicine in healthcare access during the covid-19 pandemic: a scoping review
  • T6 36570860 ↗ — Full GSA 2022 Abstract Book PDF
  • T6 40986224 ↗ — World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2025)
  • T6 PMC11688754 ↗ — Full GSA 2024 Abstract Book PDF
  • T6 39252016 ↗ — Proceedings of the 31st European Paediatric Rheumatology Congress: part 1
  • T6 PMC9073161 ↗ — ESOC 2022 Abstract Book
  • T6 PMC8853075 ↗ — World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Po
  • T6 36673555 ↗ — Telerehabilitation, A Viable Option in Patients with Persistent Post-COVID Syndrome: A Systematic Re
  • T6 37761716 ↗ — Efficacy and Safety of Respiratory Telerehabilitation in Patients with Long COVID-19: A Systematic R
  • T6 36851746 ↗ — Post-COVID-19 Syndrome Comprehensive Assessment: From Clinical Diagnosis to Imaging and Biochemical-
  • T6 37185117 ↗ — Year in Review: Long COVID and Pulmonary Rehabilitation
Telerehabilitation program based on cardiorespiratory principles
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
Temelimab /kg
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT05497089 ↗ — Temelimab as a Disease Modifying Therapy in Patients With Neuropsychiatric Symptoms in Post-COVID 19
To Measure levels of circulating monocyte/ T cell doublets at Baseline
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
  • T1REGISTERED-ONLY NCT07189936 ↗ — Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS
To measure levels of circulating monocyte/ T cell doublets after 28 days of 2 HOBA treatment
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
  • T1REGISTERED-ONLY NCT07189936 ↗ — Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS
Tonabersat
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT06437223 ↗ — Study of Xiflam™ Treatment in Patients Post COVID-19 Infection Suffering From What is Known as Long
Traditional Chinese medicine treatment
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
12 sources
  • T1 NCT06095258 ↗ — A Practical RCT of TCM in the Treatment of LCOVID and Analysis of Syndrome Types and Medication Char
  • T6 36703736 ↗ — The pathological mechanism of the COVID-19 convalescence and its treatment with traditional Chinese
  • T6 38893693 ↗ — A Comprehensive Review of the Global Epidemiology, Clinical Management, Socio-Economic Impacts, and
  • T6 37243072 ↗ — Clinical Characteristics of Mild Patients with Breakthrough Infection of Omicron Variant in China af
  • T6 35571407 ↗ — Changes in inpatient admissions before and during COVID-19 outbreak in a large tertiary hospital in
  • T6 38092887 ↗ — Epidemiological and clinical features of SARS-CoV-2 Omicron variant infection in Quanzhou, Fujian pr
  • T6INDIRECT 38576710 ↗ — Acupressure: a possible therapeutic strategy for anxiety related to COVID-19: a meta-analysis of ran
  • T4 35648696 ↗ — COVID-19 Patients' Views and Experiences of Traditional Chinese Medicine Treatment in South Africa
  • T6INDIRECT 37505151 ↗ — 2023 International Conference on Life, Health and Modern Medicine
  • T6 39057037 ↗ — Potential Protective Factors for Allergic Rhinitis Patients Infected with COVID-19
  • T6 40182854 ↗ — Explainable machine learning model and nomogram for predicting the efficacy of Traditional Chinese M
  • T6 40234823 ↗ — Follow-up of long COVID based on the definition of WHO: a multi-centre cross-sectional questionnaire
Transcutaneous Non-Invasive Vagus Nerve Stimulation
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
Transcutaneous vagus nerve stimulator
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
Transfer Package
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVIDME/CFS
7 sources
  • T1REGISTERED-ONLY NCT06095297 ↗ — Long COVID Brain Fog: Cognitive Rehabilitation Trial
  • T2REGISTERED-ONLY NCT07523113 ↗ — ME/CFS Brain Fog: Cognitive Rehabilitation Trial
  • T6INDIRECT 40310209 ↗ — Long COVID brain fog treatment: An early-phase randomized controlled trial of constraint-induced cog
  • T6 PPR342074 ↗ — Fiscal Policy Responses to COVID-19 in Danida Priority Countries in Sub-Saharan Africa
  • T6 37373305 ↗ — Bioengineered Enzymes and Precision Fermentation in the Food Industry
  • T6 40726475 ↗ — 11th European Stroke Organisation Conference Abstracts - 21-23 May 2025, Helsinki, Finland
  • T6 PMC7103908 ↗ — Symposia
Treatment as Usual
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVIDME/CFS
44 sources
  • T1REGISTERED-ONLY NCT06928480 ↗ — Effectiveness and Acceptability of the Unified Protocol for the Transdiagnostic Treatment of Emotion
  • T2 NCT04593225 ↗ — Effectiveness of VIRTUAL SFCAMINA STUDY
  • T6INDIRECT 34964542 ↗ — Remote provision of breastfeeding support and education: Systematic review and meta-analysis
  • T6INDIRECT 36634261 ↗ — The Usability, Feasibility, Acceptability, and Efficacy of Digital Mental Health Services in the COV
  • T6INDIRECT 34523128 ↗ — Continuing education meetings and workshops: effects on professional practice and healthcare outcome
  • T6INDIRECT 35414491 ↗ — Telerehabilitation improves physical function and reduces dyspnoea in people with COVID-19 and post-
  • T6INDIRECT 34693988 ↗ — Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pu
  • T6INDIRECT 33326409 ↗ — Implementation of Telehealth Services to Assess, Monitor, and Treat Neurodevelopmental Disorders: Sy
  • T1 36695483 ↗ — Remdesivir for the treatment of COVID-19
  • T6INDIRECT 35768406 ↗ — Interventions for mental health, cognition, and psychological wellbeing in long COVID: a systematic
  • T6INDIRECT 34913421 ↗ — Early Intervention in Psychosis services: A systematic review and narrative synthesis of the barrier
  • T6INDIRECT 37193738 ↗ — Effectiveness of a telerehabilitation intervention using ReCOVery APP of long COVID patients: a rand
  • T6 35039676 ↗ — Immune targets for therapeutic development in depression: towards precision medicine
  • T6HARM 35727534 ↗ — Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment
  • T6INDIRECT 20350028 ↗ — The effect of mindfulness-based therapy on anxiety and depression: A meta-analytic review
  • T6INDIRECT 26730878 ↗ — Exercise-based cardiac rehabilitation for coronary heart disease
  • T6INDIRECT 28045199 ↗ — Yoga for improving health-related quality of life, mental health and cancer-related symptoms in wome
  • T6INDIRECT 30284240 ↗ — Psychological interventions for needle-related procedural pain and distress in children and adolesce
  • T6INDIRECT 18646067 ↗ — Cognitive behaviour therapy for chronic fatigue syndrome in adults
  • T6INDIRECT 26358158 ↗ — Exercise therapy for fatigue in multiple sclerosis
  • T6INDIRECT 31369582 ↗ — Helping patients help themselves: A systematic review of self-management support strategies in prima
  • T6INDIRECT 20091628 ↗ — Shared decision making interventions for people with mental health conditions
  • T2 17119141 ↗ — Surgical vs nonoperative treatment for lumbar disk herniation: the Spine Patient Outcomes Research T
  • T6INDIRECT 35654766 ↗ — Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a ra
  • T6 20471738 ↗ — Sleep disturbance as transdiagnostic: consideration of neurobiological mechanisms
  • T6 23459093 ↗ — The Efficacy of Cognitive Behavioral Therapy: A Review of Meta-analyses
  • T6INDIRECT 39482575 ↗ — Hallmarks of primary headache: part 1 - migraine
  • T6INDIRECT 35571085 ↗ — Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implicat
  • T6INDIRECT 34118499 ↗ — Addressing Pediatric Mental Health Using Telehealth During Coronavirus Disease-2019 and Beyond: A Na
  • T6 39363044 ↗ — Vagus nerve stimulation (VNS): recent advances and future directions
  • T6 38891970 ↗ — Human Gut Microbiota for Diagnosis and Treatment of Depression
  • T6 37795783 ↗ — Psychosocial interventions for survivors of rape and sexual assault experienced during adulthood
  • T6 37713568 ↗ — Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epide
  • T2 23990997 ↗ — Mindfulness-based therapies in the treatment of somatization disorders: a systematic review and meta
  • T6INDIRECT 34770209 ↗ — Sleep Disorders in Cancer-A Systematic Review
  • T6INDIRECT 25365763 ↗ — Interoceptive dysfunction: toward an integrated framework for understanding somatic and affective di
  • T4 28052319 ↗ — Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Ro
  • T6 23235630 ↗ — Interventions to facilitate return to work in adults with adjustment disorders
  • T6 32691879 ↗ — Psychological interventions to foster resilience in healthcare students
  • T6 35561510 ↗ — How do psychologically based interventions for chronic musculoskeletal pain work? A systematic revie
  • T6 34352116 ↗ — Primary-level worker interventions for the care of people living with mental disorders and distress
  • T6 32296353 ↗ — Depression, Mindfulness, and Psilocybin: Possible Complementary Effects of Mindfulness Meditation an
  • T6 37049975 ↗ — The Role of Probiotics and Their Metabolites in the Treatment of Depression
  • T6 35115105 ↗ — Interventions for Frailty Among Older Adults With Cardiovascular Disease: JACC State-of-the-Art Revi
Treatment as usual
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
21 sources
  • T1 NCT05798221 ↗ — Complementary Self-help Strategies for Patients With Post-COVID-19 Syndrome
  • T6 NCT05212467 ↗ — AIR-program and HUS Internet Therapy Compared to Treatment as Usual in Functional Disorders and Post
  • T6INDIRECT 34964542 ↗ — Remote provision of breastfeeding support and education: Systematic review and meta-analysis
  • T6INDIRECT 36634261 ↗ — The Usability, Feasibility, Acceptability, and Efficacy of Digital Mental Health Services in the COV
  • T6INDIRECT 34523128 ↗ — Continuing education meetings and workshops: effects on professional practice and healthcare outcome
  • T6INDIRECT 35414491 ↗ — Telerehabilitation improves physical function and reduces dyspnoea in people with COVID-19 and post-
  • T6INDIRECT 34693988 ↗ — Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pu
  • T6INDIRECT 33326409 ↗ — Implementation of Telehealth Services to Assess, Monitor, and Treat Neurodevelopmental Disorders: Sy
  • T1 36695483 ↗ — Remdesivir for the treatment of COVID-19
  • T6INDIRECT 35768406 ↗ — Interventions for mental health, cognition, and psychological wellbeing in long COVID: a systematic
  • T6INDIRECT 34913421 ↗ — Early Intervention in Psychosis services: A systematic review and narrative synthesis of the barrier
  • T6INDIRECT 37193738 ↗ — Effectiveness of a telerehabilitation intervention using ReCOVery APP of long COVID patients: a rand
  • T6 35039676 ↗ — Immune targets for therapeutic development in depression: towards precision medicine
  • T6HARM 35727534 ↗ — Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment
  • T6INDIRECT 39482575 ↗ — Hallmarks of primary headache: part 1 - migraine
  • T6INDIRECT 35571085 ↗ — Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implicat
  • T6INDIRECT 34118499 ↗ — Addressing Pediatric Mental Health Using Telehealth During Coronavirus Disease-2019 and Beyond: A Na
  • T6 39363044 ↗ — Vagus nerve stimulation (VNS): recent advances and future directions
  • T6 38891970 ↗ — Human Gut Microbiota for Diagnosis and Treatment of Depression
  • T6 37795783 ↗ — Psychosocial interventions for survivors of rape and sexual assault experienced during adulthood
  • T6 37713568 ↗ — Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epide
Trigeminal Nerve Stimulation
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
12 sources
  • T1REGISTERED-ONLY NCT05855369 ↗ — Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)
  • T6 38627548 ↗ — Corneal neuropathic pain: a review to inform clinical practice
  • T6 36501098 ↗ — Eating Habits and Body Weight Changes Induced by Variation in Smell and Taste in Patients with Previ
  • T6 40293510 ↗ — Alpha-synuclein pathology and Parkinson's disease-related olfactory dysfunctions: an update on precl
  • T6 34002281 ↗ — Navigating migraine care through the COVID-19 pandemic: an update
  • T6 37705568 ↗ — The Effect of Epipharyngeal Abrasive Therapy (EAT) on the Baroreceptor Reflex (BR)
  • T6INDIRECT 41781173 ↗ — A Review of Vagus Nerve Stimulation for Disease: Comprehensive Theory and Evidence for Mechanisms of
  • T6INDIRECT 34488620 ↗ — The International Headache Congress - IHS and EHF joint congress 2021 : Virtual. 8-12 September 2021
  • T4 PMC11292956 ↗ — Abstracts from the 17th European Headache Congress (EHC)
  • T4 PPR634307 ↗ — Novel Protocol Using a Comprehensive Training ‘N’ Treatment (TNT) Approach Rapidly Reverses Olfactor
  • T6 PMC11077711 ↗ — Proceedings of the 101st Annual Meeting of The Physiological Society of Japan
  • T6 36350954 ↗ — 2022 Brazilian Thoracic Association recommendations for long-term home oxygen therapy
Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
5 sources
  • T1REGISTERED-ONLY NCT06928480 ↗ — Effectiveness and Acceptability of the Unified Protocol for the Transdiagnostic Treatment of Emotion
  • T1 41701690 ↗ — Effectiveness and acceptability of the unified protocol for the transdiagnostic treatment of emotion
  • T6 40779512 ↗ — Preliminary feasibility and clinical utility of the Unified Protocol for the transdiagnostic treatme
  • T6 37920733 ↗ — Unified Protocol for the transdiagnostic treatment of emotional disorders in people with post COVID-
  • T6 41039861 ↗ — &lt;i&gt;Taking Control of Your Functional Cognitive Symptoms: Workbook&lt;/i&gt;-A Novel Interventi
Valacyclovir
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
22 sources
  • T1REGISTERED-ONLY NCT07597902 ↗ — SARS-CoV-2 and Herpesvirus Inhibition for Ending Long COVID Dysfunction
  • T6INDIRECT 36736577 ↗ — Systematic review with meta-analysis of active herpesvirus infections in patients with COVID-19: Old
  • T6INDIRECT 39916377 ↗ — Facial Nerve Palsy Amid the SARS-CoV-2 Pandemic: A Pooled Analysis
  • T6INDIRECT 35316551 ↗ — A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendat
  • T6INDIRECT 37101275 ↗ — Viral reactivations and co-infections in COVID-19 patients: a systematic review
  • T6INDIRECT 35731363 ↗ — Neuropathic Pain Associated with COVID-19: a Systematic Review of Case Reports
  • T6INDIRECT 35648785 ↗ — Oro-facial mucocutaneous manifestations of Coronavirus Disease-2019 (COVID-19): A systematic review
  • T6INDIRECT 39390499 ↗ — Meningitis after COVID-19 vaccination, a systematic review of case reports and case series
  • T6INDIRECT 37735648 ↗ — Clinical characteristics and prognosis of temporary miller fisher syndrome following COVID-19 vaccin
  • T6INDIRECT 41562079 ↗ — Patient-reported improvements from use of IMC-2 alone and IMC-2 and Paxlovid&lt;sup&gt;®&lt;/sup&gt;
  • T6 39326415 ↗ — Mechanisms of long COVID and the path toward therapeutics
  • T6 33595463 ↗ — COVID-19 and Eye: A Review of Ophthalmic Manifestations of COVID-19
  • T6 36899952 ↗ — Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutic
  • T6INDIRECT 35716105 ↗ — Cutaneous manifestations following COVID-19 vaccination: A report of 25 cases
  • T6INDIRECT 36851614 ↗ — Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Aut
  • T6INDIRECT 36969241 ↗ — Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOV
  • T6INDIRECT 35214800 ↗ — Ocular Complications Following Vaccination for COVID-19: A One-Year Retrospective
  • T6INDIRECT 35137496 ↗ — COVID-19 and the peripheral nervous system. A 2-year review from the pandemic to the vaccine era
  • T6INDIRECT 34826968 ↗ — After the Storm: Ophthalmic Manifestations of COVID-19 Vaccines
  • T6 35925897 ↗ — Viruses in neurodegenerative diseases: More than just suspects in crimes
  • T6 36148238 ↗ — The role of virus infections in Sjögren's syndrome
  • T6 38500880 ↗ — The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches
Valacyclovir celecoxib dose 1
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT06316843 ↗ — Valacyclovir Plus Celecoxib for Post-Acute Sequelae of SARS-CoV-2
Valacyclovir celecoxib dose 2
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT06316843 ↗ — Valacyclovir Plus Celecoxib for Post-Acute Sequelae of SARS-CoV-2
Vericiguat Tablet
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
1 source
  • T1REGISTERED-ONLY NCT05697640 ↗ — Study to Investigate Improvement in Physical Function in SF-36 With Vericiguat Compared With Placebo
Vitamin B compound
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
2 sources
  • T1 NCT05638633 ↗ — Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome
  • T6 38184567 ↗ — Feasibility, safety and effectiveness of prednisolone and vitamin B1, B6, and B12 in patients with p
Vitamin K2
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
21 sources
  • T1 NCT05356936 ↗ — Pilot Study of Vitamin K2 (MK-7) and Vitamin D3 Supplementation and the Effects on PASC Symptomatolo
  • T6INDIRECT 36349400 ↗ — Clinical trials on the pharmacological treatment of long COVID: A systematic review
  • T1 39940457 ↗ — Vitamin D Deficiency Meets Hill's Criteria for Causation in SARS-CoV-2 Susceptibility, Complications
  • T1 39861434 ↗ — Vitamins K2 and D3 Improve Long COVID, Fungal Translocation, and Inflammation: Randomized Controlled
  • T6INDIRECT 37739466 ↗ — Dietary supplements to reduce symptom severity and duration in people with SARS-CoV-2: a double-blin
  • T6 34991982 ↗ — An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
  • T6 36364899 ↗ — A Comprehensive Review on Nutraceuticals: Therapy Support and Formulation Challenges
  • T6 34680457 ↗ — Biomarkers and Utility of the Antioxidant Potential of Probiotic Lactobacilli and Bifidobacteria as
  • T6 39861407 ↗ — Vitamin D: Evidence-Based Health Benefits and Recommendations for Population Guidelines
  • T6 33469977 ↗ — Molecular Simulations suggest Vitamins, Retinoids and Steroids as Ligands of the Free Fatty Acid Poc
  • T6 35241474 ↗ — Dietary supplements to reduce symptom severity and duration in people with SARS-CoV-2: study protoco
  • T6INDIRECT 34684123 ↗ — Possible Adrenal Involvement in Long COVID Syndrome
  • T6INDIRECT 39854158 ↗ — Long COVID and gut microbiome: insights into pathogenesis and therapeutics
  • T6INDIRECT 39114419 ↗ — Knee osteonecrosis after SARS-CoV-2 infection: a systematic case-based review
  • T6INDIRECT 36008648 ↗ — World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2022)
  • T6INDIRECT 34748955 ↗ — A naturopathic treatment approach for mild and moderate COVID-19: A retrospective chart review
  • T6 37410739 ↗ — Blood-based epigenome-wide analyses of 19 common disease states: A longitudinal, population-based li
  • T6 36139859 ↗ — Vitamin E and Metabolic Health: Relevance of Interactions with Other Micronutrients
  • T6 36978981 ↗ — Links between Vitamin K, Ferroptosis and SARS-CoV-2 Infection
  • T6 36671555 ↗ — Exogenous Players in Mitochondria-Related CNS Disorders: Viral Pathogens and Unbalanced Microbiota i
  • T6 39940312 ↗ — Minerals and Human Health: From Deficiency to Toxicity
Viusid Solution
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT06437210 ↗ — Evaluation of Treatment With Viusid in Post-COVID-19 Syndrome
Vocational Rehabilitation
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
24 sources
  • T1REGISTERED-ONLY NCT06095297 ↗ — Long COVID Brain Fog: Cognitive Rehabilitation Trial
  • T6INDIRECT 38438114 ↗ — Factors influencing the implementation of early discharge hospital at home and admission avoidance h
  • T6INDIRECT 41062137 ↗ — Return to work with long COVID: a rapid review of support and challenges
  • T1 41039517 ↗ — Return to work for people with chronic health conditions after medical or vocational rehabilitation
  • T6INDIRECT 42168956 ↗ — Factors influencing work ability and return-to-work in individuals affected by post-COVID: a systema
  • T1 39614629 ↗ — Effectiveness of early vocational rehabilitation versus usual care to support RETurn to work after s
  • T6INDIRECT 42261574 ↗ — Impact of Tailored Interventions on Suicidal Ideation Recovery: Addressing Hopelessness Among Econom
  • T6 34678213 ↗ — Addressing the post-acute sequelae of SARS-CoV-2 infection: a multidisciplinary model of care
  • T6 37795783 ↗ — Psychosocial interventions for survivors of rape and sexual assault experienced during adulthood
  • T6 32470131 ↗ — The COVID-19 rehabilitation pandemic
  • T6 34346558 ↗ — Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fati
  • T6 36169154 ↗ — Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of aut
  • T6MIXED 35580970 ↗ — LOng COvid Multidisciplinary consortium Optimising Treatments and servIces acrOss the NHS (LOCOMOTIO
  • T6INDIRECT 39429966 ↗ — COVID-19 and multiple sclerosis: challenges and lessons for patient care
  • T6INDIRECT 36588206 ↗ — Rhino-orbito-cerebral mucormycosis and its resurgence during COVID-19 pandemic: A review
  • T6INDIRECT 38616276 ↗ — What is quality in long covid care? Lessons from a national quality improvement collaborative and mu
  • T6INDIRECT 34899105 ↗ — What does Success Look Like for Leaders of Integrated Health and Social Care Systems? a Realist Revi
  • T6INDIRECT 34160029 ↗ — Apparent Discordance Between the Epidemiology of COVID-19 and Recommended Outcomes and Treatments: A
  • T6 35741569 ↗ — Cognitive Remediation in Psychiatric Disorders: State of the Evidence, Future Perspectives, and Some
  • T6 35252582 ↗ — Main Abstracts
  • T6 41358855 ↗ — Canadian Adaptation of REVEAL(OT) for Chronic Pain Management: Rapid Qualitative Analysis Results
  • T6 37915105 ↗ — Abstracts of Scientific Presentations: 2023 AALAS National Meeting, Salt Lake City, Utah
  • T6 33988148 ↗ — The times they are a-changin: implementing new psychiatric rehabilitation models within a community
  • T6 PMC11391898 ↗ — ESOC 2023 Abstract Book
Vortioxetine
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
24 sources
  • T1 NCT05047952 ↗ — Vortioxetine for Post-COVID-19 Condition
  • T6INDIRECT 39603702 ↗ — Interventions for the management of long covid (post-covid condition): living systematic review
  • T6INDIRECT 36349400 ↗ — Clinical trials on the pharmacological treatment of long COVID: A systematic review
  • T6INDIRECT 35768406 ↗ — Interventions for mental health, cognition, and psychological wellbeing in long COVID: a systematic
  • T6INDIRECT 39384321 ↗ — Systematic review of interventions for mental health, cognition and psychological well-being in long
  • T6INDIRECT 38228914 ↗ — Connectivity-guided intermittent theta burst versus repetitive transcranial magnetic stimulation for
  • T1 37936330 ↗ — Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial
  • T6INDIRECT 39356507 ↗ — Lithium Aspartate for Long COVID Fatigue and Cognitive Dysfunction: A Randomized Clinical Trial
  • T6INDIRECT 38520501 ↗ — Assessing the Effects of Metabolic Disruption, Body Mass Index and Inflammation on Depressive Sympto
  • T6INDIRECT 41212544 ↗ — Evaluation of Interventions for Cognitive Symptoms in Long COVID: A Randomized Clinical Trial
  • T6INDIRECT 38860901 ↗ — Association between fatigue and depressive symptoms in persons with post-COVID-19 condition: a post
  • T6 37076602 ↗ — Therapeutic strategies for COVID-19: progress and lessons learned
  • T6 37451743 ↗ — Faecalibacterium: a bacterial genus with promising human health applications
  • T6INDIRECT 36969241 ↗ — Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOV
  • T6INDIRECT 36831861 ↗ — Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Di
  • T6INDIRECT 37091719 ↗ — Late-life depression: Epidemiology, phenotype, pathogenesis and treatment before and during the COVI
  • T6INDIRECT 36532316 ↗ — Antidepressants with anti-inflammatory properties may be useful in long COVID depression
  • T6INDIRECT 37388279 ↗ — Long COVID: Complications, Underlying Mechanisms, and Treatment Strategies
  • T6 37907497 ↗ — The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of lon
  • T6 37457901 ↗ — Post-COVID cognitive dysfunction: current status and research recommendations for high risk populati
  • T6 35943535 ↗ — Selective serotonin reuptake inhibitor (SSRI) antidepressants reduce COVID-19 infection: prospects f
  • T6 40141784 ↗ — Neuropsychiatric Manifestations of Long COVID-19: A Narrative Review of Clinical Aspects and Therape
  • T6 38755657 ↗ — Individualized strategies for depression: narrative review of clinical profiles responsive to vortio
  • T6 35874958 ↗ — Long COVID and its Management
Walking
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
23 sources
  • T1REGISTERED-ONLY NCT06928116 ↗ — Heat thErapy And mobiLity in COVID-19 Survivors
  • T6INDIRECT 36215063 ↗ — Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symp
  • T6INDIRECT 35182760 ↗ — ESCMID rapid guidelines for assessment and management of long COVID
  • T6INDIRECT 34192010 ↗ — Changes in physical activity and sedentary behaviours from before to during the COVID-19 pandemic lo
  • T6INDIRECT 33925784 ↗ — Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Com
  • T6INDIRECT 33977626 ↗ — Frequency, signs and symptoms, and criteria adopted for long COVID-19: A systematic review
  • T6INDIRECT 35866452 ↗ — Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection
  • T6INDIRECT 35564579 ↗ — Rehabilitation Interventions for Post-Acute COVID-19 Syndrome: A Systematic Review
  • T6INDIRECT 34017846 ↗ — Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic
  • T6INDIRECT 36476156 ↗ — Effects of a concurrent training, respiratory muscle exercise, and self-management recommendations o
  • T6INDIRECT 33306721 ↗ — Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection
  • T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
  • T6 33753937 ↗ — Post-acute COVID-19 syndrome
  • T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6INDIRECT 34687662 ↗ — The 2021 report of the Lancet Countdown on health and climate change: code red for a healthy future
  • T6INDIRECT 33146552 ↗ — Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease.
  • T6INDIRECT 32475821 ↗ — The Stanford Hall consensus statement for post-COVID-19 rehabilitation
  • T6 32529595 ↗ — Post-COVID-19 global health strategies: the need for an interdisciplinary approach
  • T6 32422178 ↗ — Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
  • T6 35304603 ↗ — Exerkines in health, resilience and disease
  • T6 33857435 ↗ — Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuro
  • T6 29155571 ↗ — Oxygen Activation by Cu LPMOs in Recalcitrant Carbohydrate Polysaccharide Conversion to Monomer Suga
Wearable device
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
28 sources
  • T1REGISTERED-ONLY NCT05741112 ↗ — The Long COVID-19 Wearable Device Study
  • T6INDIRECT 38791798 ↗ — Changes in Sleep Duration and Sleep Timing in the General Population from before to during the First
  • T1 34502679 ↗ — The Rise of Wearable Devices during the COVID-19 Pandemic: A Systematic Review
  • T6INDIRECT 34693988 ↗ — Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pu
  • T1 37222916 ↗ — Sensitivity and Specificity of Wearables for Atrial Fibrillation in Elderly Populations: A Systemati
  • T6INDIRECT 37100544 ↗ — Readiness for implementation of novel digital health interventions for postoperative monitoring: a s
  • T1 36768002 ↗ — Self-Management of Subclinical Common Mental Health Disorders (Anxiety, Depression and Sleep Disorde
  • T6INDIRECT 34831725 ↗ — The Development of Telemedicine and eHealth in Surgery during the SARS-CoV-2 Pandemic
  • T6INDIRECT 36673664 ↗ — The Impact of SARS-CoV-2 Infection on Heart Rate Variability: A Systematic Review of Observational S
  • T6INDIRECT 35113860 ↗ — The development and pilot testing of a behavioral activation-based treatment for depressed mood and
  • T6 37117704 ↗ — Wearable chemical sensors for biomarker discovery in the omics era
  • T6 37373940 ↗ — A Review of the Role of Artificial Intelligence in Healthcare
  • T6 34505369 ↗ — The growing field of digital psychiatry: current evidence and the future of apps, social media, chat
  • T6INDIRECT 34199831 ↗ — Integrating Digital Technologies and Public Health to Fight Covid-19 Pandemic: Key Technologies, App
  • T6INDIRECT 32823223 ↗ — Unlocking challenges and opportunities presented by COVID-19 pandemic for cross-cutting disruption i
  • T4 38958517 ↗ — Revolutionary Point-of-Care Wearable Diagnostics for Early Disease Detection and Biomarker Discovery
  • T6INDIRECT 36074973 ↗ — Sinus Tachycardia: a Multidisciplinary Expert Focused Review
  • T6INDIRECT 33648821 ↗ — Health-related quality of life of hospitalized COVID-19 survivors: An initial exploration in Nanning
  • T6 37705603 ↗ — Artificial intelligence in clinical medicine: catalyzing a sustainable global healthcare paradigm
  • T6 35584269 ↗ — A Concept Development for the Symptom Science Model 2.0
  • T6 36671900 ↗ — Role of Wearable Sensing Technology to Manage Long COVID
  • T6 35084716 ↗ — Multiomics Analysis-Based Biomarkers in Diagnosis of Polycystic Ovary Syndrome
  • T6 40997277 ↗ — Next-Generation Piezoelectric Materials in Wearable and Implantable Devices for Continuous Physiolog
  • T6 34297318 ↗ — Abstracts from the 2021 Annual Meeting of the Society of General Internal Medicine
  • T6 34713021 ↗ — Wearable Sensors for COVID-19: A Call to Action to Harness Our Digital Infrastructure for Remote Pat
  • T6 34451032 ↗ — Review of Wearable Devices and Data Collection Considerations for Connected Health
  • T6 33372894 ↗ — Promotion of Physical Activity in Older People Using mHealth and eHealth Technologies: Rapid Review
  • T6 37799217 ↗ — Reimagining Healthcare: Unleashing the Power of Artificial Intelligence in Medicine
Western medicine treatment
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
13 sources
  • T1 NCT06095258 ↗ — A Practical RCT of TCM in the Treatment of LCOVID and Analysis of Syndrome Types and Medication Char
  • T1 34715330 ↗ — Guidelines on the treatment with integrated traditional Chinese medicine and western medicine for se
  • T6 39220224 ↗ — Traditional Chinese Rehabilitation Exercise (TCRE) for Myofascial Pain: Current Evidence and Further
  • T6 38571669 ↗ — Guideline for the Management of Diabetes Mellitus in the Elderly in China (2024 Edition)
  • T6 38335408 ↗ — The impact of "long COVID" on menstruation in Chinese female college students and the intervention o
  • T6 40395923 ↗ — Treatment Strategy for Long COVID Based on Traditional Chinese Medicine
  • T6INDIRECT 40696628 ↗ — Facial edema after covid-19 ameliorated by acupuncture: A CARE-compliant case report
  • T6INDIRECT 37802610 ↗ — Acupuncture as a therapeutic intervention for post-COVID-19 vaccination urticaria: a systematic revi
  • T4 PMC12163242 ↗ — Publication Only
  • T4 PMC10586546 ↗ — Platform Abstracts
  • T6 41282609 ↗ — Mechanistic insights into traditional Chinese medicine for viral pneumonia treatment: signaling path
  • T6 41496055 ↗ — Bibliometric analysis of research on traditional Chinese medicine for prevention and treatment of my
  • T6 39403141 ↗ — Traditional clinical symptoms and signs: Kampo pattern diagnosis in modern gastrointestinal disease
Xltranplus, Xltran
T1
T1 — RCT in LC/PASC/PACVS
WithdrawnLong COVID
1 source
  • T1WITHDRAWN NCT05467904 ↗ — Double-Blind Randomized Placebo-Controlled Trial of a Proprietary Full Hemp Flower Formulation for L
Yoga Therapy
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
20 sources
  • T1REGISTERED-ONLY NCT05890599 ↗ — Yoga Versus Health Education for the Treatment of Persistent Fatigue in Patients With Post COVID-19
  • T6INDIRECT 42111473 ↗ — Yoga interventions and randomized controlled trials: key issues and the centered impact on sedentary
  • T6INDIRECT 40189695 ↗ — Virtual reality enhanced mindfulness and yoga intervention for postpartum depression and anxiety in
  • T6 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6HARM 38931833 ↗ — Insight into the Functional Dynamics and Challenges of Exosomes in Pharmaceutical Innovation and Pre
  • T6 36525872 ↗ — Yoga for COVID-19: An ancient practice for a new condition - A literature review
  • T6 34305355 ↗ — Role of Ayurveda and Yoga-Based lifestyle in the COVID-19 pandemic - A narrative review
  • T6 39812093 ↗ — International perspective on social cognition in schizophrenia: current stage and the next steps
  • T6 41130694 ↗ — Yoga versus health education for persistent fatigue in patients with post-COVID-19 syndrome: protoco
  • T6INDIRECT 38157657 ↗ — Usefulness of Yoga in the management of tinnitus during COVID-19: A narrative review
  • T6INDIRECT 38111478 ↗ — Arts therapies for mental disorders in COVID-19 patients: a comprehensive review
  • T6INDIRECT 39569098 ↗ — Validation and efficacy of a tele-yoga intervention for improving psychological stress, mental healt
  • T6INDIRECT 37292532 ↗ — The Effectiveness of Adjuvant Attangaogam (Athanam) Yoga Asana-Pranayamam Practices With Regard to B
  • T6INDIRECT 34628664 ↗ — Apart, but still together: Separated parents living in limbo during COVID-19
  • T4 PMC13111897 ↗ — 2026 International Congress Abstract Supplement
  • T4 PMC11873978 ↗ — Lifestyle Medicine 2024 Annual Conference Research Abstracts
  • T6 34191699 ↗ — SARS-Cov-2 Damage on the Nervous System and Mental Health
  • T6 35645588 ↗ — COVID 19 pandemic challenges and their management: A review of medicines, vaccines, patents and clin
  • T6 PMC12625850 ↗ — 10th International Conference on Behavioral Addictions (ICBA 2025) July 7–9, 2025, Nantes, France
  • T6 35941050 ↗ — A century of 'The science of yoga' (1921-2021): Revival, renewal and renaissance
accelerated intermittent theta burst stimulation
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
6 sources
  • T1REGISTERED-ONLY NCT06940609 ↗ — Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation
  • T6HARM 38931833 ↗ — Insight into the Functional Dynamics and Challenges of Exosomes in Pharmaceutical Innovation and Pre
  • T6 41688232 ↗ — Clinical utility and prospective of TMS-EEG: Updated review from an international expert group
  • T6 40584527 ↗ — Adaptive trial for the treatment of depressive symptoms associated with concussion using accelerated
  • T6 PMC11932181 ↗ — ANCIPS – 2025 – E-POSTERS
  • T6 PMC10729596 ↗ — ACNP 62nd Annual Meeting: Poster Abstracts P251 – P500
acupuncture
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVIDME/CFS
54 sources
  • T1 NCT05890508 ↗ — Electro-acupuncture for Long Covid Neuropsychiatric Symptoms
  • T1 NCT05212688 ↗ — Randomised Study to Investigate the Effectiveness of Acupuncture for the Relief of Long COVID-19 Rel
  • T1REGISTERED-ONLY NCT07357688 ↗ — The Effect of Acupuncture Therapy on Cognitive Function in Post-COVID-19 Myalgic Encephalomyelitis/C
  • T2 NCT01534130 ↗ — Acupuncture for the Sleep Disorder of Chronic Fatigue Syndrome
  • T2 NCT01907711 ↗ — Clinical Trial to Evaluate the Effectiveness of Acupuncture as a Treatment in Patients Diagnosed Wit
  • T2 NCT02924831 ↗ — High-tech Acupuncture for Treatment of Chronic Fatigue Syndrome
  • T6INDIRECT 35182760 ↗ — ESCMID rapid guidelines for assessment and management of long COVID
  • T6INDIRECT 35265644 ↗ — Effect of Pulmonary Rehabilitation for Patients With Post-COVID-19: A Systematic Review and Meta-Ana
  • T6INDIRECT 39603702 ↗ — Interventions for the management of long covid (post-covid condition): living systematic review
  • T6INDIRECT 35893864 ↗ — The Efficacy of Vitamin D Supplementation in the Treatment of Fibromyalgia Syndrome and Chronic Musc
  • T6INDIRECT 34752489 ↗ — A mixed-methods systematic review of post-viral fatigue interventions: Are there lessons for long Co
  • T6INDIRECT 36642173 ↗ — A systematic review of trials currently investigating therapeutic modalities for post-acute COVID-19
  • T6INDIRECT 34425929 ↗ — Impact of olfactory dysfunction on quality of life in coronavirus disease 2019 patients: a systemati
  • T6INDIRECT 29544455 ↗ — Identification, description and appraisal of generic PROMs for primary care: a systematic review
  • T6INDIRECT 35489367 ↗ — An online breathing and wellbeing programme (ENO Breathe) for people with persistent symptoms follow
  • T6INDIRECT 35416437 ↗ — Qingjin Yiqi granules for post-COVID-19 condition: A randomized clinical trial
  • T6 35176758 ↗ — Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus
  • T6 37402746 ↗ — TRP (transient receptor potential) ion channel family: structures, biological functions and therapeu
  • T6INDIRECT 22197740 ↗ — Neuroimaging of the periaqueductal gray: state of the field
  • T6INDIRECT 30284240 ↗ — Psychological interventions for needle-related procedural pain and distress in children and adolesce
  • T6INDIRECT 18646067 ↗ — Cognitive behaviour therapy for chronic fatigue syndrome in adults
  • T6INDIRECT 21833945 ↗ — Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome
  • T6INDIRECT 29652088 ↗ — Non-invasive brain stimulation techniques for chronic pain
  • T6INDIRECT 29370149 ↗ — A Systematic Review and Meta-Analysis of Mindfulness-Based (Baduanjin) Exercise for Alleviating Musc
  • T6INDIRECT 24881045 ↗ — Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing p
  • T6INDIRECT 34770209 ↗ — Sleep Disorders in Cancer-A Systematic Review
  • T6INDIRECT 29710099 ↗ — Effect of Pain Neuroscience Education Combined With Cognition-Targeted Motor Control Training on Chr
  • T6INDIRECT 19597976 ↗ — "Maybe I made up the whole thing": placebos and patients' experiences in a randomized controlled tri
  • T6 29462012 ↗ — Neuroinflammation and Central Sensitization in Chronic and Widespread Pain
  • T6 29876878 ↗ — Role of the Prefrontal Cortex in Pain Processing
  • T6INDIRECT 36174032 ↗ — Post-acute sequelae of COVID-19 symptom phenotypes and therapeutic strategies: A prospective, observ
  • T6INDIRECT 34682909 ↗ — Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): An Overview
  • T6INDIRECT 36969241 ↗ — Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOV
  • T6INDIRECT 37298527 ↗ — Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeut
  • T6INDIRECT 35449490 ↗ — Association of mast-cell-related conditions with hypermobile syndromes: a review of the literature
  • T6INDIRECT 34607799 ↗ — Recommendations for the recognition, diagnosis, and management of long COVID: a Delphi study
  • T6 38152837 ↗ — Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications
  • T6 37907497 ↗ — The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of lon
  • T6 36174571 ↗ — Bioelectronic medicine: Preclinical insights and clinical advances
  • T6 33441072 ↗ — PTSD in the COVID-19 Era
  • T6 37372912 ↗ — What Do We Know about Nociplastic Pain?
  • T6 35198136 ↗ — Neurological manifestations of long-COVID syndrome: a narrative review
  • T6 37840685 ↗ — Current challenges and potential solutions to the use of digital health technologies in evidence gen
  • T6 33909761 ↗ — Brazilian Guidelines of Hypertension - 2020
  • T6 41092926 ↗ — Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life e
  • T6INDIRECT 12830308 ↗ — Patients presenting with somatic complaints: epidemiology, psychiatric comorbidity and management
  • T6INDIRECT 26267006 ↗ — Physical exercise as non-pharmacological treatment of chronic pain: Why and when
  • T6INDIRECT 26330672 ↗ — Chronic Pain: Where the Body Meets the Brain
  • T6 23235630 ↗ — Interventions to facilitate return to work in adults with adjustment disorders
  • T6 24239063 ↗ — The neuroimmune basis of fatigue
  • T6 29357856 ↗ — Clinical relevance of contextual factors as triggers of placebo and nocebo effects in musculoskeleta
  • T6 29487504 ↗ — Potential Mechanisms Underlying Centralized Pain and Emerging Therapeutic Interventions
  • T6 25573802 ↗ — Chemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogr
  • T6 24944467 ↗ — Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine
advice literature with naturopathy
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT05289154 ↗ — Acupressure and Qigong in Chronic Fatigue Post COVID-19.
amantadine
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
22 sources
  • T1 NCT05667077 ↗ — The Effect of Amantadine on Post-COVD-19 Fatigue
  • T1 NCT06055244 ↗ — Amantadine Therapy for Cognitive Impairment in Long COVID
  • T6INDIRECT 38459000 ↗ — Possible temporal relationship between SARS-CoV-2 infection and anti-NMDA receptor encephalitis: a m
  • T6INDIRECT 40047167 ↗ — Adverse events associated with monoclonal antibodies used for treatment of COVID-19: A systematic re
  • T1 38228731 ↗ — A randomized open-label clinical trial on the effect of Amantadine on post Covid 19 fatigue
  • T6INDIRECT 40730806 ↗ — Intermittent fasting and a no-sugar diet for Long COVID symptoms: a randomized crossover trial
  • T6 34991982 ↗ — An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
  • T6 36776881 ↗ — The development of COVID-19 treatment
  • T6 32885037 ↗ — COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside
  • T6 33755344 ↗ — Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers"
  • T6 34346558 ↗ — Multidisciplinary collaborative consensus guidance statement on the assessment and treatment of fati
  • T6INDIRECT 36464706 ↗ — Small molecules in the treatment of COVID-19
  • T6INDIRECT 36717892 ↗ — Links between COVID-19 and Parkinson's disease/Alzheimer's disease: reciprocal impacts, medical care
  • T6INDIRECT 34942956 ↗ — Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson's Disease?
  • T6INDIRECT 35216358 ↗ — Kidney Injury in COVID-19: Epidemiology, Molecular Mechanisms and Potential Therapeutic Targets
  • T6INDIRECT 39897928 ↗ — SARS-CoV-2 drug resistance and therapeutic approaches
  • T6INDIRECT 37388279 ↗ — Long COVID: Complications, Underlying Mechanisms, and Treatment Strategies
  • T6INDIRECT 35861926 ↗ — Therapeutic Approaches to the Neurologic Manifestations of COVID-19
  • T6 33240091 ↗ — Challenges for Drug Repurposing in the COVID-19 Pandemic Era
  • T6 38699242 ↗ — Macrophage based drug delivery: Key challenges and strategies
  • T6 35698330 ↗ — A state-of-the-art review on fucoidan as an antiviral agent to combat viral infections
  • T6 32846164 ↗ — COVID-19: Pathophysiology, treatment options, nanotechnology approaches, and research agenda to comb
baricitinib
T1
T1 — RCT in LC/PASC/PACVS
WithdrawnLong COVID
25 sources
  • T1WITHDRAWN NCT05858515 ↗ — REVERSE-Long COVID-19 With Baricitinib Study
  • T6INDIRECT 34911695 ↗ — The impact of therapeutics on mortality in hospitalised patients with COVID-19: systematic review an
  • T6INDIRECT 32454187 ↗ — Review of trials currently testing treatment and prevention of COVID-19
  • T6INDIRECT 36385229 ↗ — Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on eviden
  • T6INDIRECT 34658014 ↗ — Colchicine for the treatment of COVID-19
  • T6INDIRECT 35316551 ↗ — A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendat
  • T6INDIRECT 34082281 ↗ — Digital imaging, technologies and artificial intelligence applications during COVID-19 pandemic
  • T6INDIRECT 34467402 ↗ — Fostamatinib for the Treatment of Hospitalized Adults With Coronavirus Disease 2019: A Randomized Tr
  • T1 33962573 ↗ — Impact of high dose of baricitinib in severe COVID-19 pneumonia: a prospective cohort study in Bangl
  • T6 35271343 ↗ — The immunology and immunopathology of COVID-19
  • T6 33743212 ↗ — COVID-19 and the human innate immune system
  • T6 37076602 ↗ — Therapeutic strategies for COVID-19: progress and lessons learned
  • T6 36253560 ↗ — Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential t
  • T6INDIRECT 33856918 ↗ — COVID-19 and Cardiovascular Disease: From Bench to Bedside
  • T6INDIRECT 33529600 ↗ — Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning
  • T6INDIRECT 34944099 ↗ — New Onset of Autoimmune Diseases Following COVID-19 Diagnosis
  • T6INDIRECT 32584441 ↗ — Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the
  • T6INDIRECT 36100326 ↗ — Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue s
  • T6INDIRECT 36182669 ↗ — SARS-CoV-2 in immunocompromised individuals
  • T6INDIRECT 35912863 ↗ — Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches
  • T6INDIRECT 33586189 ↗ — COVID-19: immunopathology, pathophysiological mechanisms, and treatment options
  • T6 35931818 ↗ — Understanding COVID-19-associated coagulopathy
  • T6 39326415 ↗ — Mechanisms of long COVID and the path toward therapeutics
  • T6 34991982 ↗ — An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
  • T6 36631691 ↗ — Innate immune evasion strategies of SARS-CoV-2
cognitive rehabilitation
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
26 sources
  • T1 NCT05731570 ↗ — Cognitive Rehabilitation for People With Cognitive Covid19
  • T6 NCT07184398 ↗ — Use of a Cysteine-rich Whey Protein Isolate in Post COVID-19 Cognitive Impairment
  • T6INDIRECT 36657196 ↗ — Attention and memory after COVID-19 as measured by neuropsychological tests: Systematic review and m
  • T6INDIRECT 35564579 ↗ — Rehabilitation Interventions for Post-Acute COVID-19 Syndrome: A Systematic Review
  • T1 35537236 ↗ — COVID-19 associated cognitive impairment: A systematic review
  • T6INDIRECT 33637294 ↗ — Rehabilitation to enable recovery from COVID-19: a rapid systematic review
  • T6INDIRECT 35768406 ↗ — Interventions for mental health, cognition, and psychological wellbeing in long COVID: a systematic
  • T6INDIRECT 33584506 ↗ — COVID-19 Pathophysiology Predicts That Ischemic Stroke Occurrence Is an Expectation, Not an Exceptio
  • T6INDIRECT 36642173 ↗ — A systematic review of trials currently investigating therapeutic modalities for post-acute COVID-19
  • T1 38850628 ↗ — Neurocognitive Impairment in Long COVID: A Systematic Review
  • T6INDIRECT 36334288 ↗ — Recognizing the psychological impact of a glioma diagnosis on mental and behavioral health: a system
  • T6INDIRECT 37193738 ↗ — Effectiveness of a telerehabilitation intervention using ReCOVery APP of long COVID patients: a rand
  • T6 34818601 ↗ — The impact of the prolonged COVID-19 pandemic on stress resilience and mental health: A critical rev
  • T6 39326415 ↗ — Mechanisms of long COVID and the path toward therapeutics
  • T6INDIRECT 32990925 ↗ — Multiple Neuroinvasive Pathways in COVID-19
  • T4 34173049 ↗ — Cognitive decline following acute viral infections: literature review and projections for post-COVID
  • T6INDIRECT 35636906 ↗ — Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
  • T6INDIRECT 32475821 ↗ — The Stanford Hall consensus statement for post-COVID-19 rehabilitation
  • T6 37457901 ↗ — Post-COVID cognitive dysfunction: current status and research recommendations for high risk populati
  • T6 37795206 ↗ — Understanding Post-Sepsis Syndrome: How Can Clinicians Help?
  • T6 38094503 ↗ — Peripheral inflammation and neurocognitive impairment: correlations, underlying mechanisms, and ther
  • T6 35414261 ↗ — Brain Fog in Hypothyroidism: What Is It, How Is It Measured, and What Can Be Done About It
  • T6 37056914 ↗ — COVID-19 delirium and encephalopathy: Pathophysiology assumed in the first 3 years of the ongoing pa
  • T6 36103031 ↗ — Neurological Consequences, Mental Health, Physical Care, and Appropriate Nutrition in Long-COVID-19
  • T6 33789937 ↗ — Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chron
  • T6 34764200 ↗ — Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective st
concurrent training
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
25 sources
  • T1 NCT05204511 ↗ — Exercise and Post-COVID/ Long-COVID: Effects of Different Training Modalities on Various Parameters
  • T6INDIRECT 40122540 ↗ — Effectiveness and tolerance of exercise interventions for long COVID: a systematic review of randomi
  • T6INDIRECT 40115437 ↗ — Exercise-induced adaptations in the kynurenine pathway: implications for health and disease manageme
  • T6INDIRECT 38890699 ↗ — Effectiveness of pulmonary rehabilitation programmes and/or respiratory muscle training in patients
  • T6INDIRECT 39260851 ↗ — Clinical practice guidelines and expert consensus statements on rehabilitation for patients with COV
  • T6INDIRECT 36111386 ↗ — Rehabilitation for post-COVID-19 condition through a supervised exercise intervention: A randomized
  • T1 36476156 ↗ — Effects of a concurrent training, respiratory muscle exercise, and self-management recommendations o
  • T6INDIRECT 39665835 ↗ — Exercise rehabilitation in post COVID-19 patients: a randomized controlled trial of different traini
  • T6INDIRECT 38102536 ↗ — Effect of different types of supervised exercise programs on cardiorespiratory and muscular fitness,
  • T6INDIRECT 38937986 ↗ — Telerehabilitation improves cardiorespiratory and muscular fitness and body composition in older peo
  • T6INDIRECT 36901146 ↗ — Effects of a Multi-Professional Intervention on Mental Health of Middle-Aged Overweight Survivors of
  • T6 33001410 ↗ — Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss
  • T6 34067776 ↗ — Post-COVID-19 Syndrome and the Potential Benefits of Exercise
  • T6INDIRECT 36560801 ↗ — Efficacy of Therapeutic Exercise in Reversing Decreased Strength, Impaired Respiratory Function, Dec
  • T6INDIRECT 37841213 ↗ — Complementary and alternative medicine for long COVID: a systematic review of randomized controlled
  • T6INDIRECT 41003635 ↗ — Post-Acute COVID-19 Syndrome (PACS) and Exercise Interventions: A Systematic Review of Randomized Co
  • T6INDIRECT 38711990 ↗ — Management of cognitive impairment associated with post-COVID-19 syndrome: recommendations for prima
  • T6INDIRECT 40805931 ↗ — Physical Training Protocols for Improving Dyspnea and Fatigue in Long COVID: A Systematic Review wit
  • T6INDIRECT 41741003 ↗ — Assessment and management of post-COVID-19 pulmonary complications: a rapid review
  • T6INDIRECT 42188575 ↗ — Strength and Conditioning Society (SCS) 8th Annual Meeting, Oslo, Norway, 2025
  • T6INDIRECT 39411230 ↗ — Recent highlights from the <i>International Journal of Cardiology Heart and Vasculature</i>: Spatiot
  • T6 38063644 ↗ — Effects of Different Protocols of Moderate-Intensity Intermittent Hypoxic Training on Mental Health
  • T6 36107382 ↗ — Abstracts of the XL Congress of the Spanish Society of Physiological Sciences (SECF)
  • T6 34861297 ↗ — Physical activity and COVID-19. The basis for an efficient intervention in times of COVID-19 pandemi
  • T6 37987274 ↗ — Long COVID and Physical Therapy: A Systematic Review
endurance training
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
26 sources
  • T1 NCT05204511 ↗ — Exercise and Post-COVID/ Long-COVID: Effects of Different Training Modalities on Various Parameters
  • T6INDIRECT 37725376 ↗ — Rehabilitation Interventions for Physical Capacity and Quality of Life in Adults With Post-COVID-19
  • T6INDIRECT 35908659 ↗ — Effect of Pulmonary Rehabilitation Approaches on Dyspnea, Exercise Capacity, Fatigue, Lung Functions
  • T6INDIRECT 34192010 ↗ — Changes in physical activity and sedentary behaviours from before to during the COVID-19 pandemic lo
  • T6INDIRECT 35265644 ↗ — Effect of Pulmonary Rehabilitation for Patients With Post-COVID-19: A Systematic Review and Meta-Ana
  • T6INDIRECT 36606682 ↗ — Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstr
  • T6INDIRECT 36334288 ↗ — Recognizing the psychological impact of a glioma diagnosis on mental and behavioral health: a system
  • T6INDIRECT 36717302 ↗ — Effects of physical rehabilitation interventions in COVID-19 patients following discharge from hospi
  • T6INDIRECT 36111386 ↗ — Rehabilitation for post-COVID-19 condition through a supervised exercise intervention: A randomized
  • T6INDIRECT 37271020 ↗ — Effectiveness of exercise training on the dyspnoea of individuals with long COVID: A randomised cont
  • T6INDIRECT 36815161 ↗ — Inpatient post-COVID-19 rehabilitation program featuring virtual reality-Preliminary results of rand
  • T6 33001410 ↗ — Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss
  • T6 34067776 ↗ — Post-COVID-19 Syndrome and the Potential Benefits of Exercise
  • T6INDIRECT 35108624 ↗ — Respiratory rehabilitation in patients recovering from severe acute respiratory syndrome: A systemat
  • T6INDIRECT 33303102 ↗ — Screening of Potential Cardiac Involvement in Competitive Athletes Recovering From COVID-19: An Expe
  • T6INDIRECT 32483768 ↗ — Returning to Play after Prolonged Training Restrictions in Professional Collision Sports
  • T6INDIRECT 33801080 ↗ — Exercise Training and Cardiac Rehabilitation in COVID-19 Patients with Cardiovascular Complications:
  • T6INDIRECT 36615087 ↗ — Post-Acute Sequelae of COVID-19: The Potential Role of Exercise Therapy in Treating Patients and Ath
  • T6INDIRECT 34095290 ↗ — Benefits of pulmonary rehabilitation in COVID-19: a prospective observational cohort study
  • T6INDIRECT 34240576 ↗ — Providing rehabilitation to patients recovering from COVID-19: A scoping review
  • T6 37107158 ↗ — The Key Role of Mitochondrial Function in Health and Disease
  • T6 35336728 ↗ — Role of Epicardial Adipose Tissue in Cardiovascular Diseases: A Review
  • T6 36551869 ↗ — Understanding Long COVID; Mitochondrial Health and Adaptation-Old Pathways, New Problems
  • T6 38339220 ↗ — Role of microRNAs in Immune Regulation with Translational and Clinical Applications
  • T6 39679477 ↗ — Immune aging and infectious diseases
  • T6 33909761 ↗ — Brazilian Guidelines of Hypertension - 2020
fluvoxamine
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
27 sources
  • T1 NCT05874037 ↗ — Fluvoxamine for Long COVID-19
  • T1 NCT06128967 ↗ — A Multicenter, Adaptive, Randomized, doublE-blinded, Placebo-controlled Study in Participants With L
  • T6INDIRECT 35726131 ↗ — Ivermectin for preventing and treating COVID-19
  • T6INDIRECT 38105461 ↗ — Outpatient randomized controlled trials to reduce COVID-19 hospitalization: Systematic review and me
  • T6INDIRECT 36399837 ↗ — Psychotropic drug repurposing for COVID-19: A Systematic Review and Meta-Analysis
  • T6INDIRECT 34318930 ↗ — Ivermectin for preventing and treating COVID-19
  • T6INDIRECT 36062970 ↗ — Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction
  • T1 33180097 ↗ — Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Random
  • T1 36070710 ↗ — Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19
  • T6INDIRECT 37302406 ↗ — Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT)
  • T6INDIRECT 38690892 ↗ — Favorable Antiviral Effect of Metformin on SARS-CoV-2 Viral Load in a Randomized, Placebo-Controlled
  • T6INDIRECT 35144974 ↗ — Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blin
  • T6 37076602 ↗ — Therapeutic strategies for COVID-19: progress and lessons learned
  • T6 36253560 ↗ — Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential t
  • T6INDIRECT 36271144 ↗ — Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications
  • T6INDIRECT 35727534 ↗ — Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment
  • T6INDIRECT 36969241 ↗ — Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOV
  • T6INDIRECT 33421734 ↗ — The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacol
  • T6INDIRECT 32925078 ↗ — COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications
  • T6INDIRECT 35985357 ↗ — Tobacco product use and the risks of SARS-CoV-2 infection and COVID-19: current understanding and re
  • T6INDIRECT 37445634 ↗ — Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology
  • T6INDIRECT 34893494 ↗ — Learning through a Pandemic: The Current State of Knowledge on COVID-19 and Cancer
  • T6 39326415 ↗ — Mechanisms of long COVID and the path toward therapeutics
  • T6 34991982 ↗ — An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
  • T6 35672482 ↗ — Host-directed immunotherapy of viral and bacterial infections: past, present and future
  • T6 36776881 ↗ — The development of COVID-19 treatment
  • T6 36631691 ↗ — Innate immune evasion strategies of SARS-CoV-2
hyperbaric oxygen therapy (HBOT)
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVIDME/CFS
33 sources
  • T1REGISTERED-ONLY NCT06452095 ↗ — Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbar
  • T2REGISTERED-ONLY NCT07621068 ↗ — Hyperbaric Oxygen Therapy for Chronic Fatigue Syndrome (CFS)
  • T6INDIRECT 36032234 ↗ — Post-COVID-19 fatigue: A systematic review
  • T6INDIRECT 36349400 ↗ — Clinical trials on the pharmacological treatment of long COVID: A systematic review
  • T6INDIRECT 35768406 ↗ — Interventions for mental health, cognition, and psychological wellbeing in long COVID: a systematic
  • T6INDIRECT 34752489 ↗ — A mixed-methods systematic review of post-viral fatigue interventions: Are there lessons for long Co
  • T6INDIRECT 37344767 ↗ — Clinical effectiveness of rehabilitation in ambulatory care for patients with persisting symptoms af
  • T6INDIRECT 38673384 ↗ — Pathophysiological Mechanisms in Long COVID: A Mixed Method Systematic Review
  • T1 35821512 ↗ — Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: ra
  • T1 36208548 ↗ — Effects of hyperbaric oxygen therapy on functional and structural connectivity in post-COVID-19 cond
  • T1 36670365 ↗ — Hyperbaric oxygen therapy for long COVID (HOT-LoCO), an interim safety report from a randomised cont
  • T1 38360929 ↗ — Long term outcomes of hyperbaric oxygen therapy in post covid condition: longitudinal follow-up of a
  • T6 34163217 ↗ — The Conundrum of 'Long-COVID-19': A Narrative Review
  • T6 38374451 ↗ — Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment
  • T2 36690401 ↗ — Efficacy and safety of hyperbaric oxygen therapy for fibromyalgia: a systematic review and meta-anal
  • T2 26010952 ↗ — Hyperbaric oxygen therapy can diminish fibromyalgia syndrome--prospective clinical trial
  • T6 24752591 ↗ — The glutathione system: a new drug target in neuroimmune disorders
  • T6 39548502 ↗ — Nanotechnology in healthcare, and its safety and environmental risks
  • T6 37907497 ↗ — The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of lon
  • T6INDIRECT 34215639 ↗ — Avascular necrosis as a part of 'long COVID-19'
  • T6INDIRECT 35373533 ↗ — International consensus statement on allergy and rhinology: Olfaction
  • T6INDIRECT 36299969 ↗ — Sudden Sensorineural Hearing Loss: A Review
  • T6 38534355 ↗ — Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders
  • T6 36043493 ↗ — The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid
  • T6 38998660 ↗ — <i>Aloe vera</i>-An Extensive Review Focused on Recent Studies
  • T6 34395187 ↗ — COVID-19 associated mucormycosis: Staging and management recommendations (Report of a multi-discipli
  • T6 37759498 ↗ — A Molecular Troika of Angiogenesis, Coagulopathy and Endothelial Dysfunction in the Pathology of Ava
  • T6 36283919 ↗ — Long COVID: An inevitable sequela of SARS-CoV-2 infection
  • T6INDIRECT 30210433 ↗ — Delayed Post-hypoxic Leukoencephalopathy (DPHL)-An Uncommon Variant of Hypoxic Brain Damage in Adult
  • T6INDIRECT 32161563 ↗ — Identification and Management of Paroxysmal Sympathetic Hyperactivity After Traumatic Brain Injury
  • T6INDIRECT 36246401 ↗ — Oxidative Stress in Fibromyalgia: From Pathology to Treatment
  • T6INDIRECT 24115194 ↗ — Cutaneous manifestations of ESRD
  • T6 33114203 ↗ — Fibromyalgia: Recent Advances in Diagnosis, Classification, Pharmacotherapy and Alternative Remedies
intensive combined rehabilitation therapy
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT05534997 ↗ — Rehabilitation Therapy for Post COVID 19 Chronic Fatigue Syndrome
ivabradine
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVIDPOTS
48 sources
  • T1 NCT06305806 ↗ — RECOVER-AUTONOMIC: Platform Protocol, Appendix B (Ivabradine)
  • T1 NCT06305780 ↗ — RECOVER-AUTONOMIC Platform Protocol
  • T2REGISTERED-ONLY NCT04186286 ↗ — Crossover Study of Propranolol vs Ivabradine in POTS
  • T2 NCT05481177 ↗ — Ivabradine for Long-Term Effects of COVID-19 With POTS Cohort
  • T2 NCT03182725 ↗ — Effect of Ivabradine on Patients With Postural Orthostatic Tachycardia Syndrome
  • T6 NCT01761825 ↗ — The Effect of Ivabradine on Patients With Postural Tachycardia Syndrome
  • T6INDIRECT 36349400 ↗ — Clinical trials on the pharmacological treatment of long COVID: A systematic review
  • T6INDIRECT 38673384 ↗ — Pathophysiological Mechanisms in Long COVID: A Mixed Method Systematic Review
  • T6INDIRECT 36237182 ↗ — Graves' disease following vaccination against SARS-CoV-2: A systematic review of the reported cases
  • T6INDIRECT 37094584 ↗ — Postural Orthostatic Tachycardia Syndrome After COVID-19: A Systematic Review of Therapeutic Interve
  • T6INDIRECT 39882369 ↗ — Oral medications for the treatment of postural orthostatic tachycardia syndrome; a systematic review
  • T6INDIRECT 39538129 ↗ — Postural orthostatic tachycardia syndrome after COVID-19 vaccination: A systematic review
  • T6INDIRECT 36549786 ↗ — Effect of a home-based inspiratory muscle training programme on functional capacity in postdischarge
  • T6INDIRECT 39859026 ↗ — The Role of Omega-3 Polyunsaturated Fatty Acids in Patients with Metabolic Syndrome and Endothelial
  • T6INDIRECT 33786700 ↗ — Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infect
  • T6 32201335 ↗ — Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID
  • T6 34024217 ↗ — Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
  • T6 35176758 ↗ — Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus
  • T6INDIRECT 29759520 ↗ — Ablation of Inappropriate Sinus Tachycardia: A Systematic Review of the Literature
  • T2 29330767 ↗ — Ivabradine for the Treatment of Postural Orthostatic Tachycardia Syndrome: A Systematic Review
  • T6INDIRECT 36723919 ↗ — Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrilla
  • T2 33602468 ↗ — Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syn
  • T6INDIRECT 37999672 ↗ — Noninvasive Vagus Nerve Stimulation in Postural Tachycardia Syndrome: A Randomized Clinical Trial
  • T6INDIRECT 37598401 ↗ — Semi-supervised exercise training program more effective for individuals with postural orthostatic t
  • T6INDIRECT 29217664 ↗ — Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Re
  • T6INDIRECT 31841279 ↗ — Central blood pressure for the management of hypertension: Is it a practical clinical tool in curren
  • T6INDIRECT 33723532 ↗ — Long-Haul Post-COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrom
  • T6INDIRECT 33262898 ↗ — New-onset Postural Orthostatic Tachycardia Syndrome Following Coronavirus Disease 2019 Infection
  • T6INDIRECT 34821709 ↗ — Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know?
  • T6INDIRECT 35853576 ↗ — Postural orthostatic tachycardia syndrome as a sequela of COVID-19
  • T6INDIRECT 36969241 ↗ — Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOV
  • T6 39326415 ↗ — Mechanisms of long COVID and the path toward therapeutics
  • T6 37907497 ↗ — The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of lon
  • T6 39125722 ↗ — Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detectio
  • T6 34403043 ↗ — Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor's pag
  • T6 34909198 ↗ — How COVID-19 can cause autonomic dysfunctions and postural orthostatic syndrome? A Review of mechani
  • T6 36113768 ↗ — Three-dimensional functional anatomy of the human sinoatrial node for epicardial and endocardial map
  • T6 39536116 ↗ — Translating insights into therapies for Long Covid
  • T6 34390682 ↗ — Post-COVID-19 Tachycardia Syndrome: A Distinct Phenotype of Post-Acute COVID-19 Syndrome
  • T6 35307156 ↗ — 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocard
  • T6INDIRECT 32117030 ↗ — Posterior Reversible Encephalopathy Syndrome: Clinical Features and Outcome
  • T6INDIRECT 26198889 ↗ — Postural Tachycardia Syndrome: Beyond Orthostatic Intolerance
  • T6INDIRECT 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
  • T6 29359025 ↗ — Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment
  • T6 34134525 ↗ — Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A
  • T6 33999297 ↗ — The autonomic nervous system in septic shock and its role as a future therapeutic target: a narrativ
  • T6 28428055 ↗ — Sex differences in cardiovascular disease - Impact on care and outcomes
  • T6 29222399 ↗ — Pediatric Disorders of Orthostatic Intolerance
lumbrokinase
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
11 sources
  • T1REGISTERED-ONLY NCT06511050 ↗ — Lumbrokinase for Adults With Long Covid, Post-treatment Lyme Disease Syndrome, and Myalgic Encephalo
  • T6 36043493 ↗ — The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid
  • T6 41366804 ↗ — Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): diagnosis and management
  • T6 40721817 ↗ — Perioperative and anesthetic considerations for post-acute sequelae of COVID (PASC)/long COVID
  • T6 39762640 ↗ — Impact of extended-course oral nirmatrelvir/ritonavir in established Long COVID: a case series
  • T6 40627388 ↗ — Patient-reported treatment outcomes in ME/CFS and long COVID
  • T6INDIRECT 40709992 ↗ — Vaxtherapy, a Multiphase Therapeutic Protocol Approach for Longvax, the COVID-19 Vaccine-Induced Dis
  • T4 PPR728215 ↗ — Impact of extended-course oral nirmatrelvir/ritonavir (Paxlovid) in established Long COVID: Case ser
  • T6 40274794 ↗ — A facultative plasminogen-independent thrombolytic enzyme from Sipunculus nudus
  • T6 41405757 ↗ — Investigation of the synergistic effect of enzymatic and Ultrasound-Induced amyloid microclot degrad
  • T6 42274123 ↗ — Dynamic microclot profiling: thromboelastography advances precision management in long COVID and mya
magnesium
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
27 sources
  • T1 NCT05630339 ↗ — Magnesium and Vitamin D Combination for Post-COVID Syndrome
  • T6 26404370 ↗ — Magnesium in Prevention and Therapy.
  • T6 25861976 ↗ — Ion channels in innate and adaptive immunity.
  • T6INDIRECT 34791425 ↗ — The role of vitamin B12 in viral infections: a comprehensive review of its relationship with the mus
  • T6INDIRECT 35331487 ↗ — Clinical significance of micronutrient supplements in patients with coronavirus disease 2019: A comp
  • T6INDIRECT 35660931 ↗ — Global reports of myocarditis following COVID-19 vaccination: A systematic review and meta-analysis
  • T6INDIRECT 34396514 ↗ — Systemic corticosteroids for the treatment of COVID-19
  • T6INDIRECT 34679203 ↗ — Antibiotics for the treatment of COVID-19
  • T6INDIRECT 36349400 ↗ — Clinical trials on the pharmacological treatment of long COVID: A systematic review
  • T6INDIRECT 36385229 ↗ — Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on eviden
  • T6INDIRECT 34658014 ↗ — Colchicine for the treatment of COVID-19
  • T6INDIRECT 37397709 ↗ — A systematic review of self-medication practice during the COVID-19 pandemic: implications for pharm
  • T6INDIRECT 37344767 ↗ — Clinical effectiveness of rehabilitation in ambulatory care for patients with persisting symptoms af
  • T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
  • T6 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6INDIRECT 35727534 ↗ — Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment
  • T6INDIRECT 33425823 ↗ — Multisystem Inflammatory Syndrome in Children (MIS-C), a Post-viral Myocarditis and Systemic Vasculi
  • T6INDIRECT 39482575 ↗ — Hallmarks of primary headache: part 1 - migraine
  • T6INDIRECT 36364899 ↗ — A Comprehensive Review on Nutraceuticals: Therapy Support and Formulation Challenges
  • T6INDIRECT 36100326 ↗ — Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue s
  • T6 39174535 ↗ — Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strateg
  • T6 37402746 ↗ — TRP (transient receptor potential) ion channel family: structures, biological functions and therapeu
  • T6 3070321 ↗ — Linkage map of Salmonella typhimurium, edition VII
  • T6 33807579 ↗ — Allergic Reactions to Current Available COVID-19 Vaccinations: Pathophysiology, Causality, and Thera
  • T6 34715347 ↗ — Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2
  • T6 33909761 ↗ — Brazilian Guidelines of Hypertension - 2020
melatonin
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVIDME/CFSPOTS
81 sources
  • T1 NCT06404112 ↗ — RECOVER-SLEEP: Platform Protocol, Appendix_B (CPSD)
  • T1 NCT06404086 ↗ — RECOVER-SLEEP: Platform Protocol
  • T2 NCT05454683 ↗ — Melatonin and Zinc Administration on Cardinal Symptoms in Myalgic Encephalomyelitis/Chronic Fatigue
  • T2 NCT03000777 ↗ — Oral Melatonin Plus Zinc Supplementation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/
  • T2REGISTERED-ONLY NCT00262470 ↗ — Treatment of Orthostatic Intolerance
  • T6INDIRECT 36235869 ↗ — Vitamin C Supplementation for the Treatment of COVID-19: A Systematic Review and Meta-Analysis
  • T6INDIRECT 38732592 ↗ — The Efficacy of Multivitamin, Vitamin A, Vitamin B, Vitamin C, and Vitamin D Supplements in the Prev
  • T6INDIRECT 38105461 ↗ — Outpatient randomized controlled trials to reduce COVID-19 hospitalization: Systematic review and me
  • T6INDIRECT 33205450 ↗ — Case report and systematic review suggest that children may experience similar long-term effects to
  • T6INDIRECT 33584506 ↗ — COVID-19 Pathophysiology Predicts That Ischemic Stroke Occurrence Is an Expectation, Not an Exceptio
  • T6INDIRECT 35893864 ↗ — The Efficacy of Vitamin D Supplementation in the Treatment of Fibromyalgia Syndrome and Chronic Musc
  • T6INDIRECT 37397709 ↗ — A systematic review of self-medication practice during the COVID-19 pandemic: implications for pharm
  • T6INDIRECT 36334288 ↗ — Recognizing the psychological impact of a glioma diagnosis on mental and behavioral health: a system
  • T6INDIRECT 34837648 ↗ — Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a th
  • T6INDIRECT 38908733 ↗ — Fecal Microbiota Transplantation for Sleep Disturbance in Post-acute COVID-19 Syndrome
  • T6 39174535 ↗ — Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strateg
  • T6 37117704 ↗ — Wearable chemical sensors for biomarker discovery in the omics era
  • T6INDIRECT 27664125 ↗ — Adult ADHD and Comorbid Somatic Disease: A Systematic Literature Review
  • T6INDIRECT 34902819 ↗ — Sleep, cerebrospinal fluid, and the glymphatic system: A systematic review
  • T6INDIRECT 34770209 ↗ — Sleep Disorders in Cancer-A Systematic Review
  • T6INDIRECT 17021301 ↗ — Interventions for the treatment, management and rehabilitation of patients with chronic fatigue synd
  • T6INDIRECT 19856109 ↗ — Biofield therapies: helpful or full of hype? A best evidence synthesis
  • T6INDIRECT 31478755 ↗ — Probiotics for Gastrointestinal Symptoms and Quality of Life in Autism: A Placebo-Controlled Pilot T
  • T6INDIRECT 22728166 ↗ — Antioxidant supplementation reduces endometriosis-related pelvic pain in humans
  • T6INDIRECT 25002497 ↗ — Effect of sleep deprivation on the human metabolome
  • T6INDIRECT 17081700 ↗ — Stress sensitivity in metastatic breast cancer: analysis of hypothalamic-pituitary-adrenal axis func
  • T6 30920354 ↗ — The Sleep-Immune Crosstalk in Health and Disease
  • T6 24370461 ↗ — The role of microbiome in central nervous system disorders
  • T6 29936690 ↗ — The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer's Disease-a Critica
  • T6INDIRECT 22328094 ↗ — REM sleep behavior disorder and REM sleep without atonia as an early manifestation of degenerative n
  • T6INDIRECT 33224097 ↗ — Cyclic Vomiting Syndrome in Children
  • T6INDIRECT 33173517 ↗ — Perioperative Sleep Disturbances and Postoperative Delirium in Adult Patients: A Systematic Review a
  • T6INDIRECT 36268467 ↗ — Clinical Features in Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency: A Systematic Review
  • T6INDIRECT 34472659 ↗ — Movement disorders in patients with Rett syndrome: A systematic review of evidence and associated cl
  • T2 21729284 ↗ — The effects of melatonin versus placebo on delirium in hip fracture patients: study protocol of a ra
  • T2 24495468 ↗ — Melatonin reduces tachycardia in postural tachycardia syndrome: a randomized, crossover trial
  • T6INDIRECT 32986682 ↗ — The D1/D5 Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson's Disease: A Feasibility
  • T6INDIRECT 36751940 ↗ — Baseline characteristics of the North American prodromal Synucleinopathy cohort
  • T6 23672628 ↗ — Understanding the somatic consequences of depression: biological mechanisms and the role of depressi
  • T6 33856918 ↗ — COVID-19 and Cardiovascular Disease: From Bench to Bedside
  • T6INDIRECT 29744873 ↗ — Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - as
  • T6INDIRECT 27863901 ↗ — A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease f
  • T6INDIRECT 32244523 ↗ — Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioact
  • T6INDIRECT 23233021 ↗ — A randomised controlled trial of bumetanide in the treatment of autism in children
  • T6INDIRECT 22549286 ↗ — Orexin receptor antagonism, a new sleep-enabling paradigm: a proof-of-concept clinical trial
  • T2 22348451 ↗ — Melatonin pharmacokinetics following two different oral surge-sustained release doses in older adult
  • T6 29075003 ↗ — Trends in GPCR drug discovery: new agents, targets and indications
  • T6 25731881 ↗ — Assessment and management of behavioral and psychological symptoms of dementia
  • T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
  • T6INDIRECT 35727534 ↗ — Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment
  • T6INDIRECT 33519510 ↗ — SARS-CoV-2 Mediated Endothelial Dysfunction: The Potential Role of Chronic Oxidative Stress
  • T6INDIRECT 36464706 ↗ — Small molecules in the treatment of COVID-19
  • T6INDIRECT 36713204 ↗ — The role of oxidative stress in the pathogenesis of infections with coronaviruses
  • T6INDIRECT 32637987 ↗ — The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings
  • T6INDIRECT 35589549 ↗ — Identifying who has long COVID in the USA: a machine learning approach using N3C data
  • T6 36253560 ↗ — Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential t
  • T6 36899952 ↗ — Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutic
  • T6 34997196 ↗ — Mechanisms of action of fluvoxamine for COVID-19: a historical review
  • T6 35029046 ↗ — "LONG COVID"-A hypothesis for understanding the biological basis and pharmacological treatment strat
  • T6 34400495 ↗ — Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome
  • T6 37080828 ↗ — Long COVID: pathophysiological factors and abnormalities of coagulation
  • T6INDIRECT 20471738 ↗ — Sleep disturbance as transdiagnostic: consideration of neurobiological mechanisms
  • T6INDIRECT 23939821 ↗ — Key role of CRF in the skin stress response system
  • T6INDIRECT 37760929 ↗ — Mitochondria and Brain Disease: A Comprehensive Review of Pathological Mechanisms and Therapeutic Op
  • T6INDIRECT 31885788 ↗ — Oxidative Stress Indexes for Diagnosis of Health or Disease in Humans
  • T6INDIRECT 23227356 ↗ — Ehlers-danlos syndrome, hypermobility type: an underdiagnosed hereditary connective tissue disorder
  • T6 27749086 ↗ — The Functional and Clinical Significance of the 24-Hour Rhythm of Circulating Glucocorticoids
  • T6 38185705 ↗ — Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets
  • T6 33918736 ↗ — Fibromyalgia: Pathogenesis, Mechanisms, Diagnosis and Treatment Options Update
  • T6 30525268 ↗ — Role of pyroptosis in cardiovascular disease
  • T6INDIRECT 22021174 ↗ — The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor sy
  • T6INDIRECT 19484833 ↗ — Evidence-based recommendations for the assessment and management of sleep disorders in older persons
  • T6INDIRECT 31519472 ↗ — New evidence on the management of Lewy body dementia
  • T6INDIRECT 34741573 ↗ — Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considera
  • T6INDIRECT 28781611 ↗ — Best practice in the management of behavioural and psychological symptoms of dementia
  • T6 31710717 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors
  • T6 18616962 ↗ — Diabetic neuropathy: mechanisms to management
  • T6 26595642 ↗ — Lewy body dementias
  • T6 21034217 ↗ — Orexin receptors: pharmacology and therapeutic opportunities
  • T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
  • T6 24517644 ↗ — The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
metformin
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
29 sources
  • T1 NCT06147050 ↗ — Effect of Metformin in Reducing Fatigue in Long COVID in Adolescents
  • T1 NCT06128967 ↗ — A Multicenter, Adaptive, Randomized, doublE-blinded, Placebo-controlled Study in Participants With L
  • T6 NCT07280572 ↗ — RECLAIM Adaptive Platform Trial for PCC Treatments
  • T6 11832527 ↗ — Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
  • T6INDIRECT 34791425 ↗ — The role of vitamin B12 in viral infections: a comprehensive review of its relationship with the mus
  • T6INDIRECT 34318930 ↗ — Ivermectin for preventing and treating COVID-19
  • T6INDIRECT 34679203 ↗ — Antibiotics for the treatment of COVID-19
  • T6INDIRECT 36385229 ↗ — Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on eviden
  • T6INDIRECT 35316551 ↗ — A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendat
  • T1 36070710 ↗ — Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19
  • T6INDIRECT 37302406 ↗ — Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT)
  • T6INDIRECT 34837648 ↗ — Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a th
  • T1 38690892 ↗ — Favorable Antiviral Effect of Metformin on SARS-CoV-2 Viral Load in a Randomized, Placebo-Controlled
  • T6INDIRECT 36429613 ↗ — Pulmonary and Functional Rehabilitation Improves Functional Capacity, Pulmonary Function and Respira
  • T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
  • T6 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6INDIRECT 33529600 ↗ — Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning
  • T6INDIRECT 36364899 ↗ — A Comprehensive Review on Nutraceuticals: Therapy Support and Formulation Challenges
  • T6INDIRECT 36464706 ↗ — Small molecules in the treatment of COVID-19
  • T6INDIRECT 32651031 ↗ — COVID-19 in people living with diabetes: An international consensus
  • T6INDIRECT 37298527 ↗ — Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeut
  • T6 36050306 ↗ — Lactate metabolism in human health and disease
  • T6 37076602 ↗ — Therapeutic strategies for COVID-19: progress and lessons learned
  • T6 37130947 ↗ — Metformin: update on mechanisms of action and repurposing potential
  • T6 34127835 ↗ — Hypertension-induced cognitive impairment: from pathophysiology to public health
  • T6 36253560 ↗ — Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential t
  • T6 35668219 ↗ — The burden and risks of emerging complications of diabetes mellitus
  • T6 34366606 ↗ — Pancreatic cancer: A review of epidemiology, trend, and risk factors
microcrystalline cellulose
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
25 sources
  • T1 NCT06348212 ↗ — Effect of Probiotic Strain Lactobacillus Paracasei PS23 on Brain Fog in People With Long COVID
  • T6INDIRECT 34658014 ↗ — Colchicine for the treatment of COVID-19
  • T6INDIRECT 36103313 ↗ — Fluvoxamine for the treatment of COVID-19
  • T6INDIRECT 35144974 ↗ — Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blin
  • T6INDIRECT 39356507 ↗ — Lithium Aspartate for Long COVID Fatigue and Cognitive Dysfunction: A Randomized Clinical Trial
  • T6INDIRECT 37739466 ↗ — Dietary supplements to reduce symptom severity and duration in people with SARS-CoV-2: a double-blin
  • T6INDIRECT 40439228 ↗ — Efficacy of bismuth subsalicylate on the prevention of travellers' diarrhoea, 2018-2023
  • T6INDIRECT 37891178 ↗ — Standardized Brazilian green propolis extract (EPP-AF®) in COVID-19 outcomes: a randomized double-bl
  • T6 27287427 ↗ — Cellulases and beyond: the first 70 years of the enzyme producer Trichoderma reesei
  • T6 34991982 ↗ — An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
  • T6 21876164 ↗ — Insights into the oxidative degradation of cellulose by a copper metalloenzyme that exploits biomass
  • T6 21821740 ↗ — Oxidoreductive cellulose depolymerization by the enzymes cellobiose dehydrogenase and glycoside hydr
  • T6 23102010 ↗ — Production of four Neurospora crassa lytic polysaccharide monooxygenases in Pichia pastoris monitore
  • T6INDIRECT 34991703 ↗ — Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in m
  • T6INDIRECT 36015163 ↗ — Efficacy of Kan Jang<sup>®</sup> in Patients with Mild COVID-19: Interim Analysis of a Randomized, Q
  • T6INDIRECT 35241474 ↗ — Dietary supplements to reduce symptom severity and duration in people with SARS-CoV-2: study protoco
  • T6INDIRECT 40692561 ↗ — Comparative cohort study of post-acute COVID-19 infection with a nested, randomized controlled trial
  • T6INDIRECT 40280611 ↗ — Ashwagandha (&lt;i&gt;Withania somnifera (L.) Dunal&lt;/i&gt;) for promoting recovery in long covid:
  • T6 30257993 ↗ — Oxidoreductases and Reactive Oxygen Species in Conversion of Lignocellulosic Biomass
  • T6 29155571 ↗ — Oxygen Activation by Cu LPMOs in Recalcitrant Carbohydrate Polysaccharide Conversion to Monomer Suga
  • T6 35759210 ↗ — Using the Intranasal Route to Administer Drugs to Treat Neurological and Psychiatric Illnesses: Rati
  • T6 26686263 ↗ — Enzymatic cellulose oxidation is linked to lignin by long-range electron transfer
  • T6 23124232 ↗ — Cello-oligosaccharide oxidation reveals differences between two lytic polysaccharide monooxygenases
  • T6 20359453 ↗ — Thermostable enzymes as biocatalysts in the biofuel industry
  • T6 29472725 ↗ — An ancient family of lytic polysaccharide monooxygenases with roles in arthropod development and bio
mindfulness-based stress reduction and cognitive behavioral therapy
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
4 sources
  • T1 NCT05815693 ↗ — Cognitive-behavioral Therapy for Mental Disorder in COVID-19 Survivors
  • T6INDIRECT 41736971 ↗ — Resilience under pressure: a systematic review of psychological coping and endurance mechanisms amon
  • T6 35195724 ↗ — Association of Chiropractic Colleges Research Agenda Conference 2022: Wellness and Health Promotion:
  • T6 PMC11706432 ↗ — ARE HUMANS MUSICAL BEINGS? RELATIONSHIPS BETWEEN MUSIC, RHYTHM AND PSYCHOLOGICAL WELL-BEING
multi-domain Tai Chi Digital therapy Software Application
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
naltrexone (LDN)
T1
T1 — RCT in LC/PASC/PACVS
RegisteredWithdrawnLong COVIDME/CFSPOTS
65 sources
  • T1REGISTERED-ONLY NCT06366724 ↗ — LIFT: Life Improvement Trial
  • T2REGISTERED-ONLY NCT07285473 ↗ — Low-Dose Naltrexone For ME/CFS: Dose-Finding
  • T2WITHDRAWN NCT02965768 ↗ — Immune Effects of Low-dose Naltrexone in ME/CFS
  • T2REGISTERED-ONLY NCT05363514 ↗ — Low Dose Naltrexone Use in Patients With POTS
  • T6INDIRECT 39483457 ↗ — Meta-analysis of natural killer cell cytotoxicity in myalgic encephalomyelitis/chronic fatigue syndr
  • T6INDIRECT 36349400 ↗ — Clinical trials on the pharmacological treatment of long COVID: A systematic review
  • T6INDIRECT 34658014 ↗ — Colchicine for the treatment of COVID-19
  • T6INDIRECT 36409650 ↗ — A systematic review of the biological mediators of fat taste and smell
  • T6INDIRECT 39940333 ↗ — Dietary Supplementation for Fatigue Symptoms in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (
  • T6INDIRECT 38554565 ↗ — Examining inequities in access to opioid agonist treatment (OAT) take-home doses (THD): A Canadian O
  • T6INDIRECT 38360929 ↗ — Long term outcomes of hyperbaric oxygen therapy in post covid condition: longitudinal follow-up of a
  • T6INDIRECT 36196533 ↗ — Enhancing Use of Medications for Opioid Use Disorder Through External Coaching
  • T6INDIRECT 38012333 ↗ — A practice quit model to test early efficacy of medications for alcohol use disorder in a randomized
  • T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
  • T6 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
  • T6 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T2HARM 30642329 ↗ — Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a system
  • T6INDIRECT 36690401 ↗ — Efficacy and safety of hyperbaric oxygen therapy for fibromyalgia: a systematic review and meta-anal
  • T6INDIRECT 27894343 ↗ — Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a sy
  • T6INDIRECT 34352116 ↗ — Primary-level worker interventions for the care of people living with mental disorders and distress
  • T6INDIRECT 34601272 ↗ — Opioid-induced analgesia among persons with opioid use disorder receiving methadone or buprenorphine
  • T6INDIRECT 25879513 ↗ — Excessive Sugar Consumption May Be a Difficult Habit to Break: A View From the Brain and Body
  • T6INDIRECT 34014691 ↗ — Applying methods for personalized medicine to the treatment of alcohol use disorder
  • T2 19453963 ↗ — Fibromyalgia symptoms are reduced by low-dose naltrexone: a pilot study
  • T6INDIRECT 15834216 ↗ — Dissection of hypothalamic-pituitary-adrenal axis pathology in 1-month-abstinent alcohol-dependent m
  • T2 31736966 ↗ — Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natur
  • T6 2683611 ↗ — Biology of natural killer cells
  • T6INDIRECT 33687070 ↗ — Smoking cessation for improving mental health
  • T6INDIRECT 37189381 ↗ — Dupilumab in Inflammatory Skin Diseases: A Systematic Review
  • T6INDIRECT 31702122 ↗ — Autonomic dysfunction and sudden death in patients with Rett syndrome: a systematic review
  • T6INDIRECT 39882369 ↗ — Oral medications for the treatment of postural orthostatic tachycardia syndrome; a systematic review
  • T6INDIRECT 39042627 ↗ — Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgi
  • T6 34942142 ↗ — The neuropsychiatry of Parkinson's disease: advances and challenges
  • T6 34067776 ↗ — Post-COVID-19 Syndrome and the Potential Benefits of Exercise
  • T6 35172971 ↗ — Risks of mental health outcomes in people with covid-19: cohort study
  • T6INDIRECT 28922704 ↗ — Direct-acting antivirals for chronic hepatitis C
  • T6INDIRECT 23450540 ↗ — Methadone at tapered doses for the management of opioid withdrawal
  • T6INDIRECT 20680369 ↗ — A systematic review on the effectiveness of pharmacological interventions for chronic non-specific l
  • T6INDIRECT 35234292 ↗ — Pharmacotherapy for post traumatic stress disorder (PTSD)
  • T6INDIRECT 18161012 ↗ — Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse
  • T6INDIRECT 25827659 ↗ — A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and pos
  • T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6INDIRECT 36100326 ↗ — Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue s
  • T6INDIRECT 36464706 ↗ — Small molecules in the treatment of COVID-19
  • T6INDIRECT 36969241 ↗ — Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOV
  • T6 36899952 ↗ — Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutic
  • T6 37907497 ↗ — The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of lon
  • T6 33240091 ↗ — Challenges for Drug Repurposing in the COVID-19 Pandemic Era
  • T5 31911410 ↗ — Low-dose naltrexone as a treatment for chronic fatigue syndrome
  • T6INDIRECT 37445634 ↗ — Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology
  • T6INDIRECT 36169154 ↗ — Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of aut
  • T6 29462012 ↗ — Neuroinflammation and Central Sensitization in Chronic and Widespread Pain
  • T6 29867317 ↗ — Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder
  • T6 37069462 ↗ — Microglia polarization in nociplastic pain: mechanisms and perspectives
  • T6 30146050 ↗ — Pain Modulation: From Conditioned Pain Modulation to Placebo and Nocebo Effects in Experimental and
  • T6 33062901 ↗ — Exercise-induced hypoalgesia after acute and regular exercise: experimental and clinical manifestati
  • T6 30223011 ↗ — Brain glial activation in fibromyalgia - A multi-site positron emission tomography investigation
  • T6INDIRECT 25081580 ↗ — Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsess
  • T6INDIRECT 24433463 ↗ — Review of pharmacological therapies in fibromyalgia syndrome
  • T6 19345246 ↗ — Opioid receptors in the gastrointestinal tract
  • T6 31387301 ↗ — Mechanisms of Botulinum Toxin Type A Action on Pain
  • T6 29055040 ↗ — THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors
  • T6 30653247 ↗ — Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review
  • T6 30291106 ↗ — Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes As
  • T6 26650439 ↗ — The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors
nirmatrelvir/ritonavir (Paxlovid)
T1
T1 — RCT in LC/PASC/PACVS
Harm signalRegisteredLong COVID
29 sources
  • T1 NCT05576662 ↗ — Paxlovid for Treatment of Long Covid
  • T1HARM NCT05668091 ↗ — A Decentralized, Randomized Phase 2 Efficacy and Safety Study of Nirmatrelvir/Ritonavir in Adults wi
  • T1REGISTERED-ONLY NCT05852873 ↗ — PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway
  • T1 NCT05965726 ↗ — RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms
  • T1REGISTERED-ONLY NCT06792214 ↗ — Antiviral Strategies in the Prevention of Long-term Cardiovascular Outcomes Following COVID-19: The
  • T1 NCT05823896 ↗ — ImPROving Quality of LIFe in the Long COVID Patient
  • T6INDIRECT 38105461 ↗ — Outpatient randomized controlled trials to reduce COVID-19 hospitalization: Systematic review and me
  • T6INDIRECT 35878897 ↗ — Antiviral drug treatment for nonsevere COVID-19: a systematic review and network meta-analysis
  • T6INDIRECT 35955740 ↗ — COVID-19 and the Immune Response: A Multi-Phasic Approach to the Treatment of COVID-19
  • T6INDIRECT 38032024 ↗ — Nirmatrelvir combined with ritonavir for preventing and treating COVID-19
  • T6INDIRECT 38848477 ↗ — Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection: The S
  • T6INDIRECT 35995785 ↗ — Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults wit
  • T6INDIRECT 38690892 ↗ — Favorable Antiviral Effect of Metformin on SARS-CoV-2 Viral Load in a Randomized, Placebo-Controlled
  • T6INDIRECT 40188838 ↗ — Nirmatrelvir-ritonavir versus placebo-ritonavir in individuals with long COVID in the USA (PAX LC):
  • T6INDIRECT 37276589 ↗ — Effectiveness of COVID-19 Treatment With Nirmatrelvir-Ritonavir or Molnupiravir Among U.S. Veterans:
  • T6 37076602 ↗ — Therapeutic strategies for COVID-19: progress and lessons learned
  • T6 39326415 ↗ — Mechanisms of long COVID and the path toward therapeutics
  • T6 36947108 ↗ — Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
  • T6INDIRECT 36933565 ↗ — Effectiveness of nirmatrelvir-ritonavir in preventing hospital admissions and deaths in people with
  • T6INDIRECT 36182669 ↗ — SARS-CoV-2 in immunocompromised individuals
  • T6INDIRECT 35912863 ↗ — Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches
  • T6INDIRECT 36464706 ↗ — Small molecules in the treatment of COVID-19
  • T6INDIRECT 36969241 ↗ — Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOV
  • T6INDIRECT 36407883 ↗ — Immunocompromised Patients with Protracted COVID-19: a Review of "Long Persisters"
  • T6INDIRECT 36851722 ↗ — Impact of COVID-19 on Cardiovascular Disease
  • T6INDIRECT 39256346 ↗ — Emerging and reemerging infectious diseases: global trends and new strategies for their prevention a
  • T6 36899952 ↗ — Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutic
  • T6 37018987 ↗ — Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy?
  • T6 37907497 ↗ — The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of lon
online visit
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
7 sources
  • T1REGISTERED-ONLY NCT07352254 ↗ — OutreAch MediCal Care for HousEbound Patients With Post-COVID-19 Syndrome or ME/CFS of Any Cause (AC
  • T6 37265696 ↗ — Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement
  • T6 34574480 ↗ — Telemedicine and eHealth Literacy in the Era of COVID-19: A Cross-Sectional Study in a Peripheral Cl
  • T6 34205724 ↗ — Lessons Learned during a Naturalistic Study of Online Treatment for Pediatric Rehabilitation
  • T6 33994649 ↗ — Restarting "Normal" Life after Covid-19 and the Lockdown: Evidence from Spain, the United Kingdom, a
  • T6 33385246 ↗ — Implementing telemedicine for the management of benign urologic conditions: a single centre experien
  • T4 PMC8487351 ↗ — UEG Week 2021 Poster Presentations
pulmonary rehabilitation
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
28 sources
  • T1 NCT05244044 ↗ — Pulmonary Rehabilitation for Long COVID (Post COVID-19 Condition)
  • T1 NCT05379517 ↗ — Pulmonary Rehabilitation Program With Pulsed Electromagnetic Field Therapy in Patients With Post-cov
  • T1 36223120 ↗ — Use of Cardiopulmonary Exercise Testing to Evaluate Long COVID-19 Symptoms in Adults: A Systematic R
  • T6INDIRECT 35182760 ↗ — ESCMID rapid guidelines for assessment and management of long COVID
  • T6INDIRECT 37725376 ↗ — Rehabilitation Interventions for Physical Capacity and Quality of Life in Adults With Post-COVID-19
  • T6INDIRECT 34592585 ↗ — Telehealth utilization during the Covid-19 pandemic: A systematic review
  • T6INDIRECT 35564579 ↗ — Rehabilitation Interventions for Post-Acute COVID-19 Syndrome: A Systematic Review
  • T6INDIRECT 34523128 ↗ — Continuing education meetings and workshops: effects on professional practice and healthcare outcome
  • T6INDIRECT 35236727 ↗ — Inspiratory muscle training enhances recovery post-COVID-19: a randomised controlled trial
  • T6INDIRECT 36111386 ↗ — Rehabilitation for post-COVID-19 condition through a supervised exercise intervention: A randomized
  • T6INDIRECT 36476156 ↗ — Effects of a concurrent training, respiratory muscle exercise, and self-management recommendations o
  • T6INDIRECT 34351016 ↗ — Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19
  • T6 33753937 ↗ — Post-acute COVID-19 syndrome
  • T6 34265229 ↗ — Symptoms, complications and management of long COVID: a review
  • T6INDIRECT 33146552 ↗ — Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease.
  • T6INDIRECT 33609255 ↗ — A Review of Persistent Post-COVID Syndrome (PPCS)
  • T6INDIRECT 34328636 ↗ — Post-COVID-19 acute sarcopenia: physiopathology and management
  • T6INDIRECT 32475821 ↗ — The Stanford Hall consensus statement for post-COVID-19 rehabilitation
  • T6 36606682 ↗ — Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstr
  • T6 33857435 ↗ — Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuro
  • T6 36412084 ↗ — Long COVID: mechanisms, risk factors and recovery
  • T6 34451904 ↗ — Lung Fibrosis after COVID-19: Treatment Prospects
  • T6 33686978 ↗ — Post-COVID lung fibrosis: The tsunami that will follow the earthquake
  • T6 35566253 ↗ — The Pathophysiology of Long COVID throughout the Renin-Angiotensin System
  • T6 34401216 ↗ — Cellular Senescence in Idiopathic Pulmonary Fibrosis
  • T6 35472304 ↗ — Clinical characteristics with inflammation profiling of long COVID and association with 1-year recov
  • T6 35176758 ↗ — Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus
  • T6 33964245 ↗ — 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related
pyridostigmine
T1
T1 — RCT in LC/PASC/PACVS
Harm signalRegisteredLong COVIDPOTS
57 sources
  • T1REGISTERED-ONLY NCT06366724 ↗ — LIFT: Life Improvement Trial
  • T2REGISTERED-ONLY NCT03124355 ↗ — Vagal Stimulation in POTS
  • T2 NCT03261570 ↗ — Cardiovagal Baroreflex Deficits Impair Neurovascular Coupling and Cognition in POTS
  • T2HARM NCT03674541 ↗ — The Exercise Response to Pharmacologic Cholinergic Stimulation in Myalgic Encephalomyelitis / Chroni
  • T6REGISTERED-ONLY NCT00409435 ↗ — A Study of Pyridostigmine in Postural Tachycardia Syndrome
  • T6INDIRECT 39882369 ↗ — Oral medications for the treatment of postural orthostatic tachycardia syndrome; a systematic review
  • T6INDIRECT 39538129 ↗ — Postural orthostatic tachycardia syndrome after COVID-19 vaccination: A systematic review
  • T6INDIRECT 40426137 ↗ — Inspiratory muscle training and aerobic exercise for respiratory muscle strength in myasthenia gravi
  • T6INDIRECT 33460984 ↗ — Impact of COVID-19 pandemic and lockdown in a cohort of myasthenia gravis patients in India
  • T6 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
  • T6 34024217 ↗ — Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments
  • T6 33595463 ↗ — COVID-19 and Eye: A Review of Ophthalmic Manifestations of COVID-19
  • T6 34991982 ↗ — An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
  • T6INDIRECT 33723532 ↗ — Long-Haul Post-COVID-19 Symptoms Presenting as a Variant of Postural Orthostatic Tachycardia Syndrom
  • T6INDIRECT 15911704 ↗ — Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome
  • T6INDIRECT 22677718 ↗ — A randomised controlled study of the effect of cholinesterase inhibition on colon function in patien
  • T6INDIRECT 23978222 ↗ — A double-blind placebo-controlled cross-over study of the vascular effects of midodrine in neuropath
  • T2 18240245 ↗ — A six-month randomized controlled trial of exercise and pyridostigmine in the treatment of fibromyal
  • T2 29500811 ↗ — Efficacy of Propranolol, Bisoprolol, and Pyridostigmine for Postural Tachycardia Syndrome: a Randomi
  • T6INDIRECT 19506222 ↗ — Efficacy of immunotherapy in seropositive and seronegative putative autoimmune autonomic ganglionopa
  • T6INDIRECT 26387781 ↗ — Effect of neostigmine on gastroduodenal motility in patients with suspected gastrointestinal motilit
  • T6INDIRECT 17016160 ↗ — Acetylcholinesterase inhibition in patients with orthostatic intolerance
  • T6INDIRECT 23116538 ↗ — Treatment of multiple system atrophy using intravenous immunoglobulin
  • T6HARM 29442540 ↗ — Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor The
  • T6INDIRECT 34752479 ↗ — Drug-induced orthostatic hypotension: A systematic review and meta-analysis of randomised controlled
  • T6INDIRECT 22591985 ↗ — Efficacy of treatments for orthostatic hypotension: a systematic review
  • T6INDIRECT 31214762 ↗ — Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review
  • T2 16476804 ↗ — Pyridostigmine treatment trial in neurogenic orthostatic hypotension
  • T2 20837887 ↗ — Comparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotensio
  • T6INDIRECT 12933939 ↗ — Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypoten
  • T6INDIRECT 33262898 ↗ — New-onset Postural Orthostatic Tachycardia Syndrome Following Coronavirus Disease 2019 Infection
  • T6INDIRECT 33047223 ↗ — New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature
  • T6INDIRECT 34821709 ↗ — Post-Acute Sequelae of COVID-19 and Cardiovascular Autonomic Dysfunction: What Do We Know?
  • T6INDIRECT 34216297 ↗ — COVID-19 and Myositis: What We Know So Far
  • T6 33240091 ↗ — Challenges for Drug Repurposing in the COVID-19 Pandemic Era
  • T6 36174571 ↗ — Bioelectronic medicine: Preclinical insights and clinical advances
  • T6 38534355 ↗ — Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders
  • T6 38887284 ↗ — Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease
  • T6 37028776 ↗ — Neuroimmune nexus in the pathophysiology and therapy of inflammatory disorders: Role of α7 nicotinic
  • T6 39444797 ↗ — Understanding autoimmune response after SARS-CoV-2 infection and the pathogenesis/mechanisms of long
  • T6 34390682 ↗ — Post-COVID-19 Tachycardia Syndrome: A Distinct Phenotype of Post-Acute COVID-19 Syndrome
  • T6INDIRECT 29508455 ↗ — Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies
  • T6INDIRECT 23186897 ↗ — Transverse myelitis
  • T6INDIRECT 19713422 ↗ — Guidelines for the diagnosis and management of syncope (version 2009)
  • T6INDIRECT 25980576 ↗ — 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tach
  • T6 26493934 ↗ — Recent research on Gulf War illness and other health problems in veterans of the 1991 Gulf War: Effe
  • T6 28303218 ↗ — The modification of natural products for medical use
  • T6 29717928 ↗ — Impact of the Autonomic Nervous System on the Skeleton
  • T6 30793549 ↗ — Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: W
  • T6 33924103 ↗ — Treatment Options for Motor and Non-Motor Symptoms of Parkinson's Disease
  • T6 29359025 ↗ — Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment
  • T6 21962754 ↗ — Multiple system atrophy: a clinical and neuropathological perspective
  • T6 34134525 ↗ — Recognition, Prevention, and Management of Arrhythmias and Autonomic Disorders in Cardio-Oncology: A
  • T6 20103559 ↗ — Cardiac autonomic neuropathy in diabetes: a clinical perspective
  • T6 28050656 ↗ — The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic o
  • T6 23122672 ↗ — Postural tachycardia syndrome: a heterogeneous and multifactorial disorder
  • T6 19207771 ↗ — Postural tachycardia syndrome (POTS)
qEEG-neurofeedback
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
19 sources
  • T1REGISTERED-ONLY NCT07005921 ↗ — Attention, Memory and Quality of Life in Post-COVID-19 Adults
  • T6INDIRECT 39206795 ↗ — Parallel electrophysiological abnormalities due to COVID-19 infection and to Alzheimer's disease and
  • T6INDIRECT 40365003 ↗ — Using physiological biomarkers in forensic psychiatry: a scoping review
  • T6 33809957 ↗ — Changes in EEG Recordings in COVID-19 Patients as a Basis for More Accurate QEEG Diagnostics and EEG
  • T6 36081063 ↗ — Comparison of QEEG Findings before and after Onset of Post-COVID-19 Brain Fog Symptoms
  • T6 35895740 ↗ — Effect of neurofeedback therapy on neurological post-COVID-19 complications (A pilot study)
  • T6 36277052 ↗ — Quantitative electroencephalography interpretation of human brain activity after COVID-19 before and
  • T6INDIRECT 38646408 ↗ — Efficacy of Original Neurofeedback Treatment Method for Brain Fog From COVID-19: A Case Report
  • T6INDIRECT 42121889 ↗ — Alterations in Cortical Oscillatory Dynamics Following SARS-CoV-2 Infection: QEEG Biomarkers of Vuln
  • T6INDIRECT 34857904 ↗ — ACNP 60<sup>th</sup> Annual Meeting: Poster Abstracts P1 - P275
  • T6INDIRECT 40115713 ↗ — Neurofeedback for COVID-19 Brain Fog: A Secondary Analysis
  • T6 36456693 ↗ — ACNP 61<sup>st</sup> Annual Meeting: Poster Abstracts P1 - P270
  • T6 33231810 ↗ — Abstracts of the 51st Annual Conference of the Italian Society of Neurology : November 28- 30, 2020
  • T6 PMC11932184 ↗ — FREE PAPERS
  • T6 PMC10729596 ↗ — ACNP 62nd Annual Meeting: Poster Abstracts P251 – P500
  • T6 PMC10729595 ↗ — ACNP 62nd Annual Meeting: Poster Abstracts P1 – P250
  • T6 PMC8637057 ↗ — ACNP 60th Annual Meeting: Keyword Index
  • T6 40150759 ↗ — Electroencephalographic Biomarkers for Neuropsychiatric Diseases: The State of the Art
  • T6 35431842 ↗ — Possible Mechanisms Underlying Neurological Post-COVID Symptoms and Neurofeedback as a Potential The
remdesivir
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
28 sources
  • T1REGISTERED-ONLY NCT06792214 ↗ — Antiviral Strategies in the Prevention of Long-term Cardiovascular Outcomes Following COVID-19: The
  • T6INDIRECT 33549624 ↗ — COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid
  • T6INDIRECT 33246166 ↗ — COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current lite
  • T6INDIRECT 35057437 ↗ — Effectiveness of Curcumin on Outcomes of Hospitalized COVID-19 Patients: A Systematic Review of Clin
  • T6INDIRECT 34396514 ↗ — Systemic corticosteroids for the treatment of COVID-19
  • T6INDIRECT 34318930 ↗ — Ivermectin for preventing and treating COVID-19
  • T6INDIRECT 34452974 ↗ — Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19: Sys
  • T6INDIRECT 34386902 ↗ — Association of CNS demyelination and COVID-19 infection: an updated systematic review
  • T6INDIRECT 33036570 ↗ — Implications of COVID-19 in high burden countries for HIV/TB: A systematic review of evidence
  • T6INDIRECT 38848477 ↗ — Nirmatrelvir-Ritonavir and Symptoms in Adults With Postacute Sequelae of SARS-CoV-2 Infection: The S
  • T6INDIRECT 37276589 ↗ — Effectiveness of COVID-19 Treatment With Nirmatrelvir-Ritonavir or Molnupiravir Among U.S. Veterans:
  • T6 32201335 ↗ — Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID
  • T6 35271343 ↗ — The immunology and immunopathology of COVID-19
  • T6INDIRECT 32653054 ↗ — Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally a
  • T6INDIRECT 34156034 ↗ — Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebra
  • T6INDIRECT 33146552 ↗ — Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease.
  • T6INDIRECT 33723416 ↗ — The first 12 months of COVID-19: a timeline of immunological insights
  • T6INDIRECT 33856918 ↗ — COVID-19 and Cardiovascular Disease: From Bench to Bedside
  • T6INDIRECT 32857878 ↗ — Thrombosis in COVID-19
  • T6INDIRECT 33529600 ↗ — Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning
  • T6 37076602 ↗ — Therapeutic strategies for COVID-19: progress and lessons learned
  • T6 33857435 ↗ — Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuro
  • T6 39326415 ↗ — Mechanisms of long COVID and the path toward therapeutics
  • T6 33219837 ↗ — Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological
  • T6 34991982 ↗ — An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
  • T6 35216673 ↗ — A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
  • T6 33892403 ↗ — Long COVID: An overview
  • T6 35176758 ↗ — Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus
self- applied acupressure plus Qigong course plus advice literature
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT05289154 ↗ — Acupressure and Qigong in Chronic Fatigue Post COVID-19.
stellate ganglion block
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
19 sources
  • T1 NCT05638620 ↗ — Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID
  • T1 41973314 ↗ — Stellate Ganglion Block in the Treatment of Long COVID: A Systematic Review
  • T1 40504522 ↗ — Stellate Ganglion Block for the Treatment of COVID-19-Induced Parosmia: A Randomized Clinical Trial
  • T1 40739539 ↗ — A prospective randomized clinical trial on the differential effect of left versus right stellate gan
  • T6 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
  • T6 35411324 ↗ — Research Opportunities in Autonomic Neural Mechanisms of Cardiopulmonary Regulation: A Report From t
  • T6 36949968 ↗ — A Review of Stellate Ganglion Block as an Adjunctive Treatment Modality
  • T5 34922127 ↗ — Stellate ganglion block reduces symptoms of Long COVID: A case series
  • T6 35614970 ↗ — The Pathobiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Case for Neuroglial Fail
  • T5 36106285 ↗ — Stellate Ganglion Block for Anosmia and Dysgeusia Due to Long COVID
  • T5 36628048 ↗ — Stellate Ganglion Block for Long COVID Symptom Management: A Case Report
  • T5 37496529 ↗ — Efficacy of Stellate Ganglion Block in Treating Long-Term COVID-19-Related Olfactory and Gustatory D
  • T6INDIRECT 36074973 ↗ — Sinus Tachycardia: a Multidisciplinary Expert Focused Review
  • T6INDIRECT 40046430 ↗ — Neurological sequelae of long COVID: a comprehensive review of diagnostic imaging, underlying mechan
  • T6 37366867 ↗ — Post-COVID-19 Anosmia and Therapies: Stay Tuned for New Drugs to Sniff Out
  • T6 42325367 ↗ — Long COVID: current research and future directions
  • T6 37386671 ↗ — Abstracts of the ICARE 2022 76th SIAARTI National Congress : Milan, Italy. 28-30 October 2022
  • T6 35934749 ↗ — ESNR 2022
  • T6 PMC12502813 ↗ — Book of Posters
symptom-focused rehabilitation
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
1 source
  • T1 NCT05172206 ↗ — Symptom-based Rehabilitation Compared to Usual Care in Post-COVID - a Randomized Controlled Trial
tDCS-active
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
22 sources
  • T1 NCT05965739 ↗ — RECOVER-NEURO: Platform Protocol, Appendix_A to Measure the Effects of BrainHQ, PASC CoRE and tDCS I
  • T1 NCT05965752 ↗ — RECOVER-NEURO: Platform Protocol to Measure the Effects of Cognitive Dysfunction Interventions on Lo
  • T6INDIRECT 39025832 ↗ — Evaluating the effects of tDCS on depressive and anxiety symptoms from a transdiagnostic perspective
  • T6INDIRECT 38329083 ↗ — Efficacy and safety of transcranial magnetic stimulation on cognition in mild cognitive impairment,
  • T6INDIRECT 35768406 ↗ — Interventions for mental health, cognition, and psychological wellbeing in long COVID: a systematic
  • T6INDIRECT 36834176 ↗ — Non-Pharmacological Therapies for Post-Viral Syndromes, Including Long COVID: A Systematic Review
  • T6INDIRECT 38214047 ↗ — Rehabilitation and COVID-19: systematic review by Cochrane Rehabilitation
  • T6INDIRECT 36693536 ↗ — Non-invasive brain stimulation for fatigue in post-acute sequelae of SARS-CoV-2 (PASC)
  • T6INDIRECT 38272997 ↗ — Transcranial direct current stimulation (tDCS) in the treatment of neuropsychiatric symptoms of long
  • T6 38378653 ↗ — Nanotechnology's frontier in combatting infectious and inflammatory diseases: prevention and treatme
  • T6 39326415 ↗ — Mechanisms of long COVID and the path toward therapeutics
  • T6 35734582 ↗ — Non-invasive brain stimulation and neuroenhancement
  • T6 39482575 ↗ — Hallmarks of primary headache: part 1 - migraine
  • T6 39232147 ↗ — Immune system adaptation during gender-affirming testosterone treatment
  • T6INDIRECT 38962179 ↗ — Current state of clinical ultrasound neuromodulation
  • T6INDIRECT 38495306 ↗ — Neurovascular coupling impairment as a mechanism for cognitive deficits in COVID-19
  • T6INDIRECT 39536116 ↗ — Translating insights into therapies for Long Covid
  • T6INDIRECT 35911909 ↗ — Neuromodulation Strategies to Reduce Inflammation and Improve Lung Complications in COVID-19 Patient
  • T6INDIRECT 35410927 ↗ — Neuromodulation through brain stimulation-assisted cognitive training in patients with post-COVID-19
  • T6 36174571 ↗ — Bioelectronic medicine: Preclinical insights and clinical advances
  • T6 35712237 ↗ — Fish and the Thyroid: A Janus Bifrons Relationship Caused by Pollutants and the Omega-3 Polyunsatura
  • T6 33324324 ↗ — Applications of Non-invasive Neuromodulation for the Management of Disorders Related to COVID-19
tenofovir disoproxil/emtricitabine
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
3 sources
  • T1REGISTERED-ONLY NCT06511063 ↗ — Antiviral Clinical Trial for Long Covid-19
  • T6 40559563 ↗ — Digestive Manifestations of Post-COVID-19: A Focus on Therapeutic Strategies
  • T6 36609708 ↗ — Sustaining PrEP Prescriptions at a Safety-Net Hospital in New York City During COVID-19: Lessons Lea
transcranial direct current stimulation (tDCS)
T1
T1 — RCT in LC/PASC/PACVS
RegisteredWithdrawnLong COVID
24 sources
  • T6INDIRECT 39025832 ↗ — Evaluating the effects of tDCS on depressive and anxiety symptoms from a transdiagnostic perspective
  • T1 38329083 ↗ — Efficacy and safety of transcranial magnetic stimulation on cognition in mild cognitive impairment,
  • T6INDIRECT 39603702 ↗ — Interventions for the management of long covid (post-covid condition): living systematic review
  • T6INDIRECT 35768406 ↗ — Interventions for mental health, cognition, and psychological wellbeing in long COVID: a systematic
  • T6INDIRECT 36834176 ↗ — Non-Pharmacological Therapies for Post-Viral Syndromes, Including Long COVID: A Systematic Review
  • T6INDIRECT 36642173 ↗ — A systematic review of trials currently investigating therapeutic modalities for post-acute COVID-19
  • T6INDIRECT 38214047 ↗ — Rehabilitation and COVID-19: systematic review by Cochrane Rehabilitation
  • T6INDIRECT 38695969 ↗ — Intervention modalities for brain fog caused by long-COVID: systematic review of the literature
  • T6INDIRECT 36693536 ↗ — Non-invasive brain stimulation for fatigue in post-acute sequelae of SARS-CoV-2 (PASC)
  • T1 38272997 ↗ — Transcranial direct current stimulation (tDCS) in the treatment of neuropsychiatric symptoms of long
  • T6 39326415 ↗ — Mechanisms of long COVID and the path toward therapeutics
  • T6 35734582 ↗ — Non-invasive brain stimulation and neuroenhancement
  • T6INDIRECT 35727534 ↗ — Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment
  • T6INDIRECT 39482575 ↗ — Hallmarks of primary headache: part 1 - migraine
  • T6INDIRECT 34593760 ↗ — Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic inter
  • T6INDIRECT 34403043 ↗ — Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor's pag
  • T6INDIRECT 38962179 ↗ — Current state of clinical ultrasound neuromodulation
  • T6INDIRECT 38495306 ↗ — Neurovascular coupling impairment as a mechanism for cognitive deficits in COVID-19
  • T4 33281589 ↗ — Update on the Use of Transcranial Electrical Brain Stimulation to Manage Acute and Chronic COVID-19
  • T6 36174571 ↗ — Bioelectronic medicine: Preclinical insights and clinical advances
  • T6 37457901 ↗ — Post-COVID cognitive dysfunction: current status and research recommendations for high risk populati
  • T6 37372912 ↗ — What Do We Know about Nociplastic Pain?
  • T6 38931833 ↗ — Insight into the Functional Dynamics and Challenges of Exosomes in Pharmaceutical Innovation and Pre
  • T6 36411394 ↗ — Depression and Anxiety During the COVID-19 Pandemic: Epidemiology, Mechanism, and Treatment
transcranial magnetic stimulation (TMS)
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
23 sources
  • T6REGISTERED-ONLY NCT07525063 ↗ — Pain & Reward Neuromodulation of CNS Circuits
  • T6INDIRECT 39025832 ↗ — Evaluating the effects of tDCS on depressive and anxiety symptoms from a transdiagnostic perspective
  • T1 38329083 ↗ — Efficacy and safety of transcranial magnetic stimulation on cognition in mild cognitive impairment,
  • T6INDIRECT 34752489 ↗ — A mixed-methods systematic review of post-viral fatigue interventions: Are there lessons for long Co
  • T6INDIRECT 38695969 ↗ — Intervention modalities for brain fog caused by long-COVID: systematic review of the literature
  • T6INDIRECT 40234864 ↗ — Exploring depression in adults over a decade: a review of longitudinal studies
  • T1 36129719 ↗ — Effectiveness of Standard Sequential Bilateral Repetitive Transcranial Magnetic Stimulation vs Bilat
  • T1 38228914 ↗ — Connectivity-guided intermittent theta burst versus repetitive transcranial magnetic stimulation for
  • T6INDIRECT 36455453 ↗ — Co-ultramicronized palmitoylethanolamide/luteolin normalizes GABA<sub>B</sub>-ergic activity and cor
  • T6INDIRECT 38561682 ↗ — A randomized feasibility trial of medium chain triglyceride-supplemented ketogenic diet in people wi
  • T1 36610206 ↗ — Real world research on transcranial magnetic stimulation treatment strategies for neuropsychiatric s
  • T6 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6INDIRECT 39482575 ↗ — Hallmarks of primary headache: part 1 - migraine
  • T6INDIRECT 35912863 ↗ — Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches
  • T6INDIRECT 33537521 ↗ — Potential for increased prevalence of neuropathic pain after the COVID-19 pandemic
  • T6INDIRECT 35747600 ↗ — Clinical Characteristics and Mechanisms of Musculoskeletal Pain in Long COVID
  • T6INDIRECT 34403043 ↗ — Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor's pag
  • T6 37907497 ↗ — The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of lon
  • T6 36174571 ↗ — Bioelectronic medicine: Preclinical insights and clinical advances
  • T6 37372912 ↗ — What Do We Know about Nociplastic Pain?
  • T6 38931833 ↗ — Insight into the Functional Dynamics and Challenges of Exosomes in Pharmaceutical Innovation and Pre
  • T6 35734582 ↗ — Non-invasive brain stimulation and neuroenhancement
umbilical cord mesenchymal stem cell
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
16 sources
  • T1REGISTERED-ONLY NCT06492798 ↗ — Effectiveness and Safety of Mesenchymal Stem Cell Therapy in Long COVID Patients
  • T6INDIRECT 35782071 ↗ — Association between Mesenchymal Stem Cells and COVID-19 Therapy: Systematic Review and Current Trend
  • T6 35787632 ↗ — Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next g
  • T6 38152837 ↗ — Engineered Exosome for Drug Delivery: Recent Development and Clinical Applications
  • T6 34363275 ↗ — Mesenchymal stem cells and their derived exosomes to combat Covid-19
  • T6HARM 38931833 ↗ — Insight into the Functional Dynamics and Challenges of Exosomes in Pharmaceutical Innovation and Pre
  • T6 38738585 ↗ — Extracellular vesicles as human therapeutics: A scoping review of the literature
  • T6INDIRECT 34072708 ↗ — The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants
  • T4 37763198 ↗ — Fresh Umbilical Cord Blood-A Source of Multipotent Stem Cells, Collection, Banking, Cryopreservation
  • T6INDIRECT 39760094 ↗ — Persistent microbial infections and idiopathic pulmonary fibrosis - an insight into &lt;i&gt;non-typ
  • T6INDIRECT 38005826 ↗ — Immune-Cell-Based Therapy for COVID-19: Current Status
  • T6INDIRECT 36323940 ↗ — The 48<sup>th</sup> Annual Meeting of the European Society for Blood and Marrow Transplantation: Phy
  • T6INDIRECT 39444918 ↗ — Efficacy and safety of mesenchymal stem cell therapy for acute respiratory distress syndrome-a syste
  • T6 36359762 ↗ — Mesenchymal Stem Cell-Derived Extracellular Vesicles for Therapeutic Use and in Bioengineering Appli
  • T6 38888007 ↗ — Standardized Reporting of Research on Exosomes to Ensure Rigor and Reproducibility
  • T6 40720603 ↗ — Extracellular Vesicles for Clinical Diagnostics: From Bulk Measurements to Single-Vesicle Analysis
vagus nerve stimulation (VNS)
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
26 sources
  • T1REGISTERED-ONLY NCT06968104 ↗ — Vagus Nerve Stimulation to the Ear to Improve Symptoms in Post-COVID-19 and ME/CFS
  • T6INDIRECT 40514644 ↗ — Long-term neurological and cognitive impact of COVID-19: a systematic review and meta-analysis in ov
  • T6INDIRECT 35768406 ↗ — Interventions for mental health, cognition, and psychological wellbeing in long COVID: a systematic
  • T6INDIRECT 36642173 ↗ — A systematic review of trials currently investigating therapeutic modalities for post-acute COVID-19
  • T6INDIRECT 38214047 ↗ — Rehabilitation and COVID-19: systematic review by Cochrane Rehabilitation
  • T6INDIRECT 34291812 ↗ — Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  • T6INDIRECT 36062970 ↗ — Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction
  • T6INDIRECT 34291813 ↗ — Interventions for the treatment of persistent post-COVID-19 olfactory dysfunction
  • T6INDIRECT 36063364 ↗ — Interventions for the prevention of persistent post-COVID-19 olfactory dysfunction
  • T6INDIRECT 36710253 ↗ — Interleukin-17 as a spatiotemporal bridge from acute to chronic inflammation: Novel insights from co
  • T6INDIRECT 39089436 ↗ — Non-Invasive Brain Stimulation for Post-COVID-19 Conditions: A Systematic Review
  • T6 39326415 ↗ — Mechanisms of long COVID and the path toward therapeutics
  • T6 36412084 ↗ — Long COVID: mechanisms, risk factors and recovery
  • T6INDIRECT 39482575 ↗ — Hallmarks of primary headache: part 1 - migraine
  • T6INDIRECT 37845499 ↗ — Emerging role of the host microbiome in neuropsychiatric disorders: overview and future directions
  • T4 39363044 ↗ — Vagus nerve stimulation (VNS): recent advances and future directions
  • T6INDIRECT 33677650 ↗ — Is postural orthostatic tachycardia syndrome (POTS) a central nervous system disorder?
  • T6INDIRECT 36853484 ↗ — Pain Management in the Post-COVID Era-An Update: A Narrative Review
  • T6INDIRECT 35978881 ↗ — Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity
  • T6INDIRECT 36169154 ↗ — Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of aut
  • T4 32743022 ↗ — Targeting the cholinergic anti-inflammatory pathway with vagus nerve stimulation in patients with Co
  • T6 36174571 ↗ — Bioelectronic medicine: Preclinical insights and clinical advances
  • T6 35566253 ↗ — The Pathophysiology of Long COVID throughout the Renin-Angiotensin System
  • T6 37028776 ↗ — Neuroimmune nexus in the pathophysiology and therapy of inflammatory disorders: Role of α7 nicotinic
  • T6 34211370 ↗ — Microglial Implications in SARS-CoV-2 Infection and COVID-19: Lessons From Viral RNA Neurotropism an
  • T6 33324324 ↗ — Applications of Non-invasive Neuromodulation for the Management of Disorders Related to COVID-19
vitamin D
T1
T1 — RCT in LC/PASC/PACVS
Long COVID
26 sources
  • T1 NCT05630339 ↗ — Magnesium and Vitamin D Combination for Post-COVID Syndrome
  • T1 NCT05356936 ↗ — Pilot Study of Vitamin K2 (MK-7) and Vitamin D3 Supplementation and the Effects on PASC Symptomatolo
  • T6 NCT02965898 ↗ — The Effect of Vitamin D Substitution on the Development of Chronic Pancreatitis
  • T1 34160843 ↗ — Association of vitamin D deficiency with COVID-19 infection severity: Systematic review and meta-ana
  • T6INDIRECT 34523128 ↗ — Continuing education meetings and workshops: effects on professional practice and healthcare outcome
  • T6INDIRECT 34318930 ↗ — Ivermectin for preventing and treating COVID-19
  • T6INDIRECT 36032234 ↗ — Post-COVID-19 fatigue: A systematic review
  • T1 34165766 ↗ — Vitamin D supplementation and clinical outcomes in COVID-19: a systematic review and meta-analysis
  • T6INDIRECT 36606682 ↗ — Inspiratory muscle training, with or without concomitant pulmonary rehabilitation, for chronic obstr
  • T6INDIRECT 36695483 ↗ — Remdesivir for the treatment of COVID-19
  • T1 36215226 ↗ — Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respirat
  • T6INDIRECT 35450527 ↗ — Ultramicronized Palmitoylethanolamide and Luteolin Supplement Combined with Olfactory Training to Tr
  • T6INDIRECT 33126054 ↗ — Prediction of survival odds in COVID-19 by zinc, age and selenoprotein P as composite biomarker
  • T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
  • T6 33753937 ↗ — Post-acute COVID-19 syndrome
  • T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6INDIRECT 35594336 ↗ — Pathophysiology and mechanism of long COVID: a comprehensive review
  • T6INDIRECT 34328636 ↗ — Post-COVID-19 acute sarcopenia: physiopathology and management
  • T6INDIRECT 32773996 ↗ — The 2019-2020 Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2) Pandemic: A Joint
  • T6 34248921 ↗ — Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Con
  • T6 36454715 ↗ — CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond
  • T6 34991982 ↗ — An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
  • T6 33909761 ↗ — Brazilian Guidelines of Hypertension - 2020
  • T6 38676447 ↗ — Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows
  • T6 33001410 ↗ — Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss
whole body hyperthermia
T1
T1 — RCT in LC/PASC/PACVS
RegisteredLong COVID
14 sources
  • T1REGISTERED-ONLY NCT05931497 ↗ — Sauna for Long Covid
  • T6INDIRECT 41415232 ↗ — Integrative multimodal treatment approach for patients suffering from Post-COVID syndrome: a study b
  • T6 39967803 ↗ — Hyperthermia and targeting heat shock proteins: innovative approaches for neurodegenerative disorder
  • T6 38269219 ↗ — Nutritional and Wellness Strategies for Neurological and Psychiatric Recovery From Post-COVID Syndro
  • T6INDIRECT 36412591 ↗ — A Multimodal Approach in the Treatment of Persistent Post-COVID
  • T6 39274303 ↗ — Impact of Spa Therapy on Symptoms and Quality of Life in Post-COVID-19 Patients with Chronic Conditi
  • T6 37190098 ↗ — A Preliminary Study of Mild Heat Stress on Inflammasome Activation in Murine Macrophages
  • T6INDIRECT 41741003 ↗ — Assessment and management of post-COVID-19 pulmonary complications: a rapid review
  • T4 40336247 ↗ — Whole-body hyperthermia as part of a multimodal treatment for patients with post-covid syndrome - a
  • T4 PMC9471381 ↗ — ICIMH 2022 Abstracts
  • T4 PMC11047233 ↗ — 2024 International Congress on Integrative Medicine & Health Abstracts
  • T6 42174604 ↗ — Reframing ME/CFS: toward a unified mechanistic model of chronic post-infectious diseases
  • T6 PMC10806386 ↗ — Nutritional and Wellness Strategies for Neurological and Psychiatric Recovery From Post-COVID Syndro
  • T6 PMC13300933 ↗ — Sleep and Circadian Rhythms in Patients with Physical and Mental Disorders
intravenous immunoglobulin (IVIg)
T2
T2 — RCT in related condition
RegisteredLong COVIDPOTS
45 sources
  • T6 NCT05350774 ↗ — Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2
  • T6 32744608 ↗ — Expanded Clinical Phenotype, Oncological Associations, and Immunopathologic Insights of Paraneoplast
  • T6 29661905 ↗ — Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis.
  • T6 22561833 ↗ — IgE and mast cells in allergic disease.
  • T6 25517090 ↗ — Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions.
  • T6 31676858 ↗ — TIM3 comes of age as an inhibitory receptor.
  • T6INDIRECT 33837630 ↗ — Prevalence, clinical characteristics and outcomes of Guillain-Barré syndrome spectrum associated wit
  • T6INDIRECT 35660931 ↗ — Global reports of myocarditis following COVID-19 vaccination: A systematic review and meta-analysis
  • T6INDIRECT 34365148 ↗ — Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-1
  • T6INDIRECT 34386902 ↗ — Association of CNS demyelination and COVID-19 infection: an updated systematic review
  • T6INDIRECT 33036570 ↗ — Implications of COVID-19 in high burden countries for HIV/TB: A systematic review of evidence
  • T6INDIRECT 32454187 ↗ — Review of trials currently testing treatment and prevention of COVID-19
  • T6INDIRECT 35316551 ↗ — A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendat
  • T6INDIRECT 35752132 ↗ — Acute ischemic stroke and vaccine-induced immune thrombotic thrombocytopenia post COVID-19 vaccinati
  • T6INDIRECT 36098903 ↗ — Guillain-Barré syndrome in association with COVID-19 vaccination: a systematic review
  • T6 36695182 ↗ — Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association
  • T6 33753937 ↗ — Post-acute COVID-19 syndrome
  • T6 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
  • T6INDIRECT 34542573 ↗ — Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephaliti
  • T6INDIRECT 32840686 ↗ — Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cas
  • T6INDIRECT 32855289 ↗ — Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six month
  • T6INDIRECT 33949300 ↗ — Guillain Barre Syndrome as a Complication of COVID-19: A Systematic Review
  • T2 31782181 ↗ — Randomized Placebo-Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy
  • T6INDIRECT 23168581 ↗ — Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: a ra
  • T2 21745374 ↗ — Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated
  • T2 8774401 ↗ — Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal auto
  • T6 31541214 ↗ — Diagnosis and management of Guillain-Barré syndrome in ten steps
  • T6INDIRECT 23633371 ↗ — Interventions for treating pain and disability in adults with complex regional pain syndrome
  • T6INDIRECT 32653054 ↗ — Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally a
  • T6INDIRECT 38264914 ↗ — 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6INDIRECT 32201335 ↗ — Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID
  • T6INDIRECT 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6INDIRECT 34281357 ↗ — Myocarditis With COVID-19 mRNA Vaccines
  • T6INDIRECT 33903743 ↗ — Systemic and organ-specific immune-related manifestations of COVID-19
  • T6 36707719 ↗ — The role of platelets in immune-mediated inflammatory diseases
  • T6 39326415 ↗ — Mechanisms of long COVID and the path toward therapeutics
  • T6 33219837 ↗ — Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological
  • T6 34716418 ↗ — Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison
  • T6 34454673 ↗ — 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study
  • T6INDIRECT 24462240 ↗ — Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a c
  • T6INDIRECT 30218025 ↗ — Mechanisms, biomarkers and targets for adult-onset Still's disease
  • T6 23642721 ↗ — Guillain-Barré syndrome and variants
  • T6 33894193 ↗ — Challenges in the diagnosis of Parkinson's disease
  • T6 26659576 ↗ — Neurotropic virus infections as the cause of immediate and delayed neuropathology
  • T6 30285773 ↗ — Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
probiotics
T2
T2 — RCT in related condition
RegisteredLong COVIDME/CFS
49 sources
  • T2REGISTERED-ONLY NCT03773003 ↗ — Research for Pathophysiology of Cancer Related Fatigue (CRF) and Chronic Fatigue (CFS/ME)
  • T6 30721959 ↗ — Mechanisms of Action of Probiotics.
  • T6 29976412 ↗ — Benefaction of probiotics for human health: A review.
  • T6INDIRECT 35057437 ↗ — Effectiveness of Curcumin on Outcomes of Hospitalized COVID-19 Patients: A Systematic Review of Clin
  • T6INDIRECT 34791425 ↗ — The role of vitamin B12 in viral infections: a comprehensive review of its relationship with the mus
  • T6INDIRECT 34131481 ↗ — Global prevalence of prolonged gastrointestinal symptoms in COVID-19 survivors and potential pathoge
  • T6INDIRECT 39603702 ↗ — Interventions for the management of long covid (post-covid condition): living systematic review
  • T6INDIRECT 39774607 ↗ — Mucosal immune response in biology, disease prevention and treatment
  • T6INDIRECT 36349400 ↗ — Clinical trials on the pharmacological treatment of long COVID: A systematic review
  • T6INDIRECT 35409389 ↗ — Benefits and Implications of Resveratrol Supplementation on Microbiota Modulations: A Systematic Rev
  • T6INDIRECT 35893864 ↗ — The Efficacy of Vitamin D Supplementation in the Treatment of Fibromyalgia Syndrome and Chronic Musc
  • T6INDIRECT 38424099 ↗ — Effect of gut microbiome modulation on muscle function and cognition: the PROMOTe randomised control
  • T6INDIRECT 39073834 ↗ — Fecal Microbiota Transplantation for Treatment of Parkinson Disease: A Randomized Clinical Trial
  • T6 36639608 ↗ — Long COVID: major findings, mechanisms and recommendations
  • T6 39866113 ↗ — 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Ass
  • T6INDIRECT 30480772 ↗ — Fecal transplantation for treatment of inflammatory bowel disease
  • T6INDIRECT 25793197 ↗ — The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inf
  • T2 25400447 ↗ — Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the
  • T6INDIRECT 23842110 ↗ — Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut
  • T6INDIRECT 28943228 ↗ — Effect of Lactobacillus rhamnosus HN001 in Pregnancy on Postpartum Symptoms of Depression and Anxiet
  • T6INDIRECT 27208120 ↗ — Fermented Milk Containing Lactobacillus casei Strain Shirota Preserves the Diversity of the Gut Micr
  • T6INDIRECT 35654766 ↗ — Clinical, gut microbial and neural effects of a probiotic add-on therapy in depressed patients: a ra
  • T2 31478755 ↗ — Probiotics for Gastrointestinal Symptoms and Quality of Life in Autism: A Placebo-Controlled Pilot T
  • T6INDIRECT 31752370 ↗ — Effect of <i>Lactobacillus plantarum</i> TWK10 on Exercise Physiological Adaptation, Performance, an
  • T6 32582143 ↗ — The Genus <i>Alistipes</i>: Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Men
  • T6 30317530 ↗ — An insight into gut microbiota and its functionalities
  • T6INDIRECT 37451743 ↗ — Faecalibacterium: a bacterial genus with promising human health applications
  • T6INDIRECT 36271144 ↗ — Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications
  • T6INDIRECT 34328636 ↗ — Post-COVID-19 acute sarcopenia: physiopathology and management
  • T6INDIRECT 36364899 ↗ — A Comprehensive Review on Nutraceuticals: Therapy Support and Formulation Challenges
  • T6INDIRECT 36851614 ↗ — Persistent SARS-CoV-2 Infection, EBV, HHV-6 and Other Factors May Contribute to Inflammation and Aut
  • T6INDIRECT 36385449 ↗ — Neuropsychiatric aspects of long COVID: A comprehensive review
  • T6 37130947 ↗ — Metformin: update on mechanisms of action and repurposing potential
  • T6 39326415 ↗ — Mechanisms of long COVID and the path toward therapeutics
  • T6 33909761 ↗ — Brazilian Guidelines of Hypertension - 2020
  • T6 34366606 ↗ — Pancreatic cancer: A review of epidemiology, trend, and risk factors
  • T6INDIRECT 21871249 ↗ — Treating Clostridium difficile infection with fecal microbiota transplantation
  • T6INDIRECT 25402818 ↗ — The gut microbiome and the brain
  • T4 32010640 ↗ — How Probiotics Affect the Microbiota
  • T6INDIRECT 28503135 ↗ — The Gut Microbiota and Autism Spectrum Disorders
  • T4 28555037 ↗ — Evidence of the Anti-Inflammatory Effects of Probiotics and Synbiotics in Intestinal Chronic Disease
  • T6INDIRECT 25365763 ↗ — Interoceptive dysfunction: toward an integrated framework for understanding somatic and affective di
  • T6 24092857 ↗ — Recent advances in understanding enteric pathogenic Escherichia coli
  • T6 23759244 ↗ — Psychobiotics: a novel class of psychotropic
  • T6 31076401 ↗ — Leaky gut: mechanisms, measurement and clinical implications in humans
  • T6 26528128 ↗ — Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatr
  • T6 29276734 ↗ — Stress & the gut-brain axis: Regulation by the microbiome
  • T6 25392516 ↗ — Gut microbes and the brain: paradigm shift in neuroscience
  • T6 27159638 ↗ — Irritable bowel syndrome
Pathological sequelae of long-haul COVID
T4
T4 — Case series
Long COVID
7 sources
  • T6 35105985 ↗ — Pathological sequelae of long-haul COVID.
  • T6 36148558 ↗ — Neurological post-acute sequelae of SARS-CoV-2 infection
  • T6INDIRECT 35464182 ↗ — Case Report: Therapeutic and immunomodulatory effects of plasmapheresis in long-haul COVID
  • T6 36288544 ↗ — Multimodal neuroimaging in post-COVID syndrome and correlation with cognition
  • T6 37395896 ↗ — Knowledge mapping of COVID-19 and autoimmune diseases: a visual and bibliometric analysis
  • T6INDIRECT 40098132 ↗ — Abstracts of the 35th Meeting of the German Society for Pediatric and Adolescents Rheumatology (Gese
  • T4 PMC9548758 ↗ — SLEEP-DISORDERED BREATHING AND LONG-HAUL COVID-19: A CASE REPORT
Overview of Biological Factors That May Contribute to Persistent Symptoms
T6
T6 — Mechanistic / preclinical
Long COVID
7 sources
  • T6 34248921 ↗ — Long COVID or Post-acute Sequelae of COVID-19 (PASC): An Overview of Biological Factors That May Con
  • T6INDIRECT 41869328 ↗ — Global trends in research of neuroimmune in lung diseases over past decade: a bibliometric analysis
  • T6 36169154 ↗ — Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of aut
  • T6 37395896 ↗ — Knowledge mapping of COVID-19 and autoimmune diseases: a visual and bibliometric analysis
  • T6 38293444 ↗ — Visual analysis of hotspots and trends in long COVID research based on bibliometric
  • T6 36846620 ↗ — Stress, Asthenia, and Cognitive Disorders
  • T6 36818497 ↗ — [Genomics in Public Health Scientific evidence and prospects for integration in the prevention pract

Cite this page

Reusing these data? Please cite the tracker so others can find the source.

Open Source Medicine Foundation. (2026). Long COVID / PASC Therapeutic Evidence. Research Tracker. https://research.opensourcemed.info/therapeutic-agents-long-covid.html (accessed )

Weekly post-viral research digest

New peer-reviewed studies and trial activity across Long COVID, ME/CFS, PACVS, Lyme and Gulf War Illness, every week. Free, no spam.

Subscribe on Substack   Browse the digest archive · RSS

OSMF Therapeutic Evidence Grading Methodology v1.0 · ClinicalTrials.gov v2 API & Europe PMC · Pipeline run: 2026-07-02

vitalscan4pacvs.study · opensourcemed.info · contact@opensourcemed.info